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Peptidylglycine α-amidating monooxygenase (PAM) is a secretory granule membrane protein 
whose luminal enzymatic domains catalyze the Cu-dependent amidation biosynthetic step 
common to many neuroactive peptides. Aside from its essential role as the sole mammalian 
amidating enzyme, PAM alters Cu homeostasis, modulates transcription and regulates 
secretory granule trafficking. The model of PAM haploinsufficiency employs mice heterozygous 
for the Pam gene (PAM+/-); the mice show anxiety-like disorders and deficiencies in fear learning 
and memory. We performed whole-cell recordings of pyramidal neurons in the PAM+/- amygdala 
to elucidate neurophysiological correlates of the fear behavioral phenotypes. Consistent with 
these observations, thalamic afferent synapses in the PAM+/- lateral nucleus were deficient in 
long-term potentiation (LTP). This deficit was apparent in the absence and presence of the 
GABAA receptor antagonist picrotoxin and was abolished when both GABAA and GABAB 
receptors were blocked. Dietary Cu supplementation rescued the cued learned-fear deficits of 
PAM+/- mice, with little effect on the behaviors of wildtype mice. Dietary Cu supplementation also 
corrected the LTP deficit of PAM+/- mice in vitro. Bath application of the extracellular specific Cu 
chelator bathocuproine disulfonate abolished LTP in wildtype and PAM+/- amygdalae, 
demonstrating a vital role for Cu in amygdalar synaptic plasticity. Dietary Cu supplementation 
Eric Dean Gaier – University of Connecticut, 2013 
had no effect on brain Cu or PAM levels, therefore PAM+/- behavioral deficiencies do not result 
from insufficient Cu and/or PAM. Localization of the major neuronal Cu transporter, ATP7A, was 
altered in the PAM+/- brain. In addition, quantitative PCR revealed region-specific deficits in 
Atox-1 and ATP7A that may account for the physiological and behavioral defects associated 
with PAM heterozygosity. These data indicate that Cu is necessary for normal amygdalar 
synaptic function, suggesting the PAM+/- behavioral and physiological phenotype stems from 
dysregulated Cu secretion. Additional studies include analyses of serum Cu and PAM in a 
population of frail elderly men and electrophysiological study of hippocampal and nucleus 
accumbens neuronal membrane and synaptic properties in Kalirin7 null mice. Future directions 
to test the hypothesis of a direct role for PAM in regulating neuronal Cu secretion and explore 
the essential role of Cu at amygdala afferent synapses are outlined.  
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PAM and the PAM heterozygote model 
Peptides are among the most diverse and primitive signaling molecules in the animal 
kingdom. In contrast to small molecule neurotransmitters such as glutamate and -
aminobutyric acid (GABA), peptides are packaged into large dense core vesicles whose 
release is governed separately from that of small synaptic vesicles (Zupanc, 1996;Salio 
et al., 2006;Tallent, 2008). Whereas small synaptic vesicle release mediates fast 
synaptic transmission, large dense core vesicles have higher activity thresholds for 
release and their contents typically modulate neuronal activity and fast synaptic 
transmission (Tallent, 2008). Despite their diversity, many peptides share a common 
biosynthetic pathway. It is estimated that about half of all bioactive peptides are 
amidated (Eipper and Mains, 1988;Eipper et al., 1992). Peptidylglycine α-amidating 
monooxygenase (PAM) is the sole source of amidating activity to complete this essential 
reaction in mammals (Czyzyk et al., 2005a). In many cases, amidation is required to 
confer full biological activity related to optimal G-protein coupled receptor binding (Eipper 
et al., 1992). 
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PAM has two luminal enzymatic domains (peptidylglycine α-hydroxylating 
monooxygenase, PHM, and peptidyl-α-hydroxyglycine α-amidating lyase, PAL) that act 
sequentially to catalyze the cleavage of a C-terminal glycine at the N-Cα bond, creating 
an amide (-NH2). Two copper (Cu) ions are bound by the PHM enzyme and serve in 
electron transfer (Prigge et al., 2000). Two ascorbates act as reducing agents and 
molecular dioxygen contributes to water and glyoxylate products. PAL typically uses one 
Zn ion for catalysis (although other metals may substitute) and one calcium ion for 
structure. Various peptides are differentially affected by ascorbate and Cu availability 
presumably related to tissue-specificity and precursor sequence (Eipper and Mains, 
1988;Eipper et al., 1992). The complete reaction is depicted in Fig. 1-1.  
PHM and PAL are encoded by separate genes in lower organisms such as Cnidaria and  
Drosophila (Williamson et al., 2000;Kolhekar et al., 1997). In mammals, including mice 
and humans, the single PAM gene (located on chromosome 1 in mice and 5 in human) 
encodes a single protein with both enzymatic domains and is the exclusive source for 
amidating enzymatic activity in the body (Czyzyk et al., 2005a). Cu is delivered to PHM 
within the secretory pathway via Menkes disease protein ATP7A, which receives 
cytosolic Cu from Atox-1 (Fig. 1-2). 
Homozygous knockout of the Pam gene (PAM-/-) is lethal at E14.5 in mice (Czyzyk et al., 
Figure 1-1. Peptide amidation chemistry. PAM catalyzes the two-step reaction of 
C-terminal α-amidation. The monooxygenase, PHM, requires 2 Cu ions to 
hydroxylate the α carbon of the C-terminal glycine. Molecular oxygen and 2 
ascorbates are also required for hydroxylation. The lyase, PAL, uses Zn to catalyze 
the cleavage step to yield an amidated product and glyoxylate. Adapted from (Prigge 
et al., 1997). 
-- 
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2005a). PAM-/- mice die in utero with profound edema, a phenocopy of the mice with 
genetic deficiency of adrenomedullin (Czyzyk et al., 2005a). This is not surprising since 
adrenomedullin is an amidated peptide involved in maintaining vascular integrity and 
development (Czyzyk et al., 2005a;Caron and Smithies, 2001). Mice heterozygous for 
the Pam gene (PAM+/-) exhibit half of normal amidating activity and grow and reproduce 
normally, but exhibit striking physiological and behavioral abnormalities. PAM+/- mice 
display increased adiposity and impaired glucose tolerance at 10 month of age (Czyzyk 
et al., 2005a). PAM+/- mice are unable to maintain their body temperature in the cold 
(Bousquet-Moore et al., 2009), resulting from a combination of deficiencies in 
vasoconstriction and shivering (Bousquet-Moore et al., 2010b). Neurologically, PAM+/- 
Figure 1-2. PAM schematic. (left) PAM localizes to the secretory pathway of 
neuroendocrine cells. It is present in the endoplasmic reticulum (ER), golgi apparatus, 
and secretory granules that comprise the secretory pathway. PAM requires Cu for its 
catalytic activity. Cu enters cells through the Cu transporter CTR1. Cu is delivered to 
PAM by the cytosolic chaperone Atox-1 and the P-type ATPase ATP7A (not shown). 
The cytosolic domain of PAM is cleaved to yield a soluble fragment (sfCD), which 
enters the nucleus and can up-regulated expression of Atox-1. (right) Cleavage of 
PAM-1 can occurr between the enzymatic domains PHM and PAL. Sequential 
cleavage between PAL and the TMD, followed by cleavage within the TMD by γ-
secretase yields soluble PHM/PAL and the sfCD. The cytosolic domain of PAM is 
multiply phosphorylated.  
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mice are hyper-sensitive to the GABAA receptor antagonist pentylenetetrazol, displaying 
more severe seizure behaviors at lower doses than their wildtype littermates. They also 
display more anxiety-like behaviors in the elevated-zero maze (Bousquet-Moore et al., 
2010b).  
The PAM+/- phenotype could result from a deficiency in amidated neuropeptides through 
a reduction in amidating activity, but this is unlikely to be the case. Levels of amidated α-
melanocyte stimulating hormone, joining peptide and cholecystokinin are not significantly 
altered in postnatal or adult PAM+/- hypothalami (Czyzyk et al., 2005a). Even for glycine-
extended thyrotropin releasing hormone (TRH-Gly), a particularly poor PHM substrate 
due to its penultimate proline residue, PAM heterozygosity imposes only a modest 
increase in TRH-Gly levels (Bousquet-Moore et al., 2010b). This suggests that the 
mechanism of the PAM+/- phenotype likely results from alterations outside of amidating 
activity. 
Indeed PAM plays functional roles outside of amidation that involve Cu homeostasis [for 
review see (Bousquet-Moore et al., 2010a)]. Over-expression of PAM in a pituitary 
corticotropic cell line reorganizes the actin cytoskeleton, blocks regulated secretion of 
even non-amidated peptides and impairs normal secretory granule maturation and 
localization (Ciccotosto et al., 1999). These effects are mediated through the cytosolic 
domain of PAM (Alam et al., 2001) which can be cleaved to yield a soluble fragment 
(sfCD) that localizes to the nucleus (Fig. 1-2) (Rajagopal et al., 2009;Francone et al., 
2010). PAM over-expression in a corticotropic cell line increases transcription of Atox-1 
(Francone et al., 2010) and Atox-1 mRNA is reduced in the PAM+/- pituitary (Bousquet-
Moore et al., 2010b). Cu can regulate the cleavage and recycling of PAM (De et al., 
2007) and could therefore have important effects on sfCD signaling. High Cu reduces 
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the cleavage and secretion of PHM, and increases the degradation of endocytosed PAM 
to the secretory pathway (De et al., 2007). This bidirectional interaction clearly 
demonstrates a non-enzymatic role for PAM in Cu homeostasis. 
It was originally speculated that any deficit in amidating activity associated with PAM 
heterozygosity could be improved by supplementing Cu or recapitulated in wildtype mice 
by restricting Cu through the diet and thus decreasing PAM activity (Bousquet-Moore et 
al., 2010b). While our hypothesis for how PAM heterozygosity mediates its effects on 
physiology and behavior have since diverged from amidation, the experiments testing 
PAM+/- rescue and wildtype recapitulation of the PAM+/- phenotype yielded intriguing 
results. For dietary Cu supplementation, mice were given 300 parts per million (ppm; 1.2 
mM) of CuSO4 in the drinking water for 8-14 days. Despite the fact that amidation was 
not dramatically reduced in PAM+/- mice or influenced by dietary Cu supplementation, 
dietary Cu supplementation rescued temperature regulation, vasoconstriction 
impairments and anxiety-like behaviors in PAM+/- mice with little effect on wildtype mice. 
However, dietary Cu supplementation had no influence on the increased seizure 
susceptibility of PAM+/- mice. For dietary Cu restriction, mice were placed on specialized 
food with 25-fold less Cu than control food. Wildtype temperature regulation, 
vasoconstriction, anxiety-like behavior and seizure susceptibility all declined with dietary 
Cu restriction, whereas PAM+/- performance was relatively unaffected. Moreover, the 
hypothesis of PAM+/- physiological and behavioral impairment rescue with dietary Cu 
supplementation and recapitulation in wildtype mice with dietary Cu restriction was 
confirmed. If the mechanisms for the impairments exhibited by PAM+/- mice do not 
involve amidation, these data strongly suggest they involve Cu.  
When I began my graduate work, a set of preliminary data from the laboratory of our 
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collaborator, Dr. William C. Wetsel at Duke University, was completed on wildtype and 
PAM+/- mice sent from our lab. These data indicated that PAM+/- mice display increased 
anxiety-like behaviors and a marked deficit in learned fear behaviors. This paradox in 
altered fear expression intrigued me, so I took on the task of elucidating the neural basis 
for the PAM+/- fear phenotype primarily using electrophysiology as the main focus of my 
thesis project.  
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The amygdaloid complex 
The expression of anxiety-like behaviors and fear associated learning and memory both 
involve the amygdala – a group of limbic nuclei situated in the medial temporal lobe of 
the mammalian brain [for review see (Sah et al., 2003;Ledoux, 2000;Maren and Quirk, 
2004;Pare et al., 2004;LeDoux, 2007;Perez de la et al., 2008)]. Research concerning the 
amygdala is rapidly expanding in the fields of neuroscience and psychiatry. Despite the 
complexity and heterogeneity of its structure, the amygdaloid complex and the nuclei 
that comprise it house the simplest and most accessible neural correlate of learning and 
memory to date (LeDoux, 2007;Sah et al., 2008).  
The vast majority of nuclei and subnuclei are conserved throughout mammalian species 
(Moreno and Gonzalez, 2007), making the amygdala a very attractive region for brain-
behavior study applicable to human disease (Sah et al., 2008). The basolateral 
amygdaloid complex, comprised of the lateral (LA) and basolateral (BLA) nuclei, 
receives afferents from many different cortical and subcortical (thalamic) regions and is 
thus considered the input region of the amygdala (Fig. 1-3). The central amygdala group 
(CeA) receives glutamatergic fibers from LA and BLA principal neurons and acts as the 
major output region of the amygdala. GABAergic projections from CeA extend to 
hypothalamic and brain stem nuclei to drive fear and anxiety-like behaviors. The freezing 
behavior relevant to fear conditioning is mediated through GABAergic projections from 
the CeA to the periaqueductal gray in the midbrain (Pare et al., 2004). Local 
interneuronal and paracapsular GABAergic cells mediate tight feed-forward and feed-
back inhibition of excitatory signals through the amydaloid complex (Marowsky et al., 
2005;Jungling et al., 2008). While a solid framework of amygdala circuitry has been 
established, it is unclear how the physiology underlying the inputs onto and 
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interconnections between amygdala nuclei mediate fear and anxiety-like behaviors.  
Plasticity at glutamatergic afferent synapses onto LA pyramidal neurons is widely 
thought to underlie discrete associative fear learning [for review see (Ledoux, 
2000;Maren and Quirk, 2004;Kim and Jung, 2006;Sigurdsson et al., 2007;Sah et al., 
2008)]. Fear conditioning is a form of classical Pavlovian learning wherein a neutral, 
conditioned stimulus, acquires emotional valence following its temporal pairing with an 
aversive, unconditioned stimulus. During training, strong excitatory neural signals 
reaching the LA convey information concerning the conditioned and unconditioned 
stimuli. It is thought that these signals trigger synaptic changes while eliciting fear 
CeA
BLA
LA
Cortical 
afferents
Thalamic 
afferents
Input
Intra-Amygdala 
Connections
Output
Thalamic
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Inter-
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Figure 1-3. Amygdala circuitry schematic. (left) Infrared differential interference 
contrast image of the amygdala under low power. Thalamic and cortical glutamatergic 
inputs impinge on the lateral nucleus (LA). Those signals are processed and 
projected to the basolateral nucleus (BLA) and central nucleus (CeA). From CeA, 
GABAergic projection neurons trigger fear behaviors via down-stream targets in the 
midbrain and brainstem. (right) Both cortical and thalamic afferent fibers terminate on 
the same dendrites of LA pyramidal neurons as well as on local GABAergic 
interneurons which mediate feed-forward inhibition. In this way, excitatory inputs 
through both pathways are regulated by GABAergic inhibition.  
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behavior during training. Moreover, whereas the conditioned stimulus was formerly 
unable to drive fearful behavior before training, subsequent presentations are sufficient 
to elicit fear responses due to specific enhancement in synapses representing the 
conditioned stimulus. Synaptic changes elicited in the LA are thought to mediate cue-
dependent fear while changes in the BLA are thought to mediate context-, hippocampal-
dependent fear (Calandreau et al., 2005;Reijmers et al., 2007). Due to the relative 
simplicity of the circuitry involved, auditory cue-dependent fear conditioning in the LA is 
more widely studied. In this case, auditory conditioned stimulus information from the 
auditory thalamus reaches the LA through the fibers passing through the internal 
capsule and from auditory cortex through the external capsule (Weisskopf et al., 
1999;Huang and Kandel, 1998). Neural signals conveying the unconditioned stimulus 
come from the posterior intralaminar nucleus and the medial geniculate body of the 
thalamus (Lanuza et al., 2008). Both conditioned and unconditioned stimuli pathways 
are carried within thalamic afferents. The synapses contributed by thalamic versus 
cortical afferents impinging on LA pyramidal neuronal dendrites are morphologically, 
biochemically and functionally different (Humeau et al., 2005;Humeau and Luthi, 2007). 
Collaterals from cortical and thalamic afferents also impinge on the same population of 
local GABAergic interneurons within the LA (Szinyei et al., 2000) (Fig. 1-3), with 
thalamic inputs conveying stronger excitatory signals (Doyere et al., 2003;Shin et al., 
2006).  
Understanding the mechanisms of synaptic plasticity at amygdala afferent synapses 
holds great potential for elucidating the pathophysiology underlying psychiatric disorders 
of fear and anxiety (LeDoux, 2007;Mathew et al., 2008). Moreover, elucidating the 
synaptic basis for how fear memories are formed and stored is highly relevant to post-
traumatic stress disorder (Liberzon and Sripada, 2008). PAM mRNA is present in the 
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rodent amygdala at high levels as assessed by in situ hybridization (Schafer et al., 
1992a). In the context of the PAM+/- fear phenotype, investigating the role of PAM and 
Cu in amygdala function is likely to be important to this rapidly growing field of research. 
To date, there is no published work investigating the synaptic/physiological or behavioral 
roles of Cu in the amygdala.  
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Cu is a necessity for eukaryotic life and tightly regulated in complex organisms 
Copper (Cu) is an essential trace element whose ability to donate and accept electrons 
gives it great utility in multicellular life. Cu serves many functions in biology through 
oxidation-reduction reactions and its ability to bind and activate dioxygen. Cu is primarily 
found in nature in its cupric state (Cu2+) and can switch to the cuprous state (Cu1+) and 
back by accepting and donating an electron, respectively. It is believed that 
microorganisms evolved the ability to utilize Cu when oxygen became more prevalent in 
the atmosphere (Crichton and Pierre, 2001;Ridge et al., 2008). In this newly-formed 
oxidative environment, previously insoluble Cu1+ was converted to bioavailable Cu2+. 
Cleavage of dioxygen through reduction via Cu allowed these organisms to extract 
energy from fuels more efficiently. This critical evolutionary juncture coincided with the 
development of multicellular life (Decker and Terwilliger, 2000;Crichton and Pierre, 
2001). In addition, many Cu-containing enzymes have higher redox potentials than those 
of enzymes containing metals such as iron. An association between Cu and oxygen-
utilizing enzymatic reactions accompanied the appearance of Cu in biological systems.  
Cu-interacting proteins generally comprise less than 1% of an organism’s proteome 
(Andreini et al., 2008). These Cu-interacting proteins are divided into cuproenzymes, 
enzymes that bind and require Cu for their catalytic activity, and Cu-binding proteins. 
Transmembrane Cu transporters, chaperones that deliver Cu to cuproenzymes, and 
proteins that simply bind and sequester Cu are much more numerous than 
cuproenzymes. Only about a dozen cuproenzymes are encoded by the mammalian 
genome. This number pales in comparison to the number of enzymes that require other 
metals, like iron or zinc (Zn). The oldest cuproenzyme, cytochrome oxidase, evolved in 
bacteria and archaea and is involved in energy production (Ridge et al., 2008), 
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specifically in aerobic respiration which requires dioxygen. Many cuproenzymes are 
functionally and structurally conserved from yeast and worm to much more complicated 
organisms like mice and humans (Andreini et al., 2008). Interestingly, mammalian 
cuproenzymes span many biological functions, and most are not directly related to 
aerobic metabolism. For example, both PAM and dopamine β-monooxygenase (DβM) 
are biosynthetic cuproenzymes for signaling molecules and they appear only in 
multicellular organisms.  
However, the advantages of using Cu as an enzymatic co-factor come at a price. The 
same reactive properties that give Cu its utility pose a large risk for the generation of 
reactive oxygen species and subsequent oxidative cellular damage in uncontrolled 
settings (Uriu-Adams and Keen, 2005). Therefore, primitive organisms faced the 
challenge of getting Cu inside the cell while simultaneously limiting free/reactive Cu1+ 
levels. To meet this challenge, an intricate and highly refined network of binding proteins 
and transporters evolved, and its components and their interactions have yet to be fully 
characterized (Banci et al., 2010;Lutsenko, 2010).   
Kim and colleagues (Kim et al., 2010a) recently probed the breadth of the 
extracellular/inter-organ components of this network using a murine model for genetic 
cardiac-specific ablation of CTR1, a plasma membrane Cu transporter required for 
cellular Cu import. Cardiac tissue in these mice is Cu deficient, and the mice exhibit 
cardiac deficiencies like those seen in systemic Cu deficiency. Interestingly, there are 
also profound compensatory changes in the gut and liver, presumably aimed at 
increasing Cu uptake and liberating stored Cu. Kim and colleagues elegantly showed 
that these system-wide changes are mediated through an unidentified soluble factor 
released into the circulation. This study clearly demonstrates the presence and 
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physiological relevance of a multi-organ Cu regulatory pathway. While this is a ground-
breaking and very informative study, its clearest message is that the major mechanisms 
through which Cu status is communicated between organs and within a single cell are 
unclear and require further exploration. 
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Components of Cu homeostasis and specific cuproenzymes 
Cu uptake into the body through the gut is mediated primarily through CTR1 and, to a 
lesser extent, divalent metal transporter 1 (DMT1) (Lutsenko, 2010;Kaler, 2011). CTR1 
is located on the brush border of the small intestine where it imports Cu from various 
ingested food sources including legumes, liver, shellfish, nuts and chocolate (Linder and 
Hazegh-Azam, 1996;Ma and Betts, 2000). CTR1 is also a key molecule in the rest of the 
body involved in cellular Cu uptake into the cytosol. Cu then binds one of several 
cytosolic chaperones; each chaperone has a designated delivery destination for the Cu it 
carries. For example, antioxidant-1 (Atox-1, also called HAH1) is a chaperone that 
delivers Cu to the transporters that allow entry into the secretory pathway (Hamza et al., 
2001). In the case of enterocytes of the small intestine that take Cu up from the gut, 
Atox-1 is required for Cu entry into the portal circulation and delivery to the liver. Atox-1 
delivers Cu directly to P-type ATPase transmembrane transporters called ATP7A and 
ATP7B (Hamza et al., 2001;Lutsenko et al., 2007). The liver acts as the main storage 
site for Cu, and Cu can be mobilized to various organs in the body or eliminated by entry 
into the bile duct for subsequent excretion (Wijmenga and Klomp, 2004). Cu exported 
from the liver is typically loaded into newly synthesized ceruloplasmin, a Cu-dependent 
ferroxidase, and secreted into the circulation. Each ceruloplasmin molecule binds 6 Cu 
ions, and 75-95% of the Cu in the blood is bound to ceruloplasmin (Hellman and Gitlin, 
2002;Bielli and Calabrese, 2002). The remaining non-ceruloplasmin-bound Cu is bound 
to albumin or free amino acids such that very little free Cu is present in the circulation.  
Cu enters the brain through two routes, both involving CTR1 and ATP7A. The first route 
is through the blood-brain barrier, which serves as a regulated junction between the 
blood and the extracellular fluid of the brain. The second is through the blood-cerebral 
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spinal fluid (CSF) barrier, which serves as the junction between the blood and the CSF. 
The CSF fills the ventricles and subarachnoid space of the central nervous system. Both 
CTR1 and ATP7A are expressed by the endothelial cells that line the blood brain barrier 
and the epithelial cells of the choroid plexus (Choi and Zheng, 2009;Kaler, 2011).   
The cuproenzyme required for aerobic metabolism mentioned earlier is cytochrome c 
oxidase (COX). Also known as Complex IV of the electron transport chain, COX is 
comprised of 13 protein subunits in mammals, including the Cu-binding subunit Cox11. 
COX is located in the inner mitochondrial membrane and transfers 4 electrons, delivered 
from upstream Complexes I-III, to 2 protons and dioxygen to form 2 water molecules. In 
the process, COX pumps 4 protons across the inner mitochondrial membrane to 
contribute to the gradient that drives ATP biosynthesis and generation of heat. To 
accomplish this, each COX complex requires 2 molecules of Cu, which shuttle electrons 
between substrates. COX receives Cu from cytosolic Cu chaperones Cox17, Cox11 and 
Sco1 (Fig. 1-4).  
Superoxide dismutases (SODs) convert superoxide into oxygen and hydrogen peroxide. 
Intracellular (SOD1 and SOD2) and extracellular (SOD3) forms are encoded by 3 
separate genes in mammals. Cytosolic Cu/Zn SOD1 is a heterodimer with one 
component containing Cu and the other Zn. Although other metals may substitute for Zn, 
no other metals can substitute for Cu (Harris, 1992). Both metals interact to convert 
superoxide (O2-) to hydrogen peroxide (H2O2), reducing damaging oxidative potential. 
Unlike SOD1 and SOD3 which use Cu and Zn, SOD2 contains manganese at its active 
site. SOD1 is the only cytosolic cuproenzyme, and SOD2 is found in the intermembrane 
space of mitochondria. Extracellular SOD3 is secreted through a regulated pathway 
(Jeney et al., 2005). As such SOD1 and SOD3 receive Cu through separate intracellular 
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pathways (Fig. 1-4); SOD1 receives Cu from the Cu chaperone for SOD (CCS) while 
SOD3 receives Cu through Atox-1 and the P-type ATPase transmembrane Cu 
transporters ATP7A and ATP7B (Jeney et al., 2005). Mutations in Cu/Zn SOD1 have 
been linked with familial forms of Amyotrophic Lateral Sclerosis, a progressive 
neurodegenerative disease specifically affecting motor neurons. Interestingly, these 
mutations do not impair SOD1 enzymatic function [for review see (Rothstein, 2009;Vucic 
and Kiernan, 2009)].  
Lysyl oxidase, another essential cuproenzyme, uses molecular oxygen to catalyze 
oxidative deamination of lysine and hydroxylysine, facilitating the cross-linking of 
collagen and elastin. As might be inferred from its enzymatic function, lysyl oxidase is 
very important in connective tissue construction and maintenance, especially in skin, 
Figure 1-4. Schematic summarizing relevant curpoenzymes. (left) Cu enters cells 
through CTR1. Intracellular Cu is buffered by metallothioneins (MLTs). Designated Cu 
chaperones deliver Cu to specific cuproenzymes within or pump Cu directly into their 
respective organelles. Cox17, Cox11 and Sco1 deliver Cu to cytochrome c oxidase 
(COX) in mitochondria. Cytosoloic superoxide dismutase (SOD1) receives Cu through 
the Cu chaperone for SOD (CCS). Atox-1 delivers Cu to the secretory pathway. (right) 
Cu enters the secretory pathway within cells via a P-type ATPase such as ATP7A. 
Several curpoenzymes are present in the secretory pathway including dopamine-β-
monooxygenase (DβM), extracellular SOD (SOD3), lysyl oxidase (not shown) and 
PAM.  
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bone and cardiovascular tissues (Kagan and Li, 2003;Lucero and Kagan, 2006). Much 
like SOD3, the lysyl oxidase proenzyme receives Cu through Atox-1 and ATP7A (Fig. 1-
4). Upon secretion, the proenzyme is cleaved by a metalloproteinase yielding a 32 kDa 
mature, active enzyme and a smaller propeptide (Trackman et al., 1992;Smith-Mungo 
and Kagan, 1998). The reaction for which lysyl oxidase is responsible takes place 
extracellularly and requires 1 Cu ion, for which no other metal can substitute (Smith-
Mungo and Kagan, 1998). Lysyl oxidase also requires a covalently bound carbonyl 
cofactor, lysyltyrosine quinine, which is formed through autocatalytic hydroxylation and 
oxidation. 
Tyrosinase is found ubiquitously throughout nature but is best known for its role in the 
biosynthesis of melanin pigments, which are found in hair and skin. Tyrosinase is a 
monophenol monooxygenase which requires 2 Cu ions per enzyme (Olivares and 
Solano, 2009). Tyrosinase, a membrane glycoprotein whose topology closely resembles 
that of PAM, receives Cu via ATP7A (Setty et al., 2008). As its name suggests, a major 
phenol substrate of tyrosinase is L-tyrosine which is converted to L-DOPA and 
subsequently to L-dopaquinone by a related enzyme. Tyrosinase is expressed in the 
substantia nigra and locus coeruleus, two catecholaminergic centers located in the 
mammalian midbrain and brain stem, respectively. This likely accounts for the 
characteristic pigmentation of these nuclei. 
Dopamine β-monooxygenase (DβM) is a hydroxylating enzyme that shares sequence 
similarity with PHM (Klinman, 2006) and plays a vital role in catecholamine biosynthesis 
in adrenergic cells. DβM catalyses the hydroxylation of dopamine to make 
norepinephrine, requiring molecular oxygen and ascorbate as cofactors (Klinman, 
2006;Prigge et al., 2000). It is expressed in adrenergic neurons of the locus coeruleus 
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and chromaffin cells of the adrenal medulla. It is a membrane-bound tetramer that 
localizes to synaptic/secretory vesicles (Fig. 1-4) (Rush and Geffen, 1980). 
Norepinephrine is an important neurophysiological and endocrine modulator whose 
signaling regulates membrane excitability, synaptic plasticity, vascular tone, cardiac 
contractility, and many other physiological and cognitive functions.  
Cuproenzymes clearly play a very large diversity of essential roles that involve multiple 
inter-dependent organ systems including signaling molecular biosynthesis, structure, 
metabolism, pigmentation, and protection from oxidative stress (see Fig. 1-4 for a 
summary of cuproenzymes). Given the tremendous utility and potential dangers of Cu in 
biological systems, it is not surprising that evolution has equipped us with such an 
intricate network of homeostatic mechanisms. Importantly, striving to identify the 
components of that network and elucidate their interactions is paramount in advancing 
our understanding of and treatments for a range of diseases in which Cu 
handling/homeostasis is disrupted.  
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Genetic disorders of Cu regulation 
The necessity for Cu and the potential for Cu toxicity are most clearly demonstrated 
through the symptoms associated with genetic disorders of Cu transport and dietary Cu 
deficiency/toxicity. The two major genetic disorders, Menkes and Wilson’s disease, 
involve dysfunction of the P-type (auto-phosphorylating) ATPase transporters ATP7A 
and ATP7B, respectively. While each protein can transport Cu into the secretory 
pathway, the pathophysiologies of these two diseases are quite different, reflecting the 
distinct roles of the two transporters at cell- and tissue-specific levels.  
Menkes disease is an X-linked recessive disorder first characterized by John Hans 
Menkes in 1962 as an inherited form of Cu deficiency (Menkes et al., 1962)[OMIM 
309400; for review see (Kodama et al., 1999;de Bie et al., 2007;Kaler, 2011)]. 
Identification of the affected gene, ATP7A, was accomplished three decades later by 
positional cloning (Mercer et al., 1993). Naturally occurring mutations in the human 
ATP7A gene span the full length of the protein and impair Cu transport function to 
varying extents (Kaler, 2011). The Menkes gene is a known hot-spot for spontaneous 
mutations, so about 1/3 of ATP7A mutations arise de novo (Kaler, 1998). Infants born 
with Menkes disease typically begin to exhibit developmental delay and failure to thrive a 
few months after birth. Symptoms progress until death around 3 years of age. 
Symptomology associated with Menkes disease results from Cu deficiency in multiple 
organs and directly reflects deficient activities of specific cuproenzymes. 
Impaired cross-bridging due to lysyl oxidase insufficiency impairs the tensile strength of 
collagen fibers and the recoil ability of elastin fibers. This manifests as brittle bones, 
weakened, aneurysm-prone arteries and heart, loose skin and kinky, brittle hair which is 
characteristic of Menkes disease. Scarcity of melanin due to reduced tyrosinase activity 
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leads to the steely coloring of hair and pale skin that are also common in Menkes 
disease presentations. Deficiency in PAM activity may also contribute since α-
melanocyte stimulating hormone is an amidated peptide. Reduced COX activity 
contributes to muscle weakness and hypothermia of Menkes patients through insufficient 
ATP availability. Impaired function of ceruloplasmin, a ferroxidase, results in iron 
deficiency and anemia. Deficiency of DβM and PAM activity could both contribute to 
hypothermia through reductions in catecholamine signaling and impaired biosynthesis of 
thyrotropin-releasing hormone, respectively.  
Seizures are very common and seizure occurrence and severity are typically progressive 
through the course of the disease (Kodama et al., 1999;de Bie et al., 2007;Kaler, 2011). 
Deficiencies of both DβM and PAM could contribute to the seizure susceptibility through 
shifts in excitatory-inhibitory balances caused by deficiencies in catecholaminergic and 
peptidergic neuromodulators, respectively. Norepinephrine has potent anti-convulsive 
effects (Mason and Corcoran, 1978;Mason and Corcoran, 1979), and destruction of 
noradrenergic neurons of the locus coeruleus or genetic deletion of DβM lowers the 
threshold for epileptogenic stimuli in limbic structures (Mishra et al., 1994;Szot et al., 
1999). Alterations in noradrenergic tone likely shift excitatory-inhibitory balances. 
Disruption of noradrenergic tone could influence the threshold for runaway excitation in a 
given neural network and lead to epileptiform activity. GABAergic interneurons express 
and secrete a number of neuropeptides (McDonald and Pearson, 1989;Salio et al., 
2006), many of which tend to promote inhibition and/or reduce excitation [for review see 
(Bajorek et al., 1986;Zadina et al., 1986)]; examples include neuropeptide Y, 
cholecystokinin, thyrotropin releasing hormone and vasopressin (see Chapter 2 
Discussion). Reduced activity of PAM due to Cu insufficiency leads to tissue-specific 
impairments in amidation, and thus reduced bioactivity, of these inhibitory peptides 
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(Bousquet-Moore et al., 2010b). Death usually results from opportunistic infection or a 
devastating vascular event. 
Menkes disease-like manifestations have been reported in rodent models of Cu 
deficiency [for review see (Vonk et al., 2008)]. There are seven mouse lines with 
mutations in ATP7A that are collectively referred to as mottled mice. Some of the 
mottled mutations are embryonic lethal while others allow the study of disease 
pathogenesis beyond the perinatal period. Just as in other ATP7A-related disorders, 
there is an inverse relationship between disease severity and residual ATP7A activity. 
The mottled brindled mouse exhibits a phenotype most similar to Menkes disease, 
including failure to thrive, seizures, hypopigmentation, kinky hair, and early post-natal 
lethality (Mann et al., 1979). Knockout animal models for CTR1 and Atox-1 are 
embryonic lethal (Kuo et al., 2001;Lee et al., 2001;Hamza et al., 2001), corroborating the 
essentiality of Cu cellular import and entrance into the secretory pathway.  
Wilson’s disease is an autosomal recessive disorder first characterized by Samual 
Alexander Kinnier Wilson in 1912 as an inherited degenerative disease of the liver and 
brain (Compston, 2009). By way of contrast to Menkes disease, manifestations of 
Wilson’s disease result from multiple organ dysfunction secondary to Cu overload and 
typically arise in adulthood. Dysfunction of the ATP7B protein results in an inability to 
excrete Cu from hepatocytes into the bile and out of the body. Cu builds up in the liver 
over time and is thought to periodically leak from the liver into the circulation resulting in 
its deposition in multiple organs. A striking example of such deposition is Kayser-
Fleischer rings, deposits of Cu in the cornea, which are clinically considered 
pathognomonic for Wilson’s disease (de Bie et al., 2007). Pathophysiology in Wilson’s 
disease primarily involves excessive oxidative stress directly resulting from Cu overload 
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in the liver and brain [OMIM 277900; for review see (Lutsenko, 2010;de Bie et al., 
2007;Pfeiffer, 2007;Fujiwara et al., 2006;Das and Ray, 2006)].  
Wilson’s disease typically presents with acute liver failure and its associated symptoms 
which may include hypoalbuminemia, impaired hemostasis and hepatic encephalopathy 
(de Bie et al., 2007). Liver cirrhosis with subsequent failure, portal hypertension and 
hepatocellular carcinoma are common. Hemolytic anemia is also common, likely 
resulting from episodes of extreme oxidative stress imposed by free Cu leakage into the 
blood from the liver (Attri et al., 2006). Excessive Cu deposits in the brain result in 
neurodegeneration, especially of lenticular structures associated with basal ganglia 
circuitry. As such, movement disorders and psychiatric manifestations are common. 
Extrapyramidal symptoms including oculomotor defects, ataxia, dysarthria, dystonic 
posturing and tremor are common (Das and Ray, 2006). Psychiatric disturbances may 
be severe enough for patients to reach diagnostic criteria for Axis I affective/mood and/or 
anxiety disorders (Pfeiffer, 2007). Not all psychiatric symptoms are likely to result from 
neurodegeneration; rather, the many influential effects of Cu on neuronal and synaptic 
physiologies no doubt contribute to the wide variation of psychiatric manifestations 
associated with Wilson’s disease. 
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Non-enzymatic roles of Cu in neurophysiology and behavior 
While genetic and dietary disorders of Cu homeostasis support the important role played 
by Cu as an enzymatic co-factor, Cu itself has recently been shown to play a role in cell 
signaling, specifically in the nervous system. Cu, like other metals such as Zn and Fe, 
are concentrated in the brain (Que et al., 2008). Cu concentration in brain tissue has 
been estimated to be between 80 and 100 µM, about 5-fold higher than that found in 
blood (Linder and Hazegh-Azam, 1996;Que et al., 2008;Prohaska, 1987). Only the liver 
and kidney have higher Cu concentrations than the brain, near 100 and 200 µM, 
respectively (Linder and Hazegh-Azam, 1996). Cu entry into the brain requires both 
CTR1 and ATP7A; both proteins are expressed in endothelial cells of the blood-brain 
barrier and on epithelial choroids plexus cells of the blood-CSF barrier (Choi and Zheng, 
2009). The intracellular concentration of brain Cu is 2-3 orders of magnitude above the 
extracellular concentration (Que et al., 2008), and there is 2-fold more Cu found in grey 
matter than white matter (Prohaska, 1987). Cu content is region-specific with the highest 
levels in the hypothalamus (Rajan et al., 1976). Subcellularly, Cu is most abundant in 
cytosolic and mitochondrial subcellular fractions. Cu can be released with neuronal 
activation in a calcium-dependent manner (Schlief et al., 2006;Dodani et al., 2011), 
much like glutamate. Cu can reach concentrations of 100-250 µM at synapses (Kardos 
et al., 1989), although these data are based on experiments run under conditions that 
were far from physiological. Nevertheless, the reactive biochemical properties of Cu at 
these concentrations prompts consideration of the many potential effects Cu could have 
on synaptic function under physiological conditions.  
Most of the work exploring the role of Cu in synaptic transmission and plasticity has 
been conducted in the hippocampus. ATP7A is expressed at high levels in the pyramidal 
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neurons and interneurons of the neocortex and hippocampus (Schlief et al., 2005;Niciu 
et al., 2006), where Cu content is relatively high (Rajan et al., 1976;Bakirdere et al., 
2010). Cu is released from cultured hippocampal neurons in an NMDA receptor-
dependent manner, and stimulation of NMDA receptors results in the trafficking of 
ATP7A out of the late Golgi into dendrites (Schlief et al., 2005). Since NMDA receptor 
activity is crucial for different forms of synaptic plasticity and learning and memory 
(Malenka and Bear, 2004;Yashiro and Philpot, 2008), Cu is likely to be present at 
synapses during learning. Thus the influences of Cu on synaptic transmission and 
plasticity are highly relevant to learning and memory. Despite this, few groups have 
explored the effects of Cu on synaptic transmission in this region.  
Cu and synaptic transmission. Xie and colleagues (Xie et al., 1993) reported that 
concentrations of Cu  ranging from 100-300 µM enhanced both excitatory and inhibitory 
synaptic transmission in the CA3 region of the hippocampus. Subsequently, Doreulee 
and colleagues (Doreulee et al., 1997) bath-applied 1-100 µM CuSO4 onto hippocampal 
slices while monitoring synaptic transmission in the Schaffer collateral-CA1 pathway 
using extracellular recording methods. They found that 10 µM CuSO4 is needed to 
depress AMPA receptor-mediated transmission, while NMDA receptor-mediated signals 
are sensitive to 1 µM. Intracellular recordings confirm these results. They found no 
effects of Cu on presynaptic glutamate release or GABAergic inhibition, suggesting 
these effects are mediated post-synaptically. Cu (30 µM) has similar depressing effects 
on excitatory synaptic transmission in cultured olfactory bulb neurons (Trombley et al., 
1998;Horning and Trombley, 2001). 
GABAA receptors are heteropentameric ionotropic receptors structurally similar to 
nicotinic acetylcholine receptors (Hevers and Luddens, 1998;Jacob et al., 2008). There 
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are 18 subunits identified to date, and alternative splicing of those subunits also 
contributes to GABAA receptor diversity. GABAA receptors contain 2 α(1-6), 2 β(1-3) and 
a single γ(1-3), δ, ε(1-3), θ or π subunit (Fig. 1-5A). Importantly, subunit composition of 
GABAA receptors determines localization, activity and physiological function within 
neurons and networks (Wafford et al., 2004;Rudolph and Mohler, 2006). Each subunit 
has a large extracellular N-terminal domain (NTD) which includes a short cysteine loop, 
4 transmembrane domains (TMD; TMD2 lines the channel pore), and large intracellular 
loop between TMD3 and TMD4 that acts as a site for protein interactions and post-
translational modifications that regulate trafficking and channel activity (Fig. 1-5B) 
(Jacob et al., 2008). Each GABAA receptor binds 2 GABA molecules through NTDs at 
both α-β interfaces of the receptor, leading to channel pore opening and the passage of 
Cl- ions to inhibit action potential activity. Many endogenous and exogenous compounds 
bind and regulate GABAA receptor activity, including Cu. Compared to Zn, much less is 
known about the physiological effects of Cu, including those on GABAA receptors 
(Mathie et al., 2006). Nevertheless, the direct effects of Cu on GABA receptors have 
been demonstrated at physiological Cu concentrations (Ma and Narahashi, 
1993;Sharonova et al., 1998;Kim and Macdonald, 2003). Cu and Zn both have inhibitory 
effects on GABAA receptor function (Narahashi et al., 1994;Trombley et al., 
1998;Horning and Trombley, 2001) [for review see (Mathie et al., 2006)]. Cu binds 
different human GABAA receptors subtypes with equal affinity at an EC50 of 2.4 µM (Kim 
and Macdonald, 2003), unlike Zn which displays subtype preference for binding (α6, 
EC50 = 1.9 µM; α1 EC50 = 10.4 µM) (Fisher and Macdonald, 1998). Cu-mediated 
inhibition of GABAA receptors is reversible (Ma and Narahashi, 1993), but may require 
removal of Cu from its binding site by using a chelator for example (Sharonova et al., 
1998). 
27 
 
 
Leiva and colleages used extracellular recordings to investigate the effects of exogenous 
CuSO4 on mixed excitatory and inhibitory signals in acute hippocampal slices (Leiva et 
al., 2000). CuSO4 (10 µM) application reduced the amplitude and duration of mixed 
signals. Bicuculline methiodide and picrotoxin, both of which are GABAA receptor 
antagonists, had opposite effects on these mixed signals in the Schaffer-CA1 pathway; 
bicuculline reduced mixed transmission similarly to CuSO4, whereas picrotoxin 
enhanced these signals. These two compounds work through very different 
mechanisms; bicuculline competitively antagonizes the GABA binding site, whereas 
picrotoxin acts to block noncompetitively the Cl– channel (Fig. 1-5) (Krishek et al., 1996). 
Cu (10 µM) had effects similar to GABA to suppress mixed synaptic transmission. 
Adding Cu with bicuculline produced no additive effect on depression of synaptic 
transmission, suggesting Cu works through GABA receptors to depress synaptic 
transmission. By contrast, addition of Cu with picrotoxin remarkably enhanced synaptic 
transmission, demonstrating clear distinctive interactions between these two GABA 
antagonists with Cu (Leiva et al., 2000). This likely speaks to the differential 
pharmacology of these two antagonists. In addition, the plethora of GABAA receptor 
subtypes, with different physiological functions and subunit compositions (Farrant and 
Nusser, 2005), can be differentially affected by these two antagonists (Zhang et al., 
1995). Furthermore, different GABAA receptor subtypes are located on different classes 
of neurons and on different neuronal domains with brain region specificity (see 
below)(Martina et al., 2001). Confounding factors at this number and level of complexity 
can more than account for the wide range of results observed across these studies 
depending on method and small differences in concentrations used. This also makes 
interpretation of differential effects of these antagonists very difficult even within a single 
study.  
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Figure 1-5. Schematic illustrating GABAA receptor structure and Cu binding. (A) 
GABAA receptors are heteropentameric ionotropic receptors permeable to Cl- and 
thus serve an inhibitory function in the neuronal membrane. GABAA receptors 
typically comprise 2 α, 2 β, and γ (or other) subunits, as depicted on the left. On the 
right, a schematic view of the top of the channel demonstrates the central ion pore 
(white), 5 subunits (each with 4 transmembrane domains), and approximate binding 
sites for GABA, Cu, barbiturates and benzodiazepines. (B). Schematic of a single 
GABAA receptor subunit. Specific residues important for Cu binding are labeled 
according to subunit type. Phosphorylation of the loop between TMD3 and TMD4 
regulates trafficking.  
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Competing inhibitory effects of Cu and Zn on GABAA receptor function strongly suggests 
Cu and Zn act through similar mechanisms and may share a binding site (Ma and 
Narahashi, 1993;Narahashi et al., 1994;Fisher and Macdonald, 1998). Although Cu 
inhibition of GABA-activated currents follows kinetics similar to competitive antagonists, 
the site for Cu binding is notably distinct from the GABA binding site (Sharonova et al., 
1998;Sharonova et al., 2000). Thus Cu acts to inhibit the effects of GABA-binding on 
channel gating. Cu binding also influences the binding and activity of other GABAA 
receptor allosteric modulators such as benzodiazepines (Mizuno et al., 1982;Kardos et 
al., 1984). The residues important for Cu binding include a VR(Q for α2)AECPMH motif 
which spans the proximal portion of the cystine loop of the α1 NTD (Fig. 5B) (Kim and 
Macdonald, 2003). Valine 134, arginine/glutamine 135 and histidine 141 are the most 
important determinants for Cu binding, but the whole motif is required for full Cu effect 
(Fig. 5B). Additionally, two residues important in Zn binding to α6-containing receptors 
(β3-H267 in TMD2 and α6-H273 in the TMD2-TMD3 loop) are also required for Cu 
binding (Kim and Macdonald, 2003), but this is not the case for all Zn binding residues 
(Fisher and Macdonald, 1998). Taken together, these data suggest partial overlapping 
binding sites and similar mechanisms of action for Cu and Zn on GABAA receptor 
inhibition. 
Cu has differential efficacies for various GABAA receptor subtypes with stronger effects 
on α1- and α2-containing receptors compared to α4- and α6-containing receptors (Table 
1). (Kim and Macdonald, 2003). By contrast, Zn prefers α6-containing receptors over α1-
containing receptors but has similar maximal inhibitory efficacies (Fisher and Macdonald, 
1998). This subtype specificity has important functional relevance. α(1-3)-containing 
receptors localize to GABAergic synapses and mediate phasic or fast inhibition, whereas 
α(4-6)-containing receptors are extra-synaptic and mediate tonic or slow inhibition 
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(Hevers and Luddens, 1998;Jacob et al., 2008;Farrant and Nusser, 2005). Additionally, 
synaptic GABAA receptor subtypes localize to separate synapses. For example, in 
pyramidal neurons of the hippocampus, α1-containing and α2-containing receptors 
localize to parvalbumin-positive and cholecystokinin/vasoactive intestinal peptide-
positive axo-somatic and axo-axonic synapses, respectively (Nyiri et al., 2001). α5-
containing GABAA receptors are also expressed by hippocampal pyramidal neurons and 
localize to the bases of dendritic spines (Rudolph and Mohler, 2006).  
Subunit Cu Zn Role Expression Synapse 
α1  - Fast Parvalbumin Axo-somatic 
α2   " CCK/VIP Axo-axonic 
α5   Slow Hippo PNs Axo-dendritic 
α6 -  "   
 
 
Consistent with findings in vitro, dietary Cu status can affect GABAA receptor availability 
in vivo (Geiger et al., 1984). Additionally, GABAA receptors subtypes are thought to be 
involved in different behavioral pathways (Rudolph and Mohler, 2006). Thus, preference 
for GABAA receptor subtypes can have a profound impact on the complex physiological 
effects of Cu during neuronal activity. One important example is the induction of synaptic 
plasticity, which involves the coincident engagement of several neuronal and synaptic 
receptor types, including GABAergic neurons and receptors. 
Cu and synaptic plasticity. Fairly consistent effects of Cu have been observed on long-
term potentiation (LTP), a form of synaptic plasticity hypothesized to be important for 
Table 1-1. GABAA receptor α subunit characteristics. 
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learning and memory (Malenka, 2003;Lynch, 2004), in the hippocampus. Doreulee and 
colleagues (Doreulee et al., 1997) found that the depressing effects of Cu on NMDA 
receptors had consequences for LTP at 1 µM. Goldschmith and colleagues 
(Goldschmith et al., 2005) confirmed the inhibitory effects of Cu on hippocampal LTP 
using brain slices generated from rats chronically supplemented with Cu through the diet 
(8-12 mg/day for 20-25 days) and a similar LTP induction method. Years later, the same 
groups tested the effects of chronically injected Cu (1 mg/kg, i.p.) on hippocampal LTP 
with similar results (Leiva et al., 2009). It was reported in both studies that Cu levels 
were approximately 50- and 15-fold higher in the brains of Cu supplemented rats 
compared to control rats in each of the two studies, respectively. This startling 
measurement immediately calls to mind concerns of Cu toxicity in these studies. 
Nevertheless, given these results it was reasonably concluded that Cu suppresses LTP 
at Schaffer-CA1 synapses.  
This finding is consistent with biochemical evidence of the effect of Cu on key molecules 
involved in LTP induction. The NMDA receptor acts as a coincidence detector for 
synaptic activity and post-synaptic excitability. Unlike the majority of their glutamate 
receptor counterparts, NMDA receptors are permeable to calcium, which triggers a 
cascade of signaling events that ultimately lead to changes in post-synaptic receptor 
expression and/or pre-synaptic release probability (Malenka, 2003;Yashiro and Philpot, 
2008). Schlief and colleagues (Schlief et al., 2005) found that 200 µM CuCl2 inhibited 
NMDA receptor signaling. This effect was later found to depend on nitrosylation of the 
NMDA receptor (Schlief et al., 2006), which is facilitated in the presence of Cu. Cu also 
blocks high voltage-activated calcium channels in rat cortical (Castelli et al., 2003) and 
olfactory bulb neurons (Horning and Trombley, 2001). In particular,  L-type voltage-gated 
calcium channels, which are located post-synaptically on dendrites and dendritic spines 
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and contribute to calcium influx during LTP induction (Kullmann et al., 2000;Malenka and 
Bear, 2004), are sensitive to Cu in the low µM range (Korte et al., 2003). Thus Cu could 
impair LTP through multiple mechanisms (Fig. 1-6).  
However, the physiological role of Cu in the hippocampus may not be so simple. To 
determine the effect of Cu on established LTP, Leiva and colleagues (Leiva et al., 2003) 
waited until 90 min after LTP induction to bath apply 10 µM Cu, which decreased 
synaptic efficacy as observed previously. Upon washout, the synaptic response returned 
at a substantially larger size. Unfortunately, no controls were performed to rule out 
progressive potentiation as a contributing factor. In a separate set of experiments 
performed by the same group, paired pulses were applied to Schaffer collaterals at 
intervals ranging from 20 to 300 ms in hippocampal slices generated from rats on normal 
or chronic Cu supplemented diets (Goldschmith et al., 2005). Response ratios 
(second/first) decreased in both groups following LTP induction, as is to be expected 
with a pre-synaptic component of synaptic potentiation (increased pre-synaptic release 
probability). However, this change was blunted in Cu supplemented animals, and paired 
pulse ratios were reduced in Cu supplemented animals at baseline. These findings are 
consistent with enhanced pre-synaptic release probability at baseline with Cu 
supplementation and support an alternative interpretation of occluded rather than 
impaired LTP. Moreover, LTP might have already been established prior to induction in 
the case of Cu supplemented rats. By contrast, acute application of Cu has no effect on 
paired pulse responses (Doreulee et al., 1997). Together these results suggest a dual 
effect of Cu on synaptic plasticity in the hippocampus, where Cu prevents the induction 
of new LTP and may reinforce LTP that has already been established. Future studies 
should address a narrower range of hypotheses through more in depth physiological 
study with more rigorous experimental controls.   
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Other potential contributing roles of secreted Cu to synaptic plasticity remain to be 
Figure 1-6. Schematic summarizing the known roles of Cu in synaptic function. 
Cu enters cells through CTR1 and binds to cytosolic chaperones including Atox-1 
which delivers Cu to ATP7A. Cu gains entry into the secretory pathway through 
ATP7A and is stored in LDCVs along with secreted cuproenzymes DβM, SOD3 and 
PAM. Influx of Ca++ through NMDARs and VGCCs results in LDCV release and Cu 
secretion. Outside of the cell, Cu has inhibitory effects on NMDARs, VGCCs and 
GABAARs. Cu binds PrP and APP, which are synaptically localized. Cu stimulates 
MMP9 which facilitates the activation and release of BDNF along with subsequent 
binding to TrKB receptors. Abbreviations: Aβ, beta amyloid peptide; AMPAR, 2-
amino-3-(5-methyl-3-oxo-1,2- oxazol-4-yl)propanoic acid receptor; APP, amyloid 
precursor protein; Atox-1, antioxidant-1 (a.k.a. HAH1); ATP7A, Menkes disease 
protein; BDNF, brain-derived neurotrophic factor; Ca++, calcium; CTR1, Cu 
transporter 1; DβM, dopamine β-monooxygenase; GABAAR, γ-amino butyric acid A 
receptor; LDCV, large dense-core vesicle; MMP9, matrix metalloproteinase 9; 
NMDAR, N-methyl-D-aspartate receptor; PAM, peptidylglycine α-amidating 
monooxygenase; PrP, prion protein; PSD, post-synaptic density; SOD3, superoxide 
dismutase 3; TrkBR, tyrosine receptor kinase B; VGCC, voltage-gated calcium 
channel. 
Cu++
AMPAR
NMDAR
PSD
Ca++
GABAAR
VGCC
Ca++
Ca++PrP
TrkBR
APP
BDNF
Cu++
MMP9
Aβ
LDCV
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tested. Brain-derived neurotrophic factor (BDNF) is a potent stimulant of neuronal and 
synaptic growth important in brain development and learning and memory [for review 
see (Minichiello, 2009)]. BDNF is released upon activity-dependent neuronal stimulation 
and binds to tropomyosin-related kinase B (TrkB) receptors, inducing activation and 
autophosphorylation. TrkB receptors expressed on cultured cortical neurons become 
phosphorylated/activated when exposed to Cu for 15 min (10 µM optimal); Cu is more 
effective than several other metals, including Zn (Hwang et al., 2007). This effect is 
mediated through Cu-induced BDNF precursor cleavage and release that depends on 
the activity of matrix metalloproteinases (MMPs), a class of extracellular Zn-dependent 
endopeptidases. An interesting aside is that BDNF signaling enhances hippocampal and 
cortical post-synaptic NMDA receptor activity (Madara and Levine, 2008), which could 
lead to further Cu release and TrkB activation. Thus, under certain conditions Cu could 
positively influence LTP through TrkB signaling (Fig. 1-6).  
MMPs have been shown to contribute to synaptic plasticity through mechanisms outside 
of TrkB signaling. MMP-9 activation is activity-dependent in the hippocampus and is 
necessary and sufficient for hippocampal LTP and learning and memory (Nagy et al., 
2006;Bozdagi et al., 2007;Nagy et al., 2007). Moreover, MMP-9 deficient mice lack 
hippocampal LTP, but respond to LTP induced by bath application of recombinant MMP-
9 (Nagy et al., 2006). These results were later corroborated with an MMP-9-dependent 
increase in dendritic spine volume which typically accompanies increases in synaptic 
strength (Wang et al., 2008). This effect of MMP-9 is mediated through cleavage of 
ICAM-5, a post-synaptic integrin and negative regulator of synaptic strength and growth 
(Conant et al., 2010). Thus, activation of MMP-9 during LTP results in the cleavage of 
ICAM-5 and disinhibition of synaptic strength and growth. Hwang and colleagues 
(Hwang et al., 2007) further showed that neuronal, but not glial, MMP-9 is specifically 
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activated by 10 µM Cu using in situ zymography. It remains to be determined whether 
this MMP-ICAM-5-LTP pathway requires the release and extracellular availability of Cu 
(Fig. 1-6). 
To add to the many proteins that bind Cu within the cell (Fig. 1-4), other molecules 
located at the synapse bind Cu, and could therefore influence its non-enzymatic effects. 
Amyloid precursor protein (APP), whose proteolytic cleavage yields the pathological Aβ 
peptide, is implicated in Alzheimer’s disease pathology. APP contains an extracellular 
domain that binds Cu with attomolar affinity (Atwood et al., 2000). Cu binding promotes 
the proteolytic cleavage of APP to yield Aβ, and Aβ-mediated neuronal toxicity is 
enhanced in the presence of Cu (Huang et al., 1999). The connection between APP and 
Cu homeostasis is demonstrated by transgenic animals in which knockout of APP 
increases brain Cu levels (White et al., 1999), and APP over-expression results in a 
reduction of brain Cu (Maynard et al., 2002). Increasing Cu levels promote cell surface 
expression of APP and its distribution into neurites. Clearly APP plays a role in Cu 
homeostasis in normal and pathological conditions, and its localization in dendrites 
highly implicates an important role for APP in Cu-mediated modulation of synaptic 
transmission and plasticity (Fig. 1-6). 
The prion protein (PrP) is another Cu-binding transmembrane protein, which is involved 
in spongiform encephalopathies such as Creutzfeldt-Jakob disease [for review see 
(Vassallo and Herms, 2003;Zomosa-Signoret et al., 2008)]. PrP is pre- and post-
synaptically expressed in neurons and contains 5 sites that bind Cu with low µM affinity 
(Fig. 1-6) (Herms et al., 1999;Zomosa-Signoret et al., 2008). Binding of Cu to PrP 
triggers internalization of the metalloprotein complex. Genetic deficiency of PrP in mice 
results in a 50% reduction in synaptosomal Cu levels, however total brain Cu levels were 
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unchanged. The electrophysiological phenotype of these mice was consistent with 
increased Cu at synapses, including impaired LTP and reduced GABAergic inhibition in 
the hippocampus (Collinge et al., 1994). Interestingly, the synaptic plasticity deficit of 
PrP null mice corresponds with impaired spatial learning and memory consolidation 
(Criado et al., 2005). PrP clearly also plays a role in Cu homeostasis, but the details and 
significance of that role are not understood (Zomosa-Signoret et al., 2008) (Fig. 1-6). 
The Cu binding capacity of APP and PrP are not only highly suggestive of their role in 
Cu homeostatic disease states, but also implicate a pathophysiological role for disrupted 
Cu homeostasis in Alzheimer’s and prion-related diseases.  
Cu and learning and memory. Despite these consistent and striking observations made 
to this point in vitro, no group has yet demonstrated a behavioral effect of Cu on 
hippocampal-dependent learning and memory. Leiva and colleagues 2009 (Leiva et al., 
2009) showed that the same chronic Cu injection regimen had no effect on performance 
in the Morris water maze task, a cognitive behavioral task testing working and long-term 
spatial (hippocampal-dependent) memory. Another group showed that both dietary Cu 
supplementation (1 ppm CuSO4 in the drinking water) and chelation (using 0.1% D-
penicillamine dissolved in the drinking water) in rats had no effect on shuttle-box 
avoidance learning of rats (Fujiwara et al., 2006). Dietary Cu supplementation was 
anxiolytic and reduced sensorimotor gating performance in the same study. Mild dietary 
Cu restriction (0.6 ppm food Cu for 9-10 weeks) in mice has an anxiogenic effect in the 
elevated zero maze (Bousquet-Moore et al., 2010b). Thus the strength of dietary 
challenge and species differences can weigh heavily on behavioral assessment of the 
role of Cu in brain function. 
The mammalian hippocampus possesses a uniquely high density of NMDA receptors, 
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specifically at the Schaffer-CA1 synapse (Meoni et al., 1998). As such, LTP at Schaffer-
CA1 synapses is characteristically reliant on NMDA receptor-mediated signaling. 
However, LTP in other brain regions such as the cortex and amygdala does not rely as 
heavily on NMDA receptors, and may thus respond differently in the presence of Cu. 
NMDA receptor-independent LTP may also respond differently in the presence of Cu 
even within the hippocampus. Therefore, the roles of Cu in synaptic plasticity and 
learning and memory are complex and likely region-specific, which may account for the 
array of symptoms observed in disorders involving disrupted Cu homeostasis including 
Alzheimer’s disease, prion disease, and Wilson’s disease [for review see (Uriu-Adams 
and Keen, 2005)]. 
 
Conclusions. The arrival of Cu on the biological scene at such a primitive juncture in 
evolution suggests the presence of Cu during the evolution of the nervous system. The 
utility and reactivity of this metal combined with its presence at synapses highly implicate 
a physiological role for Cu in normal brain function. Studies performed to date support a 
complicated portrait of interconnected pathways through which Cu signals (Fig. 1-6). 
However, the number and breadth of these studies are extremely limited. Additionally, 
several neurological diseases with cognitive and behavioral symptomology involve 
pathology in which Cu homeostasis is disrupted. Thus, there is a strong need for further 
investigation into the complex network of Cu signaling pathways in the brain. 
Advancement of our understanding of these mechanisms will help identify new 
molecular targets for neurological and psychiatric diseases, many of which currently 
have few and poor treatment options, and it will provide great insight into the basic 
mechanisms through which humans interact with and experience the world.   
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ABSTRACT 
The mammalian amygdala expresses various neuropeptides whose signaling has been 
implicated in emotionality. Many neuropeptides require amidation for full activation by 
peptidylglycine α-amidating monooxygenase (PAM), a transmembrane vesicular 
cuproenzyme and regulator of the secretory pathway. Mice heterozygous for the Pam 
gene (PAM+/-) exhibit physiological and behavioral abnormalities related to specific 
peptidergic pathways. In the present study, we evaluated emotionality and examined 
molecular and cellular responses that characterize neurophysiological differences in the 
PAM+/- amygdala. PAM+/- mice presented with anxiety-like behaviors in the zero maze 
that were alleviated by diazepam. PAM+/- animals were deficient in short- and long-term 
contextual and cued fear conditioning and required higher shock intensities to establish 
fear-potentiated startle than their wildtype littermates. Immunohistochemical analysis of 
the amygdala revealed PAM expression in pyramidal neurons and local interneurons 
that synthesize γ-aminobutyric acid (GABA). We performed whole-cell recordings of 
pyramidal neurons in the PAM+/- amygdala to elucidate neurophysiological correlates of 
the fear behavioral phenotypes. Consistent with these observations, thalamic afferent 
synapses in the PAM+/- lateral nucleus were deficient in long-term potentiation. This 
deficit was apparent in the absence and presence of the GABAA receptor antagonist 
picrotoxin and was abolished when both GABAA and GABAB receptors were blocked. 
Both evoked and spontaneous excitatory signals were enhanced in the PAM+/- lateral 
nucleus. Phasic GABAergic signaling was also augmented in the PAM+/- amygdala, and 
this difference was comprised of activity-independent and activity-dependent 
components. These physiological findings represent perturbations in the PAM+/- 
amygdala that may underlie the aberrant emotional responses in the intact animal. 
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INTRODUCTION 
Neuropeptides are the most diverse class of neurotransmitters and many share a 
common biosynthetic pathway. Peptide α-amidation is a final and often essential step in 
conferring full biological activity to many neuropeptides (Eipper and Mains, 1988;Eipper 
et al., 1992). In mammals, this reaction is performed exclusively by a single vesicular 
transmembrane protein, peptidylglycine α-amidating monooxygenase (PAM) (Eipper et 
al., 1983;Mains et al., 1991). PAM has two luminal enzymatic domains (peptidylglycine 
α-hydroxylating monooxygenase, PHM; peptidyl α-hydroxyglycine alpha-amidating 
lyase, PAL) that act sequentially to catalyze the Cu-dependent cleavage of a C-terminal 
glycine (Prigge et al., 1997;Prigge et al., 2000). The inherently unstructured cytosolic 
domain of PAM is multiply-phosphorylated (Steveson et al., 1997;Yun et al., 
1995;Rajagopal et al., 2009), can regulate the peptidergic exocytic pathway (Ciccotosto 
et al., 1999;Alam et al., 2001), and can signal to the nucleus (Rajagopal et al., 2009).  
Our group has previously described a model of genetic PAM deficiency (Czyzyk et al., 
2005a;Bousquet-Moore et al., 2009). Homozygous deletion of Pam results in embryonic 
lethality at E14.5 and a phenotype similar to that of mice lacking the precursor of 
adrenomedullin, an amidated peptide (Caron and Smithies, 2001). Heterozygous mice 
(PAM+/-), with half the normal levels of PAM protein and amidating activity, grow normally 
and reproduce, but exhibit striking physiological and behavioral abnormalities (Bousquet-
Moore et al., 2010b;Bousquet-Moore et al., 2009) including impaired vasoconstriction 
and temperature regulation, a hyper-sensitivity to pentylenetetrazol-induced seizures, 
augmented anxiety-like behaviors, and disrupted Cu homeostasis. Here we report 
deficits in fear responses in PAM+/- mice, prompting our exploration of synaptic 
transmission in the PAM+/- amygdala.  
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The amygdala is a heterogeneous group of limbic nuclei that play a critical role in 
mediating fear and anxiety-like behaviors (LeDoux, 2007;Sah et al., 2003). The 
basolateral complex, composed of lateral and basolateral nuclei, receives the majority of 
inputs to the amygdala. Inhibition of these nuclei by local interneurons is crucial in 
maintaining low baseline amygdala activity and gating plasticity at excitatory afferent 
synapses (Marowsky et al., 2005;Shaban et al., 2006;Tully et al., 2007;Muller et al., 
2006). Among these afferent pathways are inputs carrying discrete sensory information 
relevant to Pavlovian fear conditioning, a behavioral model for fear learning and memory 
(Lanuza et al., 2008;Maren and Quirk, 2004;Pare et al., 2004). 
PAM mRNA is present throughout the rodent CNS, including cortex, hippocampus and 
amygdala (Schafer et al., 1992b). In this study, we show that PAM protein is expressed 
in pyramidal neurons and interneurons of the basolateral complex. Pyramidal neurons 
and interneurons secrete neuropeptides in addition to glutamate and γ-aminobutyric acid 
(GABA)(Salio et al., 2006). Altered function of these neurons, resulting from PAM 
limitation, could disrupt the excitatory-inhibitory balance of sensitive brain regions and 
affect behavior. To investigate this hypothesis, we performed electrophysiological 
studies in the basolateral complex of the PAM+/- amygdala. Impairment of synaptic 
plasticity at thalamic afferent synapses, increased neural excitability that was GABAA-
dependent, and enhanced activity-dependent GABAergic transmission were evident in 
the PAM+/- amygdala. Collectively these findings demonstrate that PAM+/- mice provide a 
unique model for peptidergic disruption with behavioral and physiological perturbations 
that may be relevant to anxiety-spectrum disorders in humans. 
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METHODS 
Animals  
Male and female mice for these studies were generated from PAM+/- pairings in the 
University of Connecticut Health Center (UCHC) animal facility. Wildtype and PAM+/- 
littermates (>20 generations bred into C57/BL6J background) were weaned between 
P19 and P21 and group-housed until experiments. Animals were maintained under a 12 
h light/dark cycle (lights on at 0700) and were given free access to food and water. The 
behavioral experiments were conducted at Duke University between 1100-1400 h, 
where adult male and female wildtype and PAM+/- mice (12-20 weeks of age) were 
tested. Since no sex differences were observed, the data were collapsed across this 
variable. All experiments were conducted with approved protocols from the UCHC and 
Duke University Institutional Animal Care and Use Committees and in accordance with 
NIH guidelines for animal care.  
Behavior  
Drugs. Diazepam (Sigma-Aldrich, St. Louis, MO) was dissolved in sterile water 
containing less than 0.3% Tween-80 (Sigma-Aldrich) of the total volume. The vehicle or 
benzodiazepine (Diazepam) was administered (i.p.) 30 min prior to testing. 
Neurophysiological screen.  The details of the tests used for assessment of general 
sensory and motor function and spontaneous activity in the open field have been 
described (Pogorelov et al., 2005;Taylor et al., 2008). 
Zero maze. The details of the zero maze have been published (Pogorelov et al., 2005). 
The maze was illuminated at 50-60 lux and enclosed by black curtains. A video camera 
was positioned 100 cm above the maze. Naïve mice were placed into a closed quadrant 
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and permitted to investigate the maze for 5 min. The videotapes were analyzed with 
Noldus Observer (Noldus Information Technology, Leesburg, VA) and scored for percent 
time spent in the open areas, latency to enter the open areas, and number of head-dips 
and freezing episodes (see below for definition). 
Fear conditioning.  Details of the fear conditioning tests have been published (Taylor et 
al., 2008). Mice were assigned to one of four test groups: 1 h context, 24 h context, 1 h 
cued, and 24 h cued tests. All mice were conditioned with a single 30 s 72 dB tone (CS) 
and 2 s 0.4 mA scrambled foot-shock (UCS) on day 1. One-half of the animals were 
examined 1 h after conditioning either in the context or cued test, and the remainder 
were evaluated separately 24 h later in these two respective tests. Context testing 
consisted of returning the mouse to the same chamber in which the CS-UCS pairing had 
been presented. For cued tests the mice were placed into a novel chamber with a 
different level of illumination, floor, walls, shape and dimensions than the conditioning 
chamber. All tests were video-taped and the behaviors were later scored using the 
Noldus Observer by a trained observer who was blind to the genotype of the mice and 
time-interval of testing. Freezing was defined as the lack of all movement by the animal 
except for respiration for >1 s (Anagnostaras et al., 2000;Porton et al., 2009).   
Fear-potentiated startle. This test has been described in detail elsewhere (Taylor et al., 
2008). Testing was conducted in a MedAssociates apparatus (St. Albans, VT) over 5 
days. On day 1, baseline startle responses were assessed over 18 trials with 40 ms 
bursts of white noise at 100, 105 and 110 dB presented in pseudorandom order with an 
inter-trial interval of 30–90 s. On day 2, one-half of the startle stimuli were administered 
immediately following a 30 s 12 kHz 70 dB pure tone (CS); the other half were presented 
without the CS. Twenty-four h later mice were conditioned with 10 CS-UCS pairings. 
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One-half of the mice were conditioned with 0.25 s 0.4 mA and the remainder with 0.6 mA 
scrambled shock (UCS). Forty-eight h later, mice were tested for potentiation of their 
startle responses by the CS using the same procedure described for day 2. Potentiation 
to the CS was defined as the percent increase in the startle response for the CS+startle-
stimulus trials relative to the baseline startle responses on day 1.   
Shock-threshold testing. This procedure has been described (Grove et al., 2004;Taylor 
et al., 2008). Briefly, mice were acclimated to a single test chamber (MedAssociates) for 
2 min before being presented with five different foot-shock intensities (0, 0.1, 0.2, 0.4, 
and 0.6 mA) for 2 s. Inter-shock intervals were between 30 and 90 s. Behavioral 
responses were video-taped and scored subsequently using the Noldus Observer 
program. Behaviors were given scores of 0-5. A score of 0 denoted the lowest level of 
response that involved the continuation of activity. A score of 1 signified a low-level 
response to shock that included freezing, face-wiping, self-grooming, shaking, or rapid 
forward departures. A score of 2 was a moderate response that could involve retreating 
from shock or tail-rattling. A score of 3 denoted stationary reactive responses including 
kicking and vocalization. A score of 4 signified locomotor reactivity such as darting and 
leaping. A score of 5 was indicative of jumping against the walls or ceiling of the 
chamber. Behavioral scores were summed for each animal and analyzed as a function 
of genotype and shock intensity.    
Immunocytochemistry  
Immunohistochemical staining of tissue sections from perfusion-fixed mice has been 
described previously (Ma et al., 2001;Ma et al., 2002;Ma et al., 2008a). Briefly, male 
wildtype and PAM+/- littermates were perfused transcardially with 4% formaldehyde/0.1 M 
sodium phosphate buffer (pH 7.4) under deep ketamine anesthesia. After fixation, brains 
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were post-fixed in 4% paraformaldehyde for 3 h. Coronal sections were cut (15 µm) 
through the amygdala using a cryostat and immunostained with rabbit antiserum JH629 
to the Exon A (exon 16) region of PAM1 (Maltese and Eipper, 1992); mouse monoclonal 
IgG to GAD67 (Millipore Biosciences, Billerica, MA); Alexa-488 donkey anti-rabbit (H+L) 
(Invitrogen, Molecular Probes, Eugene, OR); CyTM3-conjugated AffiniPure F(ab’)2-
fragment donkey anti-mouse (H+L) (Jackson ImmunoResearch Laboratories Inc., West 
Grove, PA) as described (Ma et al., 2001).  
Electrophysiology  
Slice preparation. Male wildtype and PAM+/- littermates 4–7 weeks of age were 
decapitated and their brains quickly removed into ice-cold artificial cerebrospinal fluid 
(aCSF) containing (in mM): 125 NaCl, 26 NaHCO3, 10 glucose, 2.3 KCl, 2 CaCl2, 2 
MgSO4, 1.26 KH2PO4; aerated with 95% O2 and 5% CO2, pH 7.3, 310 mOsm/kg (Zhou et 
al., 2008a). Coronal slices, 300 µm thick, were incubated at room temperature for at 
least 1 h before recordings.  
Whole-cell recordings. Slices were transferred to a recording chamber heated to 32°C 
and perfused with aerated aCSF. Recording pipettes had 3-5 MΩ tips. The internal 
pipette solution used in most experiments was composed of (in mM) 135 K-gluconate, 10 
HEPES, 10 P-creatine, 3 Na2ATP, 2 MgCl2, 0.3 Na2GTP, pH 7.3, 285 mOsm/kg (Zhou et 
al., 2008a). Inhibitory Post-Synaptic Currents (IPSCs) were recorded using pipette 
solution composed of (in mM) 120 CsCl, 10 HEPES, 1 EGTA, 0.1 CaCl2, 1.5 MgCl2, 4 
Na2-ATP, 0.3 Na2-GTP, 5 QX-314; pH 7.3, 310 mOsm/kg. Neurons were patched under 
visual guidance using infrared differential interference contrast optics. Data were 
collected using a Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA) and 
analyzed using pClamp 9.2 software (Molecular Devices).  
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Evoked synaptic transmission. Synaptic activity was evoked using 200 µs current pulses 
elicited with a Master 8 and an ISO-Flex stimulator (A.M.P.I., Jerusalem, Israel) through 
bipolar tungsten electrodes (World Precision Instruments, Sarasota, FL). Electrode 
placement in the internal and external capsules preferentially stimulated afferent axons 
originating in thalamic and cortical areas, respectively (Weisskopf and Ledoux, 1999). 
Input-output curves for thalamic and cortical inputs were generated from excitatory and 
inhibitory compound currents recorded at Vholding = -55 mV. Only outward currents were 
sensitive to picrotoxin (not shown). AMPA and NMDA receptor-mediated currents were 
recorded at Vholding = -70 and +50 mV, respectively. NMDA receptor-mediated current 
amplitude was measured 50 ms after the stimulus to avoid contamination by the AMPA 
component. For the majority of neurons recorded in these experiments, reversal 
potentials were assessed by recording currents at voltages between -70 and +50 mV in 
10 mV increments. Reversal potential was calculated as the X-intercept of a fit to the 
linear portion of the I-V curve for each neuron. A 2-term exponential curve was fit to 
each +50 mV current trace to assess fast and slow decay components of the mixed 
AMPA- and NMDA-mediated current. To record evoked Inhibitory Post-Synaptic 
Currents (eIPSCs), placement of the stimulating electrode locally in the amygdala 
neuropil medial to the recording pipette allowed preferential stimulation of local 
interneurons (Silberman et al., 2008;Marowsky et al., 2005) and was kept as consistent 
as possible. The axonal arbors of amygdalar interneurons are extensive, often 
encompassing the whole basolateral nucleus (Rainnie et al., 2006). In addition, 
parvalbumin-positive amygdalar interneurons (the most prevalent class of interneuron) 
are electrically coupled via dendritic and axonal gap junctions (Muller et al., 2005). 
Therefore, action potential activity could be produced reliably through local stimulation 
pulses and maximal responses consistently achieved in a given amygdala slice. Paired 
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pulses were applied, and the ratio of the second eIPSC amplitude to the first was 
interpreted as an inverse indicator of release probability.  
Synaptic plasticity. Stimulating electrodes were placed in the internal capsule to evoke 
thalamic afferents. In whole-cell configuration, experiments were conducted in current 
clamp mode in the presence and absence of picrotoxin (Tully et al., 2007;Weisskopf et 
al., 1999). The holding current was adjusted to maintain Vm = -70 mV throughout the 
course of experiments. The 10-90% rise slope of Excitatory Post-Synaptic Potentials 
(EPSPs) was used as the measure of synaptic efficacy. Stimulation strength was 
adjusted to produce a 3-6 mV EPSP, and test stimuli were applied at 0.1 Hz. After 
establishment of a steady baseline, Long-Term Potentiation (LTP) was induced using an 
action potential pairing induction protocol. This induction paradigm was originally 
characterized as being L-type voltage-gated calcium channel-dependent (Bauer et al., 
2002). Fifteen paired trains were applied at 0.1 Hz; each train consisted of 10 pulses at 
30 Hz paired with 2.5 ms current pulses of ≥ +1 nA to elicit an action potential at a 5 ms 
delay to the onset of each synaptic event. If 1 nA was not sufficient, then the pulse 
amplitude was increased by +50 pA until action potentials were observed throughout the 
train. LTP was measured as the normalized fractional difference between the 35-40 min 
interval post-induction and the 5 min interval prior to induction; neurons were pooled by 
genotype. Only one neuron was used per slice. For field potential recordings, pulse 
durations were 100 µs. Recording pipettes (3-5 MΩ) were filled with aCSF and placed in 
the neuropil of the lateral amygdala. Fast GABAergic transmission was blocked using 
100 µM picrotoxin throughout these experiments. Stimulation strength was adjusted to 
achieve 30-50% of the maximum voltage response for each slice. The same stimulation 
strength was used for test stimulation and induction. At least 20 min of stable baseline 
was recorded before applying the induction protocol. Theta Burst Stimulation consisted 
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of 4 sets at 20 s intervals; each set included 10 bursts at 200 ms intervals; each burst 
was 4 pulses at 100 Hz. Test stimulation responses for the 10 min prior to induction and 
between 50 and 60 min after induction were used in the assessment of plasticity.  
Membrane properties. A series of negative and positive current steps were applied 
immediately upon achieving whole-cell configuration (25 x 50 pA steps, –300 to +900 
pA; 500 ms steps). The 6 initial negative steps were used to calculate membrane 
resistance; single exponential curve fits yielded time constant (τ) and capacitance 
values. Action potential threshold was defined and measured as the point of voltage 
inflection for the first spike fired in the lowest current step. An action potential was 
defined as a brief, accelerating depolarization greater than 20 mV in amplitude.  
Non-evoked synaptic transmission. All non-evoked synaptic activity was recorded at 
Vholding = -70 mV. Synaptic events were filtered at 1 kHz and analyzed using MiniAnalysis 
(Synaptosoft, Decatur, GA). Events were pooled by experimental condition for statistical 
comparison. To avoid over-representation of neurons with higher frequencies in our 
analyses, the smallest number of events recorded from a single neuron in an experiment 
was used as the number of consecutive event values each neuron contributed to the 
pool. Spontaneous Excitatory Post-Synaptic Currents (sEPSCs) were quantified using 
the 5th min of activity after whole-cell conversion for each neuron. For spontaneous and 
miniature IPSCs (sIPSCs and mIPSCs), the 8th min of activity was analyzed for each 
neuron to allow equilibration of the pipette solution. Threshold amplitudes were set at 7 
pA for sEPSCs and 20 pA for sIPSCs and mIPSCs; these values were based on the 
root-mean square of the baseline noise from wildtype recordings at multiples of 4 and 5, 
respectively (Zhang et al., 2009).  
Pharmacology. All drugs were applied through the perfusate. Picrotoxin (100 µM; PTX; 
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Sigma-Aldrich) was used to block fast GABAA receptor-mediated transmission. 
CGP35348 (1 µM; Tocris Biosciences, Ellisville, MO) was used to block slow GABAB 
receptor-mediated transmission. Tetrodotoxin (1 µM; TTX; Alomone Labs, Jerusalem, 
Israel) was used to block action potential-dependent activity. 6,7-Dinitroquinoxaline-2,3-
dione (10 µM; DNQX; Sigma-Aldrich) or 6-cyano-7-nitroquinoxaline-2,3-dione (10 µM; 
CNQX; Tocris Biosciences) and 3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (3 
µM; CPP; Tocris Biosciences) were used to block glutamatergic transmission while 
recording inhibitory synaptic transmission. CNQX and DNQX stocks were prepared in 
DMSO; the final concentration of DMSO in the recording solution was 0.01%. All other 
drugs stocks were prepared in water. 
Statistics 
For behavioral data, zero maze responses were analyzed by 2-way ANOVA where 
genotype and treatment were examined; average percent freezing responses in 
contextual fear conditioning were evaluated for genotype and test-time. Repeated 
measures ANOVA (RMANOVA) was used to examine fear conditioning responses over 
time where within-subject effects were applied to the 1 min observations and between 
subject effects for genotype and test-time (i.e., 1 or 24 h). RMANOVA was also used to 
evaluate freezing responses in cued fear conditioning during the pre-CS and CS 
intervals and for fear-potentiated startle where the within-subject effects were applied to 
the three startle stimulus intensities and the between subjects effect to the two shock 
intensities and genotypes. The interactions were decomposed by Bonferroni corrected 
pair-wise comparisons. In all cases, a p≤0.05 was considered significant. 
For synaptic plasticity experiments, LTP was calculated using averaged values of EPSP 
rise slope -5 to 0 before and 35 to 40 min after AP pairing or FP rise slope -10 to 0 
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before and 50-60 min after theta burst stimulation. Successful LTP was defined within a 
group by Wilcoxon Signed Rank Test comparisons to baseline, and within a neuron as 
≥1.15 of baseline. Comparisons of proportions of neurons that potentiated between 
groups employed z-tests. Comparisons between mean LTP values between groups 
employed unpaired t-tests. ANOVA (one- and two-way) were used as indicated for 
analyses involving genotype (wildtype vs. PAM+/-) and/or treatment (aCSF vs. picrotoxin 
or mIPSC vs. sIPSC). These include membrane properties, sEPSC, mIPSC/sIPSC. 
RMANOVA was used to make genotypic comparisons across within-subject treatments 
(e.g. serial current steps or stimulation intensities). Unpaired t-tests were used to detect 
differences for individual treatments. In all cases, a p≤0.05 was considered significant. 
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RESULTS 
PAM+/- mice present with an anxiety-like phenotype that is alleviated with 
diazepam. 
A general assessment of sensory and motor function revealed the wildtype and PAM+/- 
animals to be indistinguishable (not shown). Naïve PAM+/- mice display anxiety-like 
behaviors in the elevated zero maze (Bousquet-Moore et al., 2010b), where reduced 
time in the open areas is the major indicator of this response (Shepherd et al., 1994). To 
determine whether this behavior was responsive to anxiolytic drugs, wildtype and PAM+/- 
animals were given vehicle or diazepam. As reported, vehicle-treated PAM+/- mice spent 
less time in the open areas than wildtype controls (p=0.05) (Fig. 2-1A). Diazepam dose-
dependently increased open area time in both genotypes; however, anxiolytic responses 
to diazepam were different between genotypes. For wildtype animals, 1 mg/kg diazepam 
was required to significantly increase open area time (p<0.001), whereas both doses 
were sufficient for PAM+/- animals (p values<0.01). The response in mutants to 0.5 
mg/kg diazepam was similar to that of the vehicle wildtype controls; the 1mg/kg dose 
increased the open area time of wildtype mice more than PAM+/- mice (p<0.05). The 
latency to first enter an open area revealed wildtype mice to have shorter latencies than 
PAM+/- animals (p<0.01) (Fig. 2-1B). Diazepam reduced these latencies relative to 
vehicle for the genotypes at both doses (p values<0.05). Both doses of diazepam were 
less efficacious in PAM+/- mice than in wildtype controls (p values≤0.05). Diazepam also 
dose-dependently increased head-dipping and decreased freezing behaviors in both 
genotypes (not shown). It also enhanced the numbers of closed-to-open-to-closed area 
transitions (Wt: 2.00±0.93, 3.00±1.29, 2.30±0.45 and PAM+/-: 0.00±0.05, 1.00±0.32, 
2.10±0.74 transitions to 0, 0.5, and 1 mg/kg diazepam, respectively).  Together, these 
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data demonstrate that PAM+/- mice present with an anxiety-like phenotype that can be 
alleviated with the anxiolytic drug diazepam.  
PAM+/- mice are deficient in short- and long-term conditioned fear responses. 
Naïve PAM mice were examined in fear conditioning as described (Taylor et al., 
2008;Porton et al., 2009), where a 2 s 0.4 mA scrambled foot-shock (UCS) was paired 
once with a 12 kHz tone (CS). Contextual and cued testing occurred 1 or 24 h after 
conditioning. During conditioning, no genotypic differences were observed before or 
during presentation of the CS, or following the CS-UCS pairing (not shown). At both the 
1 and 24 h contextual tests, freezing in PAM+/- mice was decreased relative to that for 
Figure 2-1. PAM+/- mice display anxiety-like behaviors that are alleviated with 
diazepam. Wildtype (Wt) and PAM+/- littermates received vehicle, 0.5 or 1 mg/kg 
diazepam (i.p.) and were tested in the zero maze 30 min later. (A) Effects of 
diazepam on percent time spent in the open areas by Wt and PAM+/- mice. (B) 
Diazepam effects on the latency to first enter the open areas. *p<0.05, compared to 
Wt mice; +p< 0.05, compared to vehicle treatment within genotype; ^p< 0.05, 
compared to vehicle-treated Wt mice between genotypes (ANOVA; Bonferroni 
corrected pair-wise comparisons). n = 10-13 mice/genotype/treatment. 
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wildtype littermates (p values<0.01) (Fig. 2-2A-B). This effect was also evident when 
freezing was collapsed over the 5 min interval (p<0.001) (Fig. 2-2E). Although freezing 
in the context tests for both genotypes increased during the 24 h relative to the 1 h test 
(p values<0.001), freezing was reduced at both times in PAM+/- mice relative to the 
wildtype controls (p values<0.001). Hence, the PAM+/- animals are deficient in contextual 
fear conditioning at both 1 and 24 h.  
Similar results were observed for cued testing (Fig. 2-2C-D). Freezing prior to 
presentation of the CS was not different between genotypes at 1 (Fig. 2-2C; left) or 24 h 
(Fig. 2-2D; left). During the 3 min CS, freezing in wildtype mice was higher than that for 
PAM+/- animals during both the 1 and 24 h tests (p values<0.001). Freezing in wildtype 
mice was stable across the 3 min period of CS presentation and was higher at 24 than at 
1 h (p values<0.001).  By comparison, freezing in PAM+/- animals was only enhanced 
during the 24 h test over the last min compared to that during the 1 h test (p<0.01). 
Analysis of collapsed data as mean percent freezing (Fig. 2-2F) demonstrated that both 
genotypes engaged in more freezing during the CS than the pre-CS interval (p 
values<0.001). Additionally, freezing by wildtype mice during the CS presentation was 
higher at 24 h than at 1 h (p<0.001); this increase was not observed in the mutants. 
Collectively, these data demonstrate that PAM+/- mice are markedly impaired in short- 
and long-term contextual and cued fear conditioning. Because amygdala lesions 
depress freezing responses in both the contextual and cued tests whereas lesions of the 
hippocampus only decrease freezing in context but leave cued freezing intact (Kim and 
Fanselow, 1992;Phillips and Ledoux, 1992), our results suggest that PAM+/- mice may 
have some amygdala dysfunction. 
72 
 
 
  
Figure 2-2. PAM+/- mice are deficient in fear conditioning. Wt and PAM+/- 
littermates were conditioned and tested 1 or 24 h later in context- and cue-dependent 
fear conditioning. (A, B) Percent time freezing during context testing 1 (A) or 24 h (B) 
after conditioning. Animals were tested in the same chamber in which they had been 
conditioned but in the absence of the CS and UCS. (C, D) Percent time freezing 
during cued testing 1 (C) or 24 h (D) after conditioning. In cued testing, animals were 
tested in a novel chamber and after 2 min the CS was presented in the absence of 
the UCS. (E) Mean percent time freezing by Wt and PAM+/- mice over the 5 min 
context test, conducted 1 and 24 h after conditioning. (F) Mean percent time freezing 
by PAM+/- mice during cued testing at 1 (left) and 24 h (right) after conditioning; the 
pre-CS results are averaged over the first 2 min interval and the CS results are over 
final 3 min of testing during CS presentation. *p<0.05, compared to Wt mice; +p<0.05, 
compared to freezing responses at 1 h; ^p<0.05, compared to the pre-CS interval in 
the cued test (ANOVA, RMANOVA, Bonferroni corrected pair-wise comparisons). n = 
10 mice/genotype/test-condition and time. 
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PAM+/- mice display aberrant fear-potentiated startle responses. 
Fear-potentiated startle was used to examine amygdala function in PAM+/- mice (Taylor 
et al., 2008;Porton et al., 2009). Mice were conditioned at one of two shock intensities 
(0.4 and 0.6 mA) and tested for potentiation at three different startle intensities (100, 
105, and 110 dB) 48 h after the CS-UCS pairing. Startle responses on test days 1 and 2 
did not differ among genotypes to the different UCS conditions (not shown). Hence, 
baseline startle reactivities and potentiation of responses to a pure tone were similar 
between wildtype and PAM+/- mice. Forty-eight h after the CS-UCS pairing, animals were 
examined for fear-potentiated startle. When conditioned with 0.4 mA shock (Fig. 2-3A; 
left), PAM+/- mice showed significantly less potentiation of their startle responses than 
Figure 2-3. PAM+/- mice show abnormal fear-potentiated startle.  Wt and PAM+/- 
littermates were conditioned with two different intensities of shock (0.4 and 0.6 mA). 
(A) Percent potentiation by Wt and PAM+/- mice  to a 12 kHz 70 dB tone preceded by 
a 100, 105 or 110 dB white-noise startle stimulus; animals were conditioned with 0.4 
(left) or 0.6 (right) mA shock. (B) Sensitivity of Wt and PAM+/- mice to varying 
intensities of scrambled foot-shock; behavioral responses are represented by 
composite scores during the application of the shock. *p< 0.05, compared to Wt mice; 
+p<0.05, compared to responses to the 100 dB startle stimulus; #p<0.05, compared 
to responses to the 105 dB startle stimulus; ^p< 0.05, compared to responses 
following 0.4 mA shock (ANOVA, RMANOVA, Bonferroni corrected pair-wise 
comparisons). n = 9-10 mice/genotype/shock-intensity for fear-potentiated startle, n = 
10 mice/genotype for shock-threshold testing. 
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wildtype controls (p<0.01); however, when the shock intensity was increased to 0.6 mA 
potentiation to the startle stimuli was similar between genotypes (Fig. 2-3A; right). 
Overall, these findings are particularly noteworthy since in shock-threshold testing (Fig. 
2-3B), no genotype differences were discerned across different intensities of foot-shock 
– including those used in the fear conditioning or fear-potentiated startle tests. Hence the 
deficiencies of the PAM+/- mice in fear conditioning and fear-potentiated startle cannot be 
attributed to genotype differences in response to shock. Together with the fear 
conditioning results, these findings for fear-potentiated startle strongly suggest that the 
amygdala is dysfunctional in PAM+/- mice.   
Pyramidal neurons and interneurons of the basolateral amygdala express PAM. 
To determine how a change in PAM expression causes these behavioral outcomes, we 
compared the cellular expression patterns of PAM in the basolateral complex of wildtype 
and PAM+/- amygdala. There were no gross differences in the structures of PAM+/- and 
wildtype amygdalae. In agreement with haploinsufficiency of the Pam gene (Czyzyk et 
al., 2005a), PAM immunoreactivity was consistently less intense in PAM+/- compared to 
wildtype amygdala (Fig. 2-4A, B). GAD67 immunoreactivity was localized to GABAergic 
presynaptic terminals and the soma of amygdala interneurons (Muller et al., 2006;Muller 
et al., 2003;Rainnie et al., 2006). In the basolateral nuclei, GAD67 immunoreactivity in 
both genotypes was consistently stronger than in the lateral nucleus (Fig. 2-5A). 
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When examined at higher magnification, PAM immunoreactivity was apparent in the 
soma of both wildtype and PAM+/- lateral amygdala neurons (Fig. 2-4C, D; green). 
Although present in secretory granules, PAM is concentrated in the trans-Golgi network 
and endocytic vesicles and is accumulated in the perinuclear region of the cell soma 
(Niciu et al., 2006). While PAM was present in both GAD67-negative pyramidal neurons 
Figure 2-4. PAM is expressed in pyramidal neurons and interneurons in the 
basolateral amygdala.  Coronal sections (15 µm) through the amygdala of Wt and 
PAM+/- mice were immunostained simultaneously with antisera to PAM (green) and 
GAD67 (red). (A, B) Low-power merged images of Wt and PAM+/- amygdalae. Lateral 
amygdala (LA); Basolateral Amygdala (BLA); Central Amygdala (CeA); Lateral 
Paracapsular Cells (LPCS); Medial Paracapsular Cells (MPCS). Scale: 100 µm. (C, 
D) High-power images of the area in LA of Wt and PAM+/- amygdala outlined in 
panels A and B. Arrows indicate GAD67-positive interneurons. Asterisks indicate 
pyramidal neurons surrounded by GAD67-immunoreactive puncta representing axo-
somatic GABAergic terminals. Staining for PAM was apparent in the soma of both 
interneurons and pyramidal neurons. Scale: 20 µm. 
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(marked by asterisks) and GAD67-positive interneurons (marked by arrows), PAM 
immunoreactivity was more intense in interneurons. This finding is consistent with earlier 
in situ hybridization analyses of PAM expression in the rat cerebral cortex and 
hippocampus (Schafer et al., 1992b). Interneurons of the basolateral nucleus also 
exhibited stronger PAM immunoreactivities than pyramidal neurons in both genotypes 
(Fig. 2-5A; arrows). 
In both lateral and basolateral nuclei, intense GAD67 immunoreactive puncta, 
representing axo-somatic GABAergic synapses, surrounded the somata of pyramidal 
neurons (Fig. 2-4C, D and Fig. 2-5A; red). These synapses are likely contributed by 
local interneurons and paracapsular neurons, which mediate the tight feed-forward and 
feed-back inhibition described in these areas (Sah et al., 2003;Marowsky et al., 
2005;Szinyei et al., 2000). We combined electrophysiological and pharmacological 
approaches to study the function of these synapses in regulating excitability and 
plasticity in the wildtype and PAM+/- amygdala. 
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Lateral paracapsular GABAergic neurons, which form the lateral intercalated cell 
masses, were identified as clusters of GAD67-positive cell bodies along the medial 
border of the external capsule and lateral border of the lateral nucleus (Fig. 2-4A, B; 
Figure 2-5. PAM and GAD67 expression in the basolateral amygdala and lateral 
intercalated islands. Coronal sections (15 µm) through the amygdala of Wt and 
PAM+/- mice were immunostained simultaneously with antisera for PAM (green) and 
GAD67 (red). (A) High power images of basolateral nuclei. Arrows indicate GAD67-
positive interneurons, which stained strongly for PAM; * indicates examples of 
GAD67-negative pyramidal neurons. Scale: 20 µm. (B) High power images of a 
lateral intercalated island. # indicates GAD67-positive paracapsular neurons, which 
were not positive for PAM. Arrow heads indicate PAM-immunoreactive puncta. Scale: 
20 µm. 
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LPCS) (Marowsky et al., 2005;Pare et al., 2004;Silberman et al., 2008). Unlike local 
interneurons, paracapsular neurons were devoid of PAM staining (Fig. 2-5B). This 
finding is consistent with the fact that no peptide co-transmitter has been identified in 
these neurons (Marowsky et al., 2005). Strong PAM immunoreactivity was evident in 
lateral intercalated regions in the form of puncta surrounding the paracapsular cell 
somata (Fig. 2-5B) (Perez de la et al., 2007). This finding supports the lack of 
peptidergic expression and abundance of peptidergic innervation of lateral paracapsular 
cells.  
The modulation of other GABAergic neurons that innervate amygdala pyramidal neurons 
could be affected in PAM+/- amygdala. Intense immunoreactivity of PAM in the neuropil 
surrounding lateral paracapsular GABAergic neurons of the intercalated cell masses 
(Fig. 2-5B) closely resembles that for the D1 receptor, as well as for cholecystokinin 
(CCK) and gastrin (Perez de la et al., 2007), both of which are amidated neuropeptides 
(Eipper et al., 1992). Therefore, disrupted peptidergic modulation of paracapsular cells 
could contribute to altered GABAergic inhibition in the PAM+/- amygdala. 
To this point, Western and enzymatic assays have been used to quantify brain PAM 
levels at half of normal (Bousquet-Moore et al., 2010b;Bousquet-Moore et al., 
2009;Czyzyk et al., 2005a). This is the first study to characterize PAM protein expression 
in the brain at a cellular level. We found a global reduction in neuronal PAM expression 
in the PAM+/- amygdala (Figs. 4, 5), as opposed to a complete loss of PAM expression 
in half of neurons. This finding allowed us to conduct cellular electrophysiological 
experiments in the PAM+/- amygdala in which single neurons were patched later in this 
study. 
Deficient synaptic plasticity at PAM+/- thalamic amygdala afferents. 
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To investigate the neurophysiological basis for the behavioral abnormalities displayed by 
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PAM+/- mice (Figs. 1-3), we performed several electrophysiological experiments in the 
PAM+/- amygdala. Extensive experiments have demonstrated that the lateral, 
basolateral, and central nuclei of the amygdala are critical to fear conditioning (Davis, 
1990;Kim and Jung, 2006;Ledoux, 2000). Auditory and somatosensory inputs, which 
carry relevant information about the CS and UCS, terminate primarily in the lateral 
nucleus which is essential to normal cued conditioning (Ledoux et al., 1990). Thalamic 
inputs to the lateral nuclei are also important at the time of the CS–UCS pairing, and 
play a more critical role in amygdala plasticity and learning than cortical pathways and 
their corresponding inputs (Quirk et al., 1997).   
Figure 2-6. PAM+/- mice exhibit a deficiency in thalamic afferent long-term 
potentiation (LTP) that relies upon GABAergic transmission. Thalamic afferents 
were stimulated and pyramidal neuron membrane responses were recorded in whole-
cell mode in the lateral nuclei of Wt and PAM+/- amygdala slices. Insets above each 
plot depict representative averaged traces for each genotype prior to (solid) and after 
(dashed) LTP induction as indicated (baseline and post-induction). (A-D) Time-course 
(1 min bins) of averaged LTP experiments using an action potential pairing (AP 
pairing) induction paradigm. Synaptic efficacy was assessed using the rise slope of 
EPSPs that were normalized for genotypic comparisons. Experiments were 
conducted in aCSF control solution (panel A; n = 10 Wt; 11 PAM+/-), aCSF with 100 
µM picrotoxin (PTX) (panel B; n = 9 Wt; 7 PAM+/-), aCSF with cGP35348 (GABAB 
receptor antagonist; 1 µM) (panel C; n= 9 Wt; 9 PAM+/-), or aCSF with PTX and 
CGP35348 (panel D; n = 12 Wt; 10 PAM+/-). (E) Values of LTP assessed at 40 min 
post-induction for individual pyramidal neurons are plotted by experimental condition 
(data from panels A-D). Bars depict mean values and error bars depict the standard 
error of the mean. #p<0.05, compared to baseline; NSNot significant compared to 
baseline (Wilcoxon Signed Rank Test). 
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Since PAM+/- mice were most deficient in cued fear conditioning (Fig. 2-2), we assessed 
the status of glutamatergic synaptic plasticity at thalamic afferent synapses (Fig. 2-6). 
Long-term potentiation (LTP) at this synapse is the strongest neural correlate to fear 
learning and memory to date (Maren and Quirk, 2004;Pare et al., 2004;Sah et al., 
2008;Sigurdsson et al., 2007). We stimulated thalamic afferents and recorded excitatory 
post-synaptic potentials (EPSPs) in wildtype and PAM+/- pyramidal neurons from the 
lateral nucleus. LTP was induced by synchronized trains of afferent stimulation with 
post-synaptically induced action potentials. In control solution, both wildtype and PAM+/- 
neurons failed to potentiate consistently above baseline, and there was no difference in 
Figure 2-7. Field potential recordings in the PAM+/- lateral nucleus demonstrate 
the deficiency in thalamic afferent LTP using a theta-burst stimulation induction 
paradigm. Thalamic afferents were stimulated and recordings were made in the 
lateral nuclei of Wt and PAM+/- amygdala slices. Time courses are plotted in 1 min 
bins. Insets above plots depict representative averaged field potential (FP) traces for 
each genotype prior to (solid) and after (dashed) LTP induction as indicated (baseline 
and post-induction). Time-course of averaged LTP experiments using a theta-burst 
stimulation induction paradigm (4 sets at 20 sec intervals; set = 10 bursts at 200 ms 
intervals; burst = 4 pulses at 100 Hz). Synaptic efficacy was assessed using FP rise 
slopes, which were normalized to make genotypic comparisons (n = 6 Wt; 6 PAM+/-). 
As was found using whole-cell recordings and action potential pairing, slices from Wt 
mice displayed reliable LTP (1.42 ± 0.17; p<0.05), whereas slices from PAM+/- mice 
did not (1.04 ± 0.06). This finding provides further support for the LTP deficit in PAM+/- 
mice we observed using action potential pairing in whole-cell mode. Experiments 
were performed in the presence of 100 µM picrotoxin. #p<0.05 compared to baseline 
(Wilcoxon Signed Rank Test). 
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mean LTP values between genotypes (Fig. 2-6A). However, a larger proportion of 
wildtype neurons could be stimulated to induce LTP than PAM+/- neurons (wildtype 7 of 
10; PAM+/- 1 of 11; p<0.05, z-test). Since previous LTP studies have shown that limiting 
fast GABAergic transmission is necessary for LTP induction in acute slices (Tully et al., 
2007;Bauer et al., 2002), we used the same induction paradigm in the presence of the 
GABAA receptor antagonist picrotoxin (PTX; 100 µM) (Fig. 2-6B). Wildtype neurons 
reliably displayed LTP under these conditions (p<0.01), while PAM+/- neurons failed to 
potentiate. We replicated this finding using a theta-burst stimulation induction paradigm, 
which is reliant on NMDA receptor-mediated post-synaptic calcium signaling (Pan et al., 
2009), and field potential recordings (Fig. 2-7).  
Many forms of LTP at thalamic afferent synapses are dependent upon NMDA receptor 
signaling (Bauer and Ledoux, 2004;Bauer et al., 2002;Sigurdsson et al., 2007;Weisskopf 
and Ledoux, 1999). Any differences in NMDA receptors could contribute to the PAM+/- 
deficit in LTP at amygdalar afferent synapses. To isolate AMPA- and mixed 
AMPA/NMDA receptor-mediated currents, we measured thalamic synaptic currents in 
the presence of PTX using 3 different stimulation strengths at holding potentials of -70 
and +50 mV (Fig. 2-8). Comparison of AMPA:NMDA ratios revealed no significant 
differences between genotypes. Thus, the NMDA receptor contribution to glutamatergic 
transmission is normal at PAM+/- thalamic afferent synapses. Moreover, the deficit in 
thalamic afferent LTP cannot be explained by inherent differences in NMDA receptor 
signaling.  
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GABAergic transmission can also suppress glutamatergic LTP induction through GABAB 
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receptors. GABAB receptors are expressed on the dendrites of amygdalar pyramidal 
neurons and the glutamatergic terminals that innervate them (McDonald et al., 2004). In 
addition, GABAB activation suppresses glutamate release from thalamic and cortical 
afferent terminals (Pan et al., 2009). To test whether GABAB receptors were involved in 
the PAM+/- LTP deficit, we induced LTP using the same action potential pairing paradigm 
described above in the presence of the GABAB receptor antagonist CGP35348 (1 µM) 
(Fig. 2-6C). LTP significantly greater than baseline was not achieved in either genotype, 
suggesting limitation of slow inhibition alone is not sufficient to gate LTP at thalamic 
afferent synapses. Next, we asked whether blockade of both GABAA and GABAB 
receptors could affect the PAM+/- LTP deficit by inducing LTP in the presence of both 
picrotoxin and CGP (Fig. 2-6D). Under these conditions, thalamic afferent synapses 
were potentiated in wildtype and PAM+/- amygdala neurons to similar extents (p 
values<0.01). Collectively, these data provide clear evidence for a synaptic plasticity 
Figure 2-8. PAM+/- thalamic afferent synapses display a normal AMPA:NMDA 
ratio. AMPA and mixed AMPA/NMDA currents were evoked by thalamic afferent 
stimulation at 100, 200 and 300 µA and recorded in pyramidal neurons in the lateral 
nucleus. The holding current was manipulated to isolate selective currents; 
recordings were performed with 100 µM picrotoxin in the perfusate. (A) 
Representative glutamatergic current traces recorded at Vholding = -70 and +50 mV 
from Wt and PAM+/- pyramidal neurons. AMPA currents were measured at the peak of 
the -70 mV traces and NMDA currents were measured 50 ms after stimulation in the 
+50 mV traces (cursors). (B) Calculated AMPA:NMDA current ratios for Wt and 
PAM+/- neurons as a function of stimulation intensity (n = 15 Wt; 21 PAM+/-). 
RMANOVA for AMPA:NMDA current ratios found no effect of genotype. (C) In a 
subset of neurons, currents were evoked with 200 µA at holding potentials from -70 to 
+50 mV at 10 mV increments to determine the reversal potential for the AMPA- and 
NMDA-mediated components of the response. Calculated reversal potentials for the 
AMPA- (peak amplitude) and NMDA- (amplitude at 50 ms after stimulation) mediated 
components of glutamatergic currents are shown (n = 14 Wt; 13 PAM+/-). There were 
no genotypic effects of calculated reversal potentials for AMPA of NMDA receptor-
mediated currents. Two-term exponential curves were fit to the decay component of 
+50 mV traces. Slow (D) and fast (E) time constant (tau) values are plotted as a 
function of stimulation strength for Wt and PAM+/- neurons. PAM+/- slow decay tau 
was significantly longer than wildtype only at the 300 µA stimulation intensity. 
RMANOVA found no effects of genotype for slow and fast decay tau values. *p<0.05, 
compared to Wt (unpaired t-test at individual stimulus intensities). 
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deficit at amygdalar afferent synapses that is reliant on GABAergic transmission and 
correlates with the fear learning and memory deficit of PAM+/- mice.  
We also tested whether LTP deficit of PAM+/- mice extends to cortical afferent synapses 
in the lateral nucleus. We performed the experiment under identical conditions to the 
aforementioned LTP experiment except cortical afferents were stimulated rather than 
thalamic (Fig. 2-9). In the presence of PTX, wildtype neurons consistently potentiated in 
response to AP pairing (p<0.05), but PAM+/- neurons failed to potentiate significantly 
above baseline on average. Therefore, the LTP deficit of PAM+/- mice applies to both 
cortical and thalamic afferent synapses, suggesting the underlying mechanism for 
PAM+/- synaptic plasticity dysfunction is likely to be intrinsic to the amygdala.  
There was considerable overlap among neurons regarding their responsiveness to LTP 
Figure 2-9. Cortical afferent amygdala LTP is disrupted in PAM+/- mice. Cortical 
afferents were stimulated and pyramidal neuron membrane responses were recorded 
in whole-cell mode in the lateral nuclei of Wt and PAM+/- amygdala slices. (A) Insets 
above depict representative averaged traces for each genotype prior to (solid) and 
after (dashed) LTP induction as indicated (baseline and post-induction). (A-D) Time-
course (1 min bins) of averaged LTP experiments using an AP pairing induction 
paradigm. Synaptic efficacy was assessed using the rise slope of EPSPs that were 
normalized for genotypic comparisons. Experiments were conducted in aCSF with 
100 µM picrotoxin (PTX) (n = 8 Wt; 9 PAM+/-). (B) Values of LTP assessed at 40 min 
post-induction for individual pyramidal neurons are plotted for thalamic and cortical 
afferent experiments. Bars depict mean values and error bars depict the standard 
error of the mean. #p<0.05, compared to baseline; NSNot significant compared to 
baseline (Wilcoxon Signed Rank Test). 
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induction between genotypes (Fig. 2-6D), where some PAM+/- neurons responded at 
wildtype levels. The difference in average LTP between genotypes resulted from a shift 
in the distribution of LTP magnitude rather than a change to all-or-none responding. This 
effect was evident in each pharmacological condition tested, supporting the notion of 
heterogeneity of pyramidal neurons in the lateral nucleus and their responsiveness to 
LTP induction that was independent of GABAergic inhibition. Collectively, these data 
provide substantial support for a deficit in amygdalar afferent synaptic plasticity that 
correlates with the deficits in fear conditioning and fear-potentiated startle in PAM+/- 
animals.
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Input-specific synaptic enhancement in the PAM+/- amygdala. 
We assessed the balance of excitation and inhibition at pathway-specific afferent 
synapses in the amygdala by stimulating thalamic or cortical inputs and recording 
current responses in pyramidal neurons of the lateral nucleus. Interneurons of the 
amygdala mediate di-synaptic feed-forward inhibition (Sah et al., 2003;Bissiere et al., 
2003;Bauer and Ledoux, 2004;Shin et al., 2006;Szinyei et al., 2000) and contribute a 
GABAergic outward current that follows the mono-synaptic glutamatergic inward current. 
We adjusted the holding potential to -55 mV to observe both of these currents in a single 
trace and generated input-output curves for thalamic and cortical input pathways (Fig. 2-
10). Both inward and outward current amplitudes increased with stimulation strength in 
both genotypes. For thalamic inputs, PAM+/- inward current amplitudes were enhanced 
compared to wildtype at stimulation intensities between 25 and 45 µA (Fig. 2-10A-C). 
PAM+/- outward currents were significantly larger over an even wider range of stimulation 
intensities. For cortical inputs, wildtype and PAM+/- inward current amplitudes were 
identical over the full stimulation ladder, and PAM+/- outward currents were significantly 
larger at only one stimulation intensity (Fig. 2-10D-F).  
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RMANOVA was used to analyze baseline synaptic efficacy at amygdala afferent 
synapses. No effect of genotype on inward current responses across stimulation 
intensities was evident, but there was an effect on outward currents (F(1,18) = 5.017; 
Figure 2-10. Baseline synaptic efficacy is enhanced at thalamic but not at 
cortical inputs to the PAM+/- lateral nucleus. Recordings of current responses 
(Vholding = -55 mV) to graded intensities of single stimuli applied to thalamic and 
cortical afferent pathways of Wt and PAM+/- lateral amygdala slices. Responses 
consisted of a monosynaptic glutamatergic inward current followed by a di-synaptic 
GABAergic outward current, representing feed-forward inhibition. Representative 
traces depict pyramidal neuron responses to thalamic (A) and cortical (D) stimulation. 
Amplitude of evoked mono-synaptic inward/excitatory current plotted as a function of 
stimulus intensity for thalamic (B) and cortical (E) inputs. Amplitude of evoked di-
synaptic outward/inhibitory current plotted as a function of stimulus intensity for 
thalamic (C) and cortical (F) inputs. Thalamic: n = 9 Wt; 11 PAM+/-; Cortical: n = 8 Wt; 
10 PAM+/-. *p<0.05, compared to Wt (unpaired t-test at individual stimulation 
intensities). 
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p<0.05) (Fig. 2-10A-C). This may reflect enhancement of interneuronal network activity 
that contributes to feed-forward inhibition; whereas the enhancement of thalamic 
glutamatergic afferent was not strong enough to achieve statistical significance by 
RMANOVA, contribution of enhanced interneuronal network activity could explain the 
genotype effect found for di-synaptic outward currents. When current responses to 
cortical afferent stimulation were analyzed, no effects for genotype were observed for 
inward or outward currents (Fig. 2-10D-F). These data demonstrate enhancement of 
afferent synaptic efficacy and feed-forward inhibition in the PAM+/- lateral amygdala that 
is specific to the thalamic pathway.  
The increase in baseline efficacy at PAM+/- thalamic afferents synapses may reflect 
compensation for enhanced inhibition. Thalamic afferents display stronger feed-forward 
inhibition than cortical afferents (Bauer and Ledoux, 2004;Humeau et al., 2005), and 
may require compensatory enhancement as a result. However, our data show larger di-
synaptic outward currents for cortical versus thalamic afferents in wildtype neurons (Fig. 
2-10C, F). This discrepancy may stem from the inclusion of lateral paracapsular neurons 
in addition to interneurons in feed-forward inhibition of cortical inputs, or unequal 
distances of stimulating electrode placements in thalamic versus cortical experiments.  
Thalamic and cortical synapses are morphologically, molecularly and physiologically 
distinct (Weisskopf and Ledoux, 1999;Doyere et al., 2003;Humeau et al., 2005;Humeau 
and Luthi, 2007;Humeau et al., 2007;Ota et al., 2008). Input specificity of the PAM+/- 
phenotype may reflect the differential importance of PAM in thalamic versus cortical 
afferent synapses. 
Subtle signs of hyperexcitability in the PAM+/- amygdala also implicate GABA. 
Alterations in the firing properties or synaptic organization of amygdalar neurons could 
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Table 2-1. Membrane properties of wildtype and PAM+/- lateral nucleus 
pyramidal neurons. Passive and active membrane property parameters for lateral 
amygdala pyramidal neurons were derived from voltage responses to hyperpolarizing 
and depolarizing current steps. Wt and PAM+/- neurons were recorded in control 
solution (aCSF) or aCSF containing 100 µM picrotoxin (PTX). Passive properties 
pertain to the kinetics of the voltage response to the current step onset (n = 39 Wt 
aCSF; 43 PAM+/- aCSF; 45 Wt PTX; 45 PAM+/- PTX). Two-way ANOVA revealed no 
significant effects. Active property parameters pertain to the first action potential fired 
by a neuron during positive current steps (n = 17 Wt aCSF; 22 PAM+/- aCSF; 22 Wt 
PTX; 24 PAM+/- PTX). ANOVA found significant main effects of PTX on action 
potential threshold (F(1,81) = 4.412; p<0.039) and half-width (F(1,81) = 12.731; p<0.001). 
Bonferroni corrected pair-wise comparisons showed only an individual effect of PTX 
on PAM+/- threshold (p<0.020). Individual effects of PTX on half-width for both 
wildtype (p<0.007) and PAM+/- (p<0.027) neurons were evident. + indicates p< 0.05, 
compared to aCSF within genotype (Bonferroni corrected pair-wise comparisons). 
 
Lateral 
nucleus  
Passive Membrane Properties Active Membrane Properties  
RMP 
(mV)  
Ri 
(MΩ)  
τ 
(ms)  
C 
(pF)  
AP 
threshold 
(mV)  
Maximum 
Rise Slope 
(mV/ms)  
Half-
Width 
(ms)  
Decay 
Slope 
(mV/ms)  
Wt 
aCSF  
-72.1 ± 
1.23 
-155.8 ± 
6.91 
12.7 ± 
0.69 
81.9 ± 
2.82 
-34.9 ± 
0.86 
283.2 ± 
10.50 
1.15 ± 
0.03 
-49.8 ± 
2.65 
PAM+/- 
aCSF  
-71.4 ± 
1.17 
170.1 ± 
6.58 
13.8 ± 
0.65 
80.3 ± 
2.68 
-35.3 ± 
0.76 
274.5 ± 
9.23 
1.14 ± 
0.02 
-46.9 ± 
2.33 
Wt PTX  -70.9 ± 1.13 
153.4 ± 
6.36 
13.1 ± 
0.63 
85.4 ± 
2.59 
-34.1 ± 
0.76 
287.1 ± 
9.23 
1.05 ± 
0.02+ 
-49.7 ± 
2.33 
PAM+/- 
PTX  
-70.2 ± 
1.14 
156.0 ± 
6.43 
12.0 ± 
0.64 
77.4 ± 
2.62 
-32.8 ± 
0.72+ 
270.0 ± 
8.83 
1.07 ± 
0.02+ 
-49.9 ± 
2.23 
influence post-synaptic and pre-synaptic responses to LTP induction, thus contributing to 
the LTP deficit observed in PAM+/- mice. The low dose effect of diazepam on anxiety-like 
behavior in PAM+/- mice (Fig. 2-1) and the hyper-sensitivity of PAM+/- mice to 
pentylenetetrazol (Bousquet-Moore et al., 2010b) suggested that GABAergic inhibition 
was abnormal. With this in mind, we recorded the membrane and synaptic activities of 
pyramidal neurons in the lateral and basolateral nuclei of the amygdala in aCSF in the 
presence and absence of PTX.  
We began these studies by measuring passive and active membrane properties. In 
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Baso-
lateral 
nucleus  
Passive Membrane Properties Active Membrane Properties  
RMP 
(mV)  
Ri 
(MΩ)  
τ 
(ms)  
C 
(pF)  
AP 
threshold 
(mV)  
Maximum 
Rise Slope 
(mV/ms)  
Half-
Width 
(ms)  
Decay 
Slope 
(mV/ms)  
Wt 
aCSF  
-72.7 ± 
0.89 
94.7 ± 
3.87 
11.7 ± 
0.54 
128.0 ± 
5.76
-43.5 ± 
1.95 
294.7 ± 
8.85 
1.07 ± 
0.03 
-60.8 ± 
2.67 
PAM+/- 
aCSF  
-72.0 ± 
0.83 
96.0 ± 
3.57 
12.5 ± 
0.50 
133.8 ± 
5.31
-45.3 ± 
1.87 
304.2 ± 
8.51 
1.05 ± 
0.03 
-64.0 ± 
2.56 
Wt PTX  -72.0 ± 1.11 
97.2 ± 
4.81 
13.8 ± 
0.67+
147.7 ± 
7.16+
-37.0 ± 
2.04+ 
311.2 ± 
9.25 
0.98 ± 
0.03+ 
-68.4 ± 
2.79 
PAM+/- 
PTX  
-73.7 ± 
0.96 
94.0 ± 
4.19 
12.2 ± 
0.58 
129.0 ± 
6.23
-42.6 ± 
1.84 
308.0 ± 
8.51 
0.99 ± 
0.03 
-63.4 ± 
2.56 
Table 2-2. Membrane properties of wildtype and PAM+/- basolateral nucleus 
pyramidal neurons. Data for passive (n = 34 Wt aCSF; 40 PAM+/- aCSF; 22 Wt PTX; 
29 PAM+/- PTX) and active (n = 24 Wt aCSF; 26 PAM+/- aCSF; 22 Wt PTX; 27 PAM+/- 
PTX) membrane properties of pyramidal neurons in the basolateral nucleus were 
obtained as described for Table 1 for lateral nucleus pyramidal neurons. Two-way 
ANOVA revealed significant interactions between genotype and treatment condition 
for tau (F(1,95) = 4.350; p<0.039) and capacitance values (F(1,95) = 3.978; p<0.048). 
Bonferroni corrected pair-wise comparisons showed that PTX increased tau 
(p<0.015) and capacitance (p<0.034) in Wt, but not PAM+/- neurons. ANOVA also 
revealed a significant main effect of PTX on action potential threshold (F(1,95) = 4.350; 
p<0.018) and half-width (F(1,95) = 7.689; p<0.007). Bonferroni corrected pair-wise 
comparisons revealed individual effects of PTX on Wt AP threshold (p<0.022) and 
half-width (p<0.038). 
current clamp mode, wildtype and PAM+/- amygdala neurons were injected with a series 
of negative and positive current steps. Passive membrane properties were derived from 
voltage responses to negative current steps and yielded no significant genotypic 
differences (Tables 2-1 and 2-2). Positive current steps induced action potentials with 
similar kinetics in wildtype and PAM+/- amygdalar pyramidal neurons (Tables 2-1 and 2-
2). Current steps of increasing amplitude were applied until the numbers of action 
potentials declined due to depolarization-induced inactivation of voltage-gated Na+ 
channels. The maximum numbers of action potentials fired in response to a single 
current step by wildtype and PAM+/- neurons in aCSF were similar in the lateral nucleus 
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(Fig. 2-11A, B). PTX increased the maximum number of action potentials similarly in 
wildtype and PAM+/- neurons; ANOVA showed a significant main effect of PTX on 
maximum action potential number (F(1,81) = 14.715; p<0.001). Bonferroni corrected pair-
wise comparisons revealed individual effects of PTX for wildtype (p<0.05) and PAM+/- 
(p<0.001) neurons (Fig. 2-11B). However, this enhancement occurred over a broader 
range of current steps in PAM+/- neurons compared to wildtype (Fig. 2-12A, B). In the 
basolateral nucleus, the number of action potentials fired was about 2-fold higher than in 
the lateral nucleus for both genotypes in aCSF (Fig. 2-11D, E), and addition of PTX did 
not alter the maximum number of action potentials fired in either genotype; no significant 
effects of PTX or genotype on maximum action potential number were observed. Under 
aCSF conditions, PAM+/- neurons tended to inactivate earlier than their wildtype controls, 
and this difference was abolished in the presence of PTX (Fig. 2-13A, B).  
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Upon termination of the current step, an after-hyperpolarization (AHP) of the membrane 
potential was often observed (Fig. 2-12E, 2-13E; arrow). In the lateral nucleus under 
control conditions, PAM+/- neurons displayed larger maximum AHP amplitudes than 
wildtype neurons (p<0.05) (Fig. 2-11C). With the addition of PTX, PAM+/- AHPs were 
significantly reduced while wildtype AHPs remained unchanged (p<0.001). ANOVA for 
maximal AHP amplitude revealed significant effects of PTX (F(1,81) = 6.696; p<0.05) and 
an interaction between genotype and PTX (F(1,81) = 5.080; p<0.05) (Fig. 2-11C). In the 
basolateral nucleus, no differences were observed between genotypes or treatment 
conditions (Fig. 2-11F). However, AHP values plotted as a function of current step 
amplitude revealed a 2-fold enhancement of the AHP in wildtype neurons with PTX, and 
this effect of PTX was not observed in PAM+/- neurons (Fig. 2-13C, D). Collectively, 
these data identify subtle but significant signs of membrane hyperexcitability, including 
enhanced action potential firing and impaired AHP, in both the lateral and basolateral 
nuclei of PAM+/- mice.  
Figure 2-11. Active membrane properties of PAM+/- amygdalar pyramidal 
neurons are largely intact, but show subtle signs of hyperexcitability. A series of 
depolarizing 500 ms current steps were applied to Wt and PAM+/- pyramidal neurons 
in the presence and absence of picrotoxin (PTX; 100 µM). (A, D) Representative 
active membrane voltage responses recorded in control solution (aCSF) (left) and in 
the presence of PTX (right). Insets below indicate current step amplitude 
corresponding to displayed voltage traces. (B, E) Action potentials (APs) elicited by 
current steps were counted and the maximum numbers of APs are plotted by 
genotype and treatment condition for lateral (panel B; n = 17 Wt; 22 PAM+/-) and 
basolateral (panel E; n = 24 Wt; 26 PAM+/-) nucleus pyramidal neurons. Scatter points 
represent values for individual neurons, and bars represent group means with 
standard errors. (C, F) Peak amplitudes of the after-hyperpolarizations (AHP) that 
occurred at the offset of each step were measured and the maximum value for each 
neuron is plotted by genotype and treatment condition for lateral (C) and basolateral 
(F) nucleus pyramidal neurons. *p<0.05, compared to Wt within treatment; +p< 0.05, 
compared to aCSF within genotype (Two-way ANOVA; Bonferroni corrected pair-wise 
comparisons). 
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The current underlying the slow AHP is generated primarily by Ca++-activated K+ 
channels such as BK and SK channels (Meis and Pape, 1997;Faber and Sah, 2002). 
This current is strongly modulated by catecholaminergic (Faber et al., 2008;Tully et al., 
2007) and cholinergic inputs (Womble and Moises, 1993;Faber et al., 2005), which are 
dense in the basolateral amygdala. Over-expression of SK channels in the basolateral 
amygdala can have behavioral and physiological consequences including reduced 
anxiety-like behavior assessed in the elevated plus maze (Mitra et al., 2009). 
Figure 2-12. Active membrane properties of lateral nucleus pyramidal neurons. 
(A-D) Mean values of action potential (AP) number and after-hyperpolarization peak 
amplitude (AHP) are plotted as a function of current step amplitude in aCSF (panels A, 
C; n = 17 Wt; 22 PAM+/-) and PTX conditions (panels B, D; 22 Wt; 24 PAM+/-). Error 
bars represent standard error of the mean. RMANOVA found no effects of genotype for 
these parameters. (E) Representative voltage response of a Wt lateral nucleus neuron 
to a +400 pA current step (inset); arrow indicates the peak of the AHP. *p<0.05, 
compared to Wt within treatment. +p< 0.05, compared to aCSF within genotype 
(unpaired t-tests at individual current step amplitudes). 
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We next examined the status of fast glutamatergic signaling in PAM+/- amygdala neurons 
(Fig. 2-14). Using the same design as in the previous experiment, we compared 
spontaneous excitatory post-synaptic currents (sEPSC) in wildtype and PAM+/- amygdala 
neurons in control and PTX conditions. Under control conditions, sEPSC frequency was 
higher in PAM+/- than wildtype neurons (p<0.05) (Fig. 2-14A). PTX reduced the 
frequency and amplitude of sEPSCs in the lateral nucleus and abolished the PAM+/- 
enhancement in frequency (Fig. 2-14B). ANOVA for sEPSC frequency recorded in the 
lateral nucleus revealed a main effect of PTX (F(1,3416) = 46.037; p<0.001) and a 
Figure 2-13. Membrane properties of basolateral nucleus pyramidal neurons. 
Data for active (n = 24 Wt aCSF; 26 PAM+/- aCSF; 22 Wt PTX; 27 PAM+/- PTX) 
membrane properties of pyramidal neurons in the basolateral nucleus were obtained 
as for lateral nucleus pyramidal neurons. (A-D) RMANOVA found no effects of 
genotype for these parameters. (E) Representative voltage response of a Wt 
basolateral nucleus neuron to a +600 pA current step (inset); arrow indicates the 
peak of the AHP. 
97 
 
 
significant interaction between genotype and PTX (F(1,3416) = 8.671; p<0.01). ANOVA of 
sEPSC amplitude also showed a significant main effect of PTX (F(1,3511) = 10.160; 
p<0.001), and no genotypic effects. The opposite was observed in the basolateral 
nucleus wherein PTX increased the sEPSC frequency (p values<0.001) and amplitude 
(p values<0.05) similarly in wildtype and PAM+/- neurons (Fig. 2-14C, D). ANOVA of 
sEPSC frequency in the basolateral nucleus revealed a significant main effect of PTX 
(F(1,5391) = 38.574; p<0.001) and no genotypic effects. ANOVA of sEPSC amplitude also 
revealed a significant main effect of PTX (F(1,5414) = 15.953; p<0.001). These data 
suggest that the membrane and baseline excitatory synaptic properties of PAM+/- 
amygdala neurons are largely intact with signs of hyperexcitability in PAM+/- lateral 
nucleus neurons that are GABA-dependent. 
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We were surprised to find that PTX decreased sEPSC frequency and amplitude in the 
Figure 2-14. Enhanced spontaneous glutamatergic activity in the PAM+/- lateral 
nucleus is dependent on GABAA receptors. Spontaneous excitatory post-synaptic 
currents (sEPSC) from Wt and PAM+/- lateral and basolateral nucleus pyramidal 
neurons were recorded at Vholding = -70 mV in the presence and absence of picrotoxin 
(PTX; 100 µM). Traces are representative examples of sEPSC activity for each 
genotype and treatment condition. (A, C) sEPSC activity from Wt and PAM+/- 
pyramidal neurons in the lateral (panel A; n = 25 Wt; 25 PAM+/-; 38 events/neuron) 
and basolateral (panel C; n = 20 Wt; 24 PAM+/-;63 events/neuron) nucleus recorded 
in control solution (aCSF). Frequency and amplitude of sEPSC events are plotted for 
each genotype (right). (B, D) sEPSC activity recorded in the presence of PTX. Data 
are from Wt and PAM+/- pyramidal neurons in the lateral (panel B; n = 24 Wt; 21 
PAM+/-) and basolateral (panel D; n = 19 Wt; 23 PAM+/-) nucleus. *p<0.05, compared 
to Wt; +p< 0.05, compared to aCSF within genotype (Two-way ANOVA; Bonferroni 
corrected pair-wise comparisons). 
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lateral nucleus (Fig. 2-14). We expected PTX would increase both parameters as was 
observed in the basolateral nucleus. This finding may reflect enhanced GABAB receptor-
mediated transmission under PTX conditions that decreased spontaneous glutamatergic 
activity in this region. GABAB receptors localize to pre-synaptic glutamatergic terminals 
and post-synaptic dendritic domains of lateral nucleus pyramidal neurons (McDonald et 
al., 2004), and their activation could account for the PTX-induced reductions in sEPSC 
frequency and amplitude, respectively. Moreover, our sEPSC data support enhanced 
GABAB receptor activation in the lateral amygdala in the presence of PTX.  
GABAergic transmission is enhanced in the PAM+/- amygdala. 
Enhanced behavioral sensitivity to low dose diazepam, and the effects of PTX on 
amygdala neuronal input and output strongly suggest that GABAergic inhibition is 
perturbed in the PAM+/- brain. To test this hypothesis directly, we recorded GABAergic 
activity in wildtype and PAM+/- lateral nucleus neurons (Fig. 2-15). Addition of 
tetrodotoxin (1 µM) blocked action potential-mediated GABAergic activity and left only 
activity-independent, “miniature” inhibitory currents (mIPSCs) (Fig. 2-16A). mIPSCs 
recorded from PAM+/- neurons displayed increased frequencies (p< 0.001) and 
amplitudes (p< 0.001) compared to those recorded from the wildtype lateral nucleus 
(Fig. 2-15A). Enhanced frequency of PAM+/- activity-independent GABAergic events in 
the lateral nucleus could result from an increase in release probability or synapse 
number. To distinguish these possibilities, we evoked inhibitory signals via local 
stimulation (Marowsky et al., 2005) and increased the stimulation strength to achieve 
maximal responses (Fig. 2-15B). The charges of evoked synaptic responses were 
significantly larger than wildtype responses across the full range of stimulation intensities 
and at their maximal values. RMANOVA revealed a main effect of genotype on evoked 
IPSC charge (F(1,35) = 11.851; p<0.01) (Fig. 2-15B). This difference in charge was 
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evidently contributed by a combination of peak current amplitude and fast decay time 
Figure 2-15. GABAergic signaling is enhanced in the PAM+/- lateral nucleus. Wt 
and PAM+/- pyramidal neurons in the lateral nucleus were dialyzed with a high [Cl-]-
containing pipette solution and inhibitory post-synaptic currents (IPSC) were recorded 
under glutamatergic blockade. (A) “Miniature” IPSCs (mIPSCs) were recorded in the 
presence of 1 µM tetrodotoxin. Representative current traces depicting mIPSCs 
recorded from Wt and PAM+/- pyramidal neurons (left). Mean mIPSC frequency and 
amplitude are plotted for both genotypes (right; n = 28 Wt; 25 PAM+/-; 37 
events/neuron). (B) Local stimulation elicited “evoked” IPSCs (eIPSCs) in Wt and 
PAM+/- neurons only in the absence of tetrodoxin. Two superimposed representative 
current traces from each genotype in response to a 20 µA single stimulus are shown 
(left). Charge (the integral of current) was used as a measure of synaptic strength and 
is plotted as a function of stimulation intensity (right; n = 21 Wt; 16 PAM+/-). *p<0.05, 
compared to Wt (unpaired t-tests at individual stimulus intensities). (C) Paired pulses 
were applied under the same conditions as in B. Averaged traces for each genotype 
depict representative current responses to paired pulses evoked at an intensity that 
elicited half-maximal responses for individual neurons (left). Ratios for both genotypes 
are plotted for 25, 50 and 100 ms intervals (right; n = 16 Wt; 13 PAM+/-). (D) 
“Spontaneous” IPSCs (sIPSCs) were recorded from Wt and PAM+/- neurons in the 
absence of tetrodoxin and local stimulation. Representative current traces depicting 
sIPSCs recorded from Wt and PAM+/- pyramidal neurons (left). Arrows indicate 
putative action potential-dependent GABAergic events. sIPSC frequency and 
amplitude are plotted for both genotypes (right; n = 25 Wt; 21 PAM+/-; 36 
events/neuron). *p<0.05, compared to Wt; +p< 0.05, compared to mIPSC value within 
genotype (ANOVA; Bonferroni correct pair-wise comparisons for mIPSC and sIPSC 
data). 
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(Fig. 2-16B-E); however, RMANOVA for all other parameters showed no significant 
Figure 2-16. Parameters of evoked GABAergic transmission in the PAM+/- lateral 
nucleus contribute to enhanced charge. A bipolar stimulating electrode was placed 
into the neuropil of the lateral amygdalar nucleus and evoked inhibitory post-synaptic 
currents (eIPSCs) were recorded. (A) A single current trace recorded from a Wt 
lateral nucleus pyramidal neuron depicting spontaneous inhibitory post-synaptic 
currents (sIPSCs) and eIPSCs. Stimulations were applied at 0.1 Hz via local 
stimulation and continued through the course of the trace. Tetrodotoxin (TTX; 1µM) 
was added after 3 min of baseline recording (top line). (B-E) eIPSCs were recorded 
during a series of graded stimulations in the neuropil. Parameters of eIPSCs plotted 
as a function of local stimulation strength (n = 21 Wt; 16 PAM+/-). Peak amplitude (B), 
10-90% rise slope (C), 90-10% decay slope (D), and the fast component of the decay 
time constant (E) are plotted a function of stimulation intensity for both genotypes. 
RMANOVA found no effects of genotype for these parameters. *p<0.05, compared to 
Wt (unpaired t-tests at individual current step amplitudes). 
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differences. Charge signified the absolute number of Cl- ions that pass in response to a 
given stimulus, and its enhancement in the PAM+/- lateral nucleus supports either a 
greater number of inhibitory synapses or enhanced release probability.  
We then adjusted the stimulation strength to that which evoked a half-maximal response 
and recorded current responses to paired pulses (Fig. 2-15C). There was no statistical 
difference in paired-pulse ratio between wildtype and PAM+/- at any of the 3 inter-pulse 
intervals tested, suggesting that the enhanced GABAergic activity observed in the 
PAM+/- lateral amygdala does not result from a difference in release probability, but 
rather from an increase in the number of GABAergic synapses. RMANOVA for paired 
pulse ratios revealed a significant interaction between genotype and inter-pulse interval 
(F(1,27) = 7.127; p<0.05). Thus, response to paired pulses, as a function of inter-pulse 
interval, depended on genotype. The complicated circuitry of the interneuronal network 
makes specific interpretation of this result difficult, but it is clear that activity-dependent 
inhibitory signals from the interneuronal network are perturbed in PAM+/- mice.  
To determine whether there is an activity-dependent component of GABAergic 
enhancement in the PAM+/- amygdala, we recorded “spontaneous” inhibitory post-
synaptic currents (sIPSCs) in the absence of tetrodotoxin. We kept glutamatergic 
transmission blocked to ensure isolation of interneuronal network activity.  
As expected, sIPSC frequency and amplitude were significantly increased compared to 
those of mIPSCs due to the addition of large activity-dependent GABAergic events (Fig. 
2-15D; arrows). While PAM+/- neurons appeared to display a larger increase in frequency 
than wildtype neurons, ANOVA found no significant interaction between tetrodotoxin 
condition and genotype. In the basolateral nucleus, sIPSC frequency was 3-fold higher 
than in the lateral nucleus (Fig. 2-17). These results correlate with the substantial 
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increase in GAD67 immunoreactivity, presumably representing GABAergic synapses, 
between the lateral and basolateral nuclei (Figs. 2-4, 2-5). sIPSC recorded from PAM+/- 
neurons displayed enhanced frequencies (p<0.05) and reduced amplitudes (p<0.001). 
Collectively, these data provide clear evidence for enhanced GABAergic transmission in 
the PAM+/- amygdala.  
Figure 2-17. sIPSCs in the PAM+/- basolateral nucleus of the amygdala are 
enhanced in frequency and reduced in amplitude. Basolateral nucleus neurons 
were dialyzed with a high [Cl-]-containing solution and sIPSCs were recorded under 
glutamatergic blockade. Representative current traces depict sIPSCs recorded in Wt 
and PAM+/- basolateral amygdala pyramidal neurons (left). Average values of sIPSC 
frequency and amplitude are plotted for Wt and PAM+/- basolateral amygdala neurons 
(n = 17 Wt; 19 PAM+/-; 58 events/neuron). *p<0.05, compared to Wt (ANOVA). 
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DISCUSSION 
This study identifies neurophysiological correlates in the amygdala that may contribute to 
the behavioral abnormalities observed in PAM deficient animals. We have previously 
shown that half the normal amount of PAM is insufficient to support normal physiology 
and that heterozygous mice exhibit an anxiety-like phenotype (Czyzyk et al., 
2005a;Bousquet-Moore et al., 2010b;Bousquet-Moore et al., 2009). Data presented here 
expand the PAM+/- behavioral phenotype to include learned fear, characterize cellular 
PAM expression in the amygdala, and demonstrate signs of enhanced inhibition that 
likely contribute to the observed deficit in amygdalar afferent synaptic plasticity. Our data 
indicate that PAM heterozygosity affects several neuronal properties and 
neurotransmitter systems in the amygdala (Fig. 2-18), which is consistent with the 
multiple modulatory/signaling pathways in which neuropeptides play a role. Our results 
emphasize the importance and sensitivity of peptidergic pathways in mammalian 
amygdala-dependent emotions and behaviors.  
Integrating the PAM+/- behavioral and physiological phenotypes 
Anxiety and fear responses. Our results show that PAM+/- mice display anxiety-like 
behaviors and are deficient in contextual and cued fear conditioning. These findings 
were unexpected because “anxious” mice often show enhanced fear responses (Korte 
and De Boer, 2003). Over the years, evidence has accrued that projections from the 
lateral bed nucleus of stria terminalis mediate certain types of anxiety and stress 
responses, whereas the medial central nucleus of the amygdala controls phasic fear 
(Iwata et al., 1986;Ledoux et al., 1988;Hitchcock and Davis, 1991). Recent studies 
indicate that anxiety and learned fear may differ in a number of attributes that include 
behavioral responses, anatomical substrates, and transmitter/signaling mechanisms 
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(Davis et al., 2010). The consequences of PAM haploinsufficiency may differentially 
affect these pathways/systems, resulting in the observed dissociated fear phenotype. 
Indeed there are neuropeptide receptor knockout models with dissociated fear 
phenotypes (Zeng et al., 2007;Shumyatsky et al., 2002). Thus, the PAM+/- fear 
phenotype may signify distinct neuropeptidergic systems in innate and learned fear 
Figure 2-18. Roles of various amygdalar neuropeptides in neurophysiological 
alterations in the PAM+/- amygdala. PAM and neuropeptides are expressed in 
glutamatergic pyramidal neurons (PN) and GABAergic interneurons (IN) of the 
basolateral complex of the amygdala. Gastrin-Releasing Peptide (GRP) is expressed 
and secreted by PNs of the basolateral complex. GRP binds to the GRP receptor, 
which is expressed on INs and signals to increase GABA release (Shumyatsky et al., 
2002). Thyrotropin-Releasing Hormone (TRH) also signals to increase GABA release 
(Gaier et al, unpublished). The major neuropeptides expressed by local interneurons 
include cholecystokinin (CCK) and Neuropeptide Y (NPY). CCK depolarizes 
interneurons to increase GABA release (Chung and Moore, 2009;Chung and Moore, 
2007). NPY acts directly on PNs, hyperpolarizing them and reducing membrane 
resistance (Sosulina et al., 2008). In the PAM+/- amygdala (right), we found signs of 
enhanced GABA release, increased GABAergic synapse number, increased baseline 
glutamatergic signaling, reduced LTP at thalamic afferent synapses, and impairment 
of PN after-hyperpolarization. 
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pathways. 
Fear learning/memory and LTP. The disruption of synaptic plasticity observed at the 
thalamic inputs to the amygdala strongly correlates with the fear learning and memory 
phenotype of PAM+/- mice, and it may serve as the neurophysiological basis for these 
behavioral impairments. Deficiencies at both short- (1 hr) and long (24 hr) time-points in 
both cued and contextual testing demonstrate impaired formation and/or consolidation of 
associative emotional memory. It is clear, however, that PAM+/- mice are capable of 
learning; deficiencies in fear-potentiated startle were observed at the low and not the 
high shock intensity. This result is quite striking since both genotypes display similar 
levels of behavioral reactivities and sensitivities to a wide range of foot-shock intensities 
that included those used in conditoning. One explanation is that enhanced GABAergic 
inhibition in the PAM+/- amygdala sets a higher threshold for plasticity induction during 
training. This notion is supported by evidence for enhanced GABAergic activity in the 
PAM+/- amygdala and the ability of complete GABAergic blockade to eliminate the LTP 
deficit in PAM+/- mice. Future experiments will focus upon determining how specific 
enhancements in GABAergic inhibition may contribute to the fear learning and memory 
deficit of PAM+/- mice. 
Anxiety-like behaviors and GABA.  PAM+/- mice display anxiety-like behaviors in the 
zero maze and the alleviation of these responses with diazepam provides 
pharmacological validation for the behavior. The anxiety-like responses of the 
heterozygotes may be due to a reduction in bioactivity of one or several PAM-requiring 
neuropeptides that normally exert anxiolytic actions. Many neuropeptides modulate the 
excitatory-inhibitory balance by regulating pyramidal neuron and interneuron membrane 
activities (Fig. 2-18). The prominent enhancement in GABAergic activity in the PAM+/- 
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amygdala signifies disruption of that balance. Augmented GABAergic tone may render 
the PAM+/- brain susceptible to inhibitory limitation during stressful behavioral tasks such 
as the elevated-zero maze (Stork et al., 2002;Martijena et al., 2002) by endogenous 
hormones/neuromodulators (e.g. catecholamines, glucocorticoids) (Tully et al., 
2007;Duvarci and Pare, 2007;Marowsky et al., 2005). This is also consistent with 
hypersensitivity of PAM+/- mice to diazepam in the elevated-zero maze and 
pentylenetetrazol during seizure induction (Bousquet-Moore et al., 2010b). Alternatively, 
changes in the functional expression of GABA and/or benzodiazepine receptors were 
not assessed in these experiments and could contribute to the anxiety-like phenotype of 
PAM+/- mice. It should be emphasized that anxiety is a complex condition that is 
mediated by a variety of brain regions that at least include the frontal cortex, bed nucleus 
of stria terminalis, and the amygdala (Maren and Quirk, 2004;Pare et al., 2004;Kim and 
Jung, 2006;Ledoux, 2000;LeDoux, 2007;Davis et al., 2010). Therefore, we cannot draw 
any definitive conclusions regarding the physiological basis for the PAM+/- anxiety-like 
phenotype and sensitivity to diazepam from these studies alone. 
PAM+/- as a model for insufficient amidation 
Approximately half of all neuropeptides are amidated, and amidation can be rate-limiting 
under physiological conditions (Merkler, 1994) and in PAM haploinsufficiency (Bousquet-
Moore et al., 2009). Insufficient amidation and the resulting reduction in bioactive 
anxiolytic peptides would be the simplest explanation for how PAM haploinsufficiency 
might affect behavior. The prototypical example is neuropeptide Y (NPY), one of the 
most abundant neuropeptides in the mammalian brain. NPY, which has a C-terminal 
tyrosine amide (Eipper et al., 1992), suppresses anxiety-like behavior and learned fear 
responses when injected directly into the basolateral amygdala (Gutman et al., 2008). 
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However, relative levels of amidated NPY are unchanged in the PAM+/- brain (Czyzyk et 
al., 2005a) and direct physiological effectors of NPY signaling (e.g. passive membrane 
properties of pyramidal neurons) (Sosulina et al., 2008) are unaltered in the PAM+/- 
amygdala  (Fig. 2-18; right). Therefore, it is unlikely that changes in NPY signaling 
dominate the PAM+/- phenotype. 
Different Gly-extended precursors have varied affinities for the PAM catalytic core. For 
example, thyrotropin releasing hormone (TRH) terminates with proline amide (Eipper et 
al., 1992), and its Gly-extended precursor (TRH-Gly) is a particularly poor substrate for 
amidation. Consistent with this, there is an abundance of TRH-Gly in the amygdala 
compared with high PAM expressing areas like the hypothalamus (PAM+/- mice are 
euthyroid) (Bousquet-Moore et al., 2009), and PAM heterozygosity further impairs 
amidation of TRH in the amygdala (E.A. Nillni, unpublished). Since TRH signaling in the 
amygdala is involved in mediating anxiety-like behavior (Thompson and Rosen, 
2000;Yarbrough et al., 2007;Zeng et al., 2007), particularly in the elevated-plus maze 
(Gutierrez-Mariscal et al., 2008;Zeng et al., 2007), the mechanism how TRH may 
influence amygdala physiology is an important avenue for future study. For example, 
TRH enhances GABAA receptor-mediated transmission in the basolateral complex 
(Gaier et al, unpublished) (Fig. 2-18), which may underlie its reported anxiolytic effects 
and relate to the genotypic differences we observed. However, TRH signaling has no 
effect on learned fear responses (Thompson and Rosen, 2000;Zeng et al., 2007), 
making it unlikely that deficient TRH signaling could solely account for the PAM+/- 
phenotype.  
Non-enzymatic roles of PAM 
Regulating the secretory pathway. PAM heterozygosity could have effects outside of a 
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reduction in amidating activity. Over-expression of PAM in a pituitary corticotropic cell 
line reorganizes the actin cytoskeleton, impairs regulated secretion of amidated and non-
modified peptides and impairs normal secretory granule maturation and localization 
(Ciccotosto et al., 1999). These effects are mediated through the cytosolic domain of 
PAM (Alam et al., 2001). Therefore, it is plausible that limitations in PAM could have the 
opposite effect and enhance stimulus-evoked secretion. In this sense, increased 
anxiogenic peptide signaling would account for the PAM+/- phenotypes. Potential 
candidates include cholecystokinin (CCK) (Chen et al., 2006;Fendt et al., 1995) and 
corticotropin releasing hormone/factor (CRH/CRF; synthesized in the central nucleus) 
(Bale and Vale, 2004), both of whose signaling increases GABAergic transmission in the 
amygdala (Chung and Moore, 2007;Chung and Moore, 2009;Nie et al., 2004). 
Regulation of GABAergic transmission is clearly a major modulatory target of amygdalar 
neuropeptides (Fig. 2-18; left). Our findings in the PAM+/- amygdala suggest net 
enhancement of that signaling, which supports a non-amidation-dependent mechanism 
for PAM haploinsufficiency. 
Gastrin-releasing peptide (GRP), another amidated peptide (Baldwin et al., 2007), is 
expressed and secreted by pyramidal neurons of the basolateral complex (Fig. 2-18). 
GRP signaling suppresses LTP by enhancing the excitability of and GABA release from 
local interneurons on which the GRP receptor is expressed (Shumyatsky et al., 2002). 
However, contradictory evidence employing GRP receptor antagonist infusion into the 
amygdala of rats (Mountney et al., 2008;Mountney et al., 2006;Roesler et al., 
2004;Bedard et al., 2007) makes it difficult to predict the role of GRP signaling in 
modulating amygdala neurophysiology and amygdala-dependent behaviors. Thus, 
altered GRP signaling in the PAM+/- brain may contribute to physiological and behavioral 
differences we observed. 
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Copper metabolism. It is clear that copper metabolism is intricately tied with PAM 
function and vice versa. Copper can regulate the cleavage and recycling of PAM (De et 
al., 2007) and could therefore have important effects on nuclear signaling. Some PAM+/- 
behavioral phenotypes can be rescued with dietary copper supplementation of PAM+/- 
mice and mimicked with mild copper depletion in wildtype mice (Bousquet-Moore et al., 
2010b;Bousquet-Moore et al., 2009). Anxiety-like behavior falls into this category while 
seizure sensitivity did not. On the other hand, PAM heterozygosity could mediate its 
effects by altering copper signaling. Copper is secreted by neurons and can suppress 
NMDA receptor function through a nitric oxide-dependent mechanism (Schlief et al., 
2006). Nitric oxide signaling is also required for auditory fear conditioning  and LTP at 
thalamic afferent amygdalar synapses (Schafe et al., 2005;Ota et al., 2008). Therefore, 
copper signaling may play a role in limiting synaptic plasticity in the PAM+/- amygdala.  
PAM+/- animals exhibit impairments involving several inter-dependent organ systems, 
and there is evidence for both amidation- and non-amidation-related mechanisms in 
explaining their behavioral and physiological deficits. These layers of complexity likely 
reflect the multi-faceted regulation of peptide signaling and the plethora of roles peptides 
play in physiology and pathophysiology. Clearly, peptidergic signaling relies on normal 
PAM function. Peptides are a promising avenue of novel therapeutics in psychiatric 
treatments of anxiety disorders (Mathew et al., 2008). Pursuing the study of how dietary, 
pharmacological and genetic influencers of PAM function can alter physiology and 
behavior brings us closer to identifying how peptidergic signaling pathways can serve as 
targets for clinical intervention. 
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CHAPTER 3: In vivo and in vitro analysis of amygdalar function following loss of 
peptide amidating monooxygenase reveals essential role for copper 
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ABSTRACT 
Peptidylglycine α-amidating monooxygenase (PAM) is a secretory granule membrane 
protein whose luminal enzymatic domains catalyze the Cu-dependent amidation 
biosynthetic step common to many neuroactive peptides. Aside from its essential role as 
the sole mammalian amidating enzyme, PAM alters Cu homeostasis, modulates 
transcription and regulates secretory granule trafficking. The model of PAM 
haploinsufficiency employs mice heterozygous for the Pam gene (PAM+/-); the mice 
show anxiety-like disorders and deficiencies in fear learning and memory that coincide 
with deficient long-term potentiation (LTP) at excitatory thalamic afferent synapses. To 
study the interaction between PAM and Cu in vivo, we supplemented the drinking water 
of wildtype and PAM+/- mice. Cu supplementation rescued the cued learned-fear deficits 
of PAM+/- mice, with little effect on the behaviors of wildtype mice. Dietary Cu 
supplementation also corrected the LTP deficit of PAM+/- mice in vitro. Bath application 
of the extracellular specific Cu chelator bathocuproine disulfonate abolished LTP in 
wildtype and PAM+/- amygdalae, demonstrating a vital role for Cu in amygdalar synaptic 
plasticity. Dietary Cu supplementation had no effect on brain Cu or PAM protein levels, 
therefore PAM+/- behavioral deficiencies do not result from insufficient Cu levels and/or 
amidating activity. Localization of the major neuronal Cu transporter, ATP7A, was 
altered in the PAM+/- brain. In addition, quantitative PCR revealed region-specific deficits 
in Atox-1 and ATP7A that may account for the physiological and behavioral defects 
associated with PAM heterozygosity. These data indicate that Cu is necessary for 
normal amygdalar synaptic function, suggesting the PAM+/- behavioral and physiological 
phenotype stems from dysregulated Cu secretion. 
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INTRODUCTION 
Peptidylglycine -amidating monooxygenase (PAM), a Cu-dependent monooxygenase, 
is necessary for the biosynthesis of many neuropeptides (Czyzyk et al., 2005b;Eipper et 
al., 1992). Mice heterozygous for PAM (PAM+/-) exhibit limited impairments including 
inability to maintain body temperature in the cold, increased susceptibility to 
pentylenetetrazol-induced seizures, and increased anxiety-like behavior (Gaier et al., 
2010;Bousquet-Moore et al., 2009;Bousquet-Moore et al., 2010b). A subset of these 
deficits can be rescued with dietary Cu supplementation and mimicked by dietary Cu 
restriction of wildtype mice (Bousquet-Moore et al., 2010b;Bousquet-Moore et al., 2009). 
The ability of dietary Cu supplementation to rescue deficits associated with PAM 
heterozygosity is striking, since neuropeptide amidation is only modestly diminished in 
PAM+/- mice (Bousquet-Moore et al., 2010b). In the present set of studies, we use the 
PAM+/- amygdala to study the role Cu in synaptic plasticity and associated behaviors.  
Copper is an essential trace element required by aerobic, multicellular organisms. Its 
redox potential and electron accepting capacity make Cu essential for several enzymes 
that consume molecular oxygen (Decker and Terwilliger, 2000;Crichton and Pierre, 
2001). Only about a dozen cuproenzymes (requiring Cu for activity) are encoded in the 
mammalian genome (Linder and Hazegh-Azam, 1996;Crichton and Pierre, 2001), 
including cytochrome c oxidase, lysyl oxidase, dopamine β-monooxygenase and PAM. 
Delivery of Cu to these enzymes involves a larger number of proteins dedicated to 
transport, binding and chaperoning of Cu. Cu is known to have direct inhibitory effects 
on several synaptic receptors and ion channels including GABAA receptors (Mathie et 
al., 2006). The function of copper bound to other proteins like Prion Protein (Vassallo 
and Herms, 2003;Zomosa-Signoret et al., 2008) and Amyloid Precursor Protein (Atwood 
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et al., 2000;Lin et al., 2010) is not well understood.  
The importance of Cu to normal nervous system function is demonstrated by the severe 
phenotype of Menkes disease, an X-linked genetic disorder of Cu transport. The Menkes 
protein, ATP7A, is a P-type ATPase responsible for Cu uptake from the gut and from 
blood into the brain (Lutsenko et al., 2007;Kaler, 2011). Some of the pathophysiological 
features of Menkes disease reflect deficits in cuproenzyme function. Notable 
neurological features include severe seizures, neurodegeneration and death, typically in 
early childhood (Kaler, 2011). However, some of these deficits could reflect deficient 
direct Cu signaling. 
Lack of Ctr1, a plasma membrane Cu transporter, is incompatible with life (Kuo et al., 
2001;Lee et al., 2001); mice lacking Ctr1 expression in the heart exhibit a profound 
increase in ATP7A expression in liver and intestine (Kim et al., 2010a). Cells exposed to 
serum from these mice express increased levels of ATP7A, revealing homeostatic 
controls responsive to tissue-specific deficits in Cu availability. Manipulation of Cu 
availability in vitro alters the proteolytic processing and endocytic trafficking of PAM (De 
et al., 2007). In vivo, manipulation of dietary Cu alters PAM secretion and genetic 
alteration of PAM affects Cu handling in multiple organs (Bousquet-Moore et al., 2010b). 
This bidirectional interaction suggests a non-enzymatic role for PAM in Cu homeostasis.  
The -secretase-mediated cleavage of PAM releases a soluble fragment, which 
accumulates in the nucleus and alters gene expression (Ciccotosto et al., 
1999;Rajagopal et al., 2009). This may be part of a pathway by which PAM regulates Cu 
homeostasis.  
Since the neural pathways involved in fear learning and memory are well understood 
(Ledoux et al., 1990;Ledoux, 2000;Maren and Quirk, 2004;Pare et al., 2004;Kim and 
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Jung, 2006), we first asked whether the amygdala-related physiological deficits observed 
in PAM+/- mice could be rescued by dietary Cu supplementation. Since they were, we 
next asked whether similar effects could be detected in slice preparations. Finally, we 
probed the effects of Cu on normal amygdalar synaptic function, testing how dysfunction 
of normal Cu signaling could account for the deficits seen in PAM+/- mice.  
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METHODS 
Animals  
Male and female mice were generated from PAM+/- pairings in the University of 
Connecticut Health Center (UCHC) animal facility. Wildtype and PAM+/- littermates (>20 
generations bred into C57/BL6J background) were weaned between P19 and P21 and 
group-housed until experiments. Animals were maintained under a 12 h light/dark cycle 
(lights on at 0700) and were given free access to food and water. The behavioral 
experiments were conducted at Duke University between 1100-1400 h, where adult 
male and female wildtype and PAM+/- mice (12-20 weeks of age) were tested. Since no 
sex differences were observed, data were pooled. Dietary Cu supplementation consisted 
of the addition of 300 ppm (1.2 mM) CuSO4 to standard reverse-osmosis drinking water 
for 10-14 days prior to experiments. This was not a toxic dose of Cu as mice 
supplemented with dietary Cu appeared and behaviored normally; no mice treated with 
dietary Cu supplementation died prematurely. All experiments were conducted with 
approved protocols from the UCHC and Duke University Institutional Animal Care and 
Use Committees and in accordance with NIH guidelines for animal care.  
Behavior  
Fear conditioning.  Details of the fear conditioning tests have been published (Taylor et 
al., 2008). Wildtype and PAM+/- mice were tested in either context or cued fear 
conditioning 24 h after training. All mice were conditioned with a single 30 s 72 dB tone 
(CS) and 2 s 0.4 mA scrambled foot-shock (US) on day 1. Context testing consisted of 
returning the mouse to the same chamber in which the CS-US pairing had been 
presented. For cued tests the mice were placed into a novel chamber with a different 
level of illumination, floor, walls, shape and dimensions than the conditioning chamber. 
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All tests were video-taped and the behaviors were later scored using the Noldus 
Observer by a trained observer who was blind to the genotype and dietary condition of 
the mice. Freezing was defined as the lack of all non-respiratory movement by the 
animal for >1 s (Anagnostaras et al., 2000;Porton et al., 2009).   
Fear-potentiated startle. This test has been described in detail (Taylor et al., 2008). 
Testing was conducted in a MedAssociates apparatus (St. Albans, VT) over 5 days. On 
day 1, baseline startle responses were assessed over 18 trials with 40 ms bursts of 
white noise at 100, 105 and 110 dB presented in pseudorandom order with an inter-trial 
interval of 30–90 s. On day 2, one-half of the startle stimuli were administered 
immediately following a 30 s 12 kHz 70 dB pure tone (CS); the other half were presented 
without the CS. Twenty-four h later mice were conditioned with 10 CS-US (0.25 s 0.4 mA 
scrambled shock) pairings. Forty-eight h later, mice were tested for potentiation of their 
startle responses by the CS using the same procedure described for day 2. Potentiation 
to the CS was defined as the percent increase in the startle response for the CS+startle-
stimulus trials relative to the baseline startle responses on day 1.   
Electrophysiology  
Slice preparation. Male wildtype and PAM+/- littermates 4–7 weeks of age were 
decapitated and their brains quickly removed into ice-cold artificial cerebrospinal fluid 
(aCSF) aerated with 95% O2 and 5% CO2, pH 7.3, 310 mOsm/kg, containing (in mM): 
125 NaCl, 26 NaHCO3, 10 glucose, 2.3 KCl, 2 CaCl2, 2 MgSO4, 1.26 KH2PO4 (Zhou et 
al., 2008a). Coronal slices, 300 µm thick, were incubated at room temperature for at 
least 1 h before recordings.  
Whole-cell recordings. Slices were transferred to a recording chamber heated to 32°C 
and perfused with aerated aCSF. Recording pipettes had 3-5 MΩ tips. The internal 
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pipette solution contained (in mM) 135 K-gluconate, 10 HEPES, 10 P-creatine, 3 
Na2ATP, 2 MgCl2, 0.3 Na2GTP, pH 7.3, 285 mOsm/kg (Zhou et al., 2008a). Neurons 
were patched under visual guidance using infrared differential interference contrast 
optics. Data were collected using a Multiclamp 700B amplifier (Molecular Devices, 
Sunnyvale, CA) and analyzed using pClamp 9.2 software (Molecular Devices). A series 
of negative and positive current steps were applied immediately upon achieving whole-
cell configuration (25 x 50 pA steps, –300 to +900 pA; 500 ms steps) and the firing 
pattern observed was used to verify pyramidal cell type. Series resistance was 
continuously monitored throughout each experiment using either a 5 mV voltage or 25 
pA current step. Neurons were eliminated from analysis if series resistance changed by 
more than 20%. Bath-application of CuSO4 did not result in a consistent change in series 
resistance.  
Evoked synaptic transmission. Synaptic activity was evoked using 200 µs current pulses 
elicited at 0.1 Hz with a Master 8 and an ISO-Flex stimulator (A.M.P.I., Jerusalem, 
Israel) through bipolar tungsten electrodes (World Precision Instruments, Sarasota, FL). 
Electrode placement in the internal capsule preferentially stimulated thalamic afferent 
axons (Weisskopf and Ledoux, 1999). For Cu wash-in experiments, neurons were 
clamped at VHolding = -35 mV to simultaneously monitor excitatory and feed-forward 
inhibitory transmission. A 5 mV, 25 ms hyperpolarizing step was applied 800 ms after 
each synaptic response to monitor passive membrane properties. The perfusate was 
switched during continuous recording to aCSF containing 10 µM CuSO4.  
Synaptic plasticity. In whole-cell configuration, experiments were conducted in current 
clamp mode in the presence of 100 µM picrotoxin (PTX) (Tully et al., 2007;Weisskopf et 
al., 1999). The holding current was adjusted to maintain Vm = -70 mV throughout the 
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course of experiments. The 10-90% rise slope of Excitatory Post-Synaptic Potentials 
(EPSPs) was used as the measure of synaptic efficacy. Stimulation strength was 
adjusted to produce a 3-6 mV EPSP. Paired pulses were applied at a 50 ms interval, 
and the ratio of the second EPSP 10-90% rise slope to that of the first was interpreted as 
an inverse indicator of release probability. After establishment of a steady baseline, 
Long-Term Potentiation (LTP) was induced using an action potential pairing induction 
protocol. This induction paradigm was originally characterized as being L-type voltage-
gated calcium channel-dependent and NMDA receptor-independent (Bauer et al., 2002). 
Fifteen paired trains were applied at 0.1 Hz; each train consisted of 10 pulses at 30 Hz 
paired with 2.5 ms current pulses of ≥ +1 nA to elicit an action potential at a 5 ms delay 
to the onset of each synaptic event. If 1 nA was not sufficient, then the pulse amplitude 
was increased by +50 pA until action potentials were observed throughout the train. LTP 
was measured as the normalized fractional difference between the 5 min baseline and 
30-40 min post-induction; neurons were pooled by genotype. Only one neuron was used 
per slice. 
Pharmacology. PTX (100 µM; Sigma-Aldrich) was used to block fast GABAA receptor-
mediated transmission. CGP35348 (1 µM; Tocris Biosciences, Ellisville, MO) was used 
to block slow GABAB receptor-mediated transmission. The open voltage-gate Na 
channel blocker QX-314 (3 mM; Sigma-Aldrich) was added to the internal pipette 
solution when indicated to block action potential activity selectively in the patched 
neuron. 
Immunocytochemistry  
Immunohistochemical staining of tissue sections from perfusion-fixed mice was 
described previously (Ma et al., 2001;Ma et al., 2002;Ma et al., 2008a). Briefly, male 
129 
 
 
wildtype and PAM+/- littermates were perfused transcardially with 4% formaldehyde/0.1 M 
sodium phosphate buffer (pH 7.4) under deep ketamine/xylazine anesthesia. After 
fixation, brains were post-fixed in 4% paraformaldehyde for 3 h. Coronal sections were 
cut (15 µm) through the amygdala using a cryostat and immunostained simultaneously 
with rabbit antiserum JH629 to the Exon A (exon 16) region of PAM1 (Maltese and 
Eipper, 1992) and mouse monoclonal IgG to ATP7A (Neuromab, University of California 
Davis, CA). Alexa-488 donkey anti-rabbit (H+L) antibody (Invitrogen, Molecular Probes, 
Eugene, OR) and CyTM3-conjugated AffiniPure F(ab’)2-fragment donkey anti-mouse 
(H+L) antibody (Jackson ImmunoResearch Laboratories Inc., West Grove, PA) were 
then applied. To-Pro3 (Invitrogen-Molecular Probes, Eugene, OR) was added separately 
as described (Ma et al., 2001). Images are single focus planes captured using an 
automated Zeiss LSM 510 Meta confocal microscope at the Center for Cell Analysis and 
Modeling, UCHC. Low power images employed a 20x 0.75 NA air objective, 92 µm 
pinhole; high power images employed a 63x 1.4 NA oil DIC objective, 92 µm pinhole.  
PSD fractionation and Western blotting 
Subcellular fractionation was used to prepare samples enriched in endoplasmic 
reticulum/Golgi, cytosol, synaptosomal membranes, synaptic vesicles, and 
synaptosomal cytosol (Ma et al., 2008a;Huttner et al., 1983). Purified PSDs were 
prepared using a modification of published procedures (Carlin et al., 1980;Ma et al., 
2008a). Samples removed from the interface of the 1.0/1.2 m sucrose layers of an 
equilibrium gradient were diluted, pelleted and then solubilized by incubation for 30 min 
at 4°C with 0.5% Triton X-100 (TX-100), 10 mm HEPES, pH 7.4. PSDs were pelleted 
and TX-100-soluble fraction was saved for analysis. Protein concentrations were 
determined using bicinchoninic acid (Pierce) with bovine serum albumin as the standard. 
Polyclonal rabbit antiserum to ATP7A (CT-77) was described previously (Niciu et al., 
130 
 
 
2006). Commercial mouse monoclonal antibodies to NR2B (clone N59/20; NeuroMab), 
GM130 (BD Biosciences, Franklin Lakes, NJ) and βIII-tubulin (Covance, Princeton, NJ) 
were used.  
Quantitative PCR 
Bilateral 2 mm diameter punches from individual mice containing the amygdalae and 
hippocampi were isolated from 1 mm coronal sections and immediately transferred from 
isotonic phosphate buffered solution, pH 7.4, into 500 µl TRIzol. RNA and cDNA were 
prepared essentially as per the manufacturer’s instructions, with minor modifications 
(Mains et al., 2011). All primers were chosen to have identical melting temperatures and 
to produce products of 120 + 5 nt, as listed in Table 3-1. The maximal rate of 
amplification was 1.9 + 0.15. All data were calculated with respect to GAPDH and 
groups of 5-6 mice were averaged. 
Table 3-1. qPCR primer sequences and melting temperatures. 
Transcript Primer Sequence TMelting (C)
GAPDH - F TTGTCAGCAATGCATCCTGCACCACC 61
GAPDH - R CTGAGTGGCAGTGATGGCATGGAC 61
mPAM - F TGCTGCTGCTGCTGGGGCTGCT 62
mPAM - R CAAGGCATTCATTGGAAAATGATCTGGTAGTTTCTTT 61
Atox-1 - F CACGAGTTCTCCGTGGACATGACC 61
Atox-1 - R GTCGATGCAGACCTTCTTGTTGGGC 61
ATP7A - F GGATGCAAATTCAATTACTATCACTGTTGAGGG 61
ATP7A - R CTTCTAGTGAAACTTTAATGTGATGGACACC 61
GABAA α1 - F CCAGTTTCGGACCAGTTTCAGACCAC 61
GABAA α1 - R TGTTTAGCCGGAGCACTGTCATGGG 61
GABAB 2 - F TCATCGCGGAATCCCTCCAAGGC 61
GABAB 2 - R CGTTGTCTGAGGGCACCGTCC 60
GAD65 - F ATGGCGTCTCCTGGCTCCGG 60
GAD65 - R CGATGCCGCCCGTGAACTTTTGG 61
GAD67 - F CATATACTACTACAAAATTACAGGAGATCTAGTTATTATTATTC 61
GAD67 - R GAGCTCTGGACATGGCTGGAGG 60
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Statistics 
For behavioral data, freezing responses were analyzed by 2-way ANOVA where 
genotype and dietary condition were examined. Repeated measures ANOVA 
(RMANOVA) was used to examine fear-potentiated startle responses over the three 
startle stimulus intensities between genotype and dietary condition. The interactions 
were decomposed by Bonferroni corrected pair-wise comparisons. For synaptic plasticity 
experiments, LTP was calculated using averaged values of EPSP rise slope -5 to 0 min 
before and 30 to 40 min after AP pairing. Successful LTP was defined within a group by 
Wilcoxon Signed Rank Test comparisons to baseline. Comparisons between mean LTP 
values between groups employed unpaired t-tests. ANOVA (one- and two-way) were 
used as indicated for analyses involving genotype and/or treatment. Unpaired t-tests 
were used to detect differences for individual treatments. In all cases, a p≤0.05 was 
considered significant. 
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RESULTS 
Cu rescues fear learning and memory deficits in PAM+/- mice 
We have previously shown that PAM+/- mice exhibit both short and long-term deficits in 
fear learning and memory assessed by classical contextual and cued fear conditioning 
as well as fear potentiated-startle (Gaier et al., 2010). Since other physiological and 
behavioral deficits of PAM+/- mice could be ameliorated by dietary Cu supplementation 
(Bousquet-Moore et al., 2009;Bousquet-Moore et al., 2010b), we asked whether the fear 
learning and memory deficit were sensitive to Cu. Wildtype and PAM+/- mice were placed 
on diets including either normal reverse-osmosis drinking water (control) or drinking 
water supplemented with CuSO4 for 10-14 days (Bousquet-Moore et al., 2010b). Mice 
were trained with a single fear conditioning trial (CS-US pairing) and tested in either 
contextual or cued fear conditioning 24 h later. Nearly identical shock sensitivities 
between genotypes were demonstrated previously (Gaier et al., 2010). Dietary Cu 
supplementation had no effect on wildtype baseline freezing (Fig. 3-1A). The only 
significant difference in baseline freezing between groups was a reduction displayed by 
PAM+/- mice on the Cu supplemented diet compared to the control diet, consistent with 
an anxiolytic effect of dietary Cu supplementation in PAM+/- mice (Bousquet-Moore et al., 
2010b). Mice of both genotypes in both dietary conditions displayed increased freezing 
on the test day compared to their respective training trials, indicating successful learning 
and memory (Fig. 3-1).  
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Figure 3-1. Dietary Cu supplementation impairs wildtype contextual and 
partially rescues PAM+/- cued fear conditioning. Wt and PAM+/- littermates were 
placed on a diet consisting of either control water (left) or Cu supplemented (right) 
water prior to conditioning. (A) Mean percent time freezing during 2 min context 
exposure and subsequent 3 min cue exposure prior to shock on the conditioning day. 
(B) Mean percent time freezing during 5 min context exposure testing 24 h after 
conditioning. Animals were tested in the same chamber in which they had been 
conditioned but in the absence of the CS and UCS. (C) Mean percent time freezing 
during cue exposure testing 24 h after conditioning. In cued testing, animals were 
tested in a novel chamber and after 2 min the CS was presented in the absence of 
the UCS for 3 min; the pre-CS results over the first 2 min are not shown. *p<0.05, 
compared to Wt mice within dietary condition; #p<0.05, compared to control water 
within genotype. (ANOVA, Bonferroni corrected pair-wise comparisons). n = 10 
mice/genotype/dietary condition. 
134 
 
 
In agreement with our previous observations, PAM+/- mice drinking control water spent 
significantly less time freezing in response to the context than wildtype mice receiving 
control water (Fig. 3-1B). Dietary Cu treatment reduced contextual freezing in wildtype 
mice but had no effect on freezing in PAM+/- mice. The context-dependent deficit 
exhibited by PAM+/- mice remained after dietary Cu supplementation. As reported 
previously, in response to cue exposure, PAM+/- mice on the control diet spent 
significantly less time freezing than wildtype mice on the control diet (Fig. 3-1C). Dietary 
Cu supplementation had no significant effect on cue-dependent freezing responses in 
wildtype mice. However, Cu supplementation significantly increased cued freezing 
responses in PAM+/- mice, abolishing the genotypic difference in cued fear conditioning. 
These data indicate that contextual and cued fear conditioning are differentially 
influenced by dietary Cu supplementation. 
Since we previously demonstrated a deficit in PAM+/- fear-potentiated startle (Gaier et 
al., 2010), we next evaluated the effects of dietary Cu on this response. Wildtype and 
PAM+/- mice on the control and Cu supplemented diet were tested. On testing day, 
PAM+/- animals on the control diet displayed impairments in startle response potentiation 
compared to their wildtype counterparts at each of the 3 startle amplitudes tested (Fig. 
3-2A), consistent with previous results (Gaier et al., 2010). Dietary Cu treatment had no 
effect on wildtype startle response potentiation at any of the 3 startle amplitudes. By 
contrast, dietary Cu supplementation increased PAM+/- potentiation to levels comparable 
to wildtype and abolished the genotypic difference at all startle amplitudes (Fig. 3-2A). 
The only difference in baseline startle observed between genotypes on the control diet 
was a reduction in response amplitude to the lowest stimulus intensity (Fig. 3-2B); this 
difference was not observed at the other stimulus intensities or in a previous study 
(Gaier et al., 2010). Dietary Cu supplementation reduced the baseline startle response 
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to all three stimulus intensities in wildtype mice, and reduced startle responses to two of 
three stimulus intensities of PAM+/- mice. This effect may be partially attributable to the 
anxiolytic effects of dietary Cu supplementation (Bousquet-Moore et al., 2010b). No 
significant differences were observed in potentiation of any startle responses by the 12 
kHz 70 dB tone between genotype or dietary condition (not shown), indicating that the 
tone does not contribute to startle response potentiatiation in mice of either genotype.. 
These data are consistent with results for cued fear conditioning, and together they 
prompted us to explore the neurophysiological effects of dietary Cu supplementation 
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Figure 3-2. Dietary Cu supplementation rescues the PAM+/- deficit in fear-
potentiated startle. Wt and PAM+/- littermates were placed on control or Cu 
supplemented diets as in Fig.1 and conditioned in the fear-potentiated startle task 
using a 0.4 mA foot shock. (A) Percent potentiation by Wt and PAM+/- mice on both 
diets in startle response to 100, 105 or 110 dB white-noise startle stimuli preceded by 
a 12 kHz 70 dB tone after conditioning.  *p< 0.05, compared to Wt mice within dietary 
condition; #p<0.05, compared to control water within genotype (ANOVA, RMANOVA, 
Bonferroni corrected pair-wise comparisons). (B) Percent peak amplitudes of startle 
responses relative to baseline of Wt and PAM+/- mice on both diets to 100, 105 or 110 
dB white-noise startle stimuli preceded by a 12 kHz 70 dB tone prior to conditioning. 
Baseline startle response to 100, 105 or 110 dB white-noise startle stimuli were 
identical (not shown). n = 10 mice/genotype/dietary condition. 
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using slice preparations.  
Cu rescues synaptic plasticity in PAM+/- mouse amygdala 
Based on previous study, the fear learning and memory deficit in PAM+/- mice is thought 
to be caused by an impairment in synaptic plasticity at thalamic afferent synapses in the 
amygdala (Gaier et al., 2010). Since some aspects of the fear learning and memory 
deficit were ameliorated with dietary Cu supplementation (Figs. 1,2), we tested whether 
the LTP deficit at thalamic afferent synapses of PAM+/- mice responded to dietary Cu 
supplementation.  
Thalamic afferent fiber bundles were stimulated and excitatory post-synaptic potentials 
(EPSPs) were recorded post-synaptically from lateral nucleus pyramidal neurons using 
whole-cell patch clamp methods. Neurons recorded from wildtype mice fed control water 
achieved statistically significant LTP (Fig. 3-3A). Confirming previous results, neurons 
from PAM+/- mice on the control diet failed to achieve significant LTP (Gaier et al., 2010). 
Normalized EPSP rise slope was significantly reduced in PAM+/- neurons compared to 
wildtype 30-40 min after LTP induction (p<0.05). Wildtype synaptic potentiation 
coincided with a reduction in the paired pulse ratio (p<0.05), indicating an enhancement 
in pre-synaptic release probability (not shown). PAM+/- paired pulse ratios remained 
unchanged following induction, corroborating the lack of change in PAM+/- release 
probability and synaptic efficacy (not shown). There was no difference in paired pulse 
ratio between genotypes at baseline. These data confirm the previously reported deficit 
in synaptic plasticity in the PAM+/- amygdala. 
Neurons from wildtype mice fed Cu supplemented water exhibited LTP that was 
indistinguishable from LTP in wildtype mice receiving control water (Fig. 3-3B versus 
Fig.3A). Importantly, dietary Cu supplementation abolished the genotypic difference in 
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LTP observed in wildtype and PAM+/- mice receiving control water. Moreover, Cu 
supplemented PAM+/- LTP was significantly higher compared to baseline and PAM+/- LTP 
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Figure 3-3. Dietary Cu 
supplementation rescues the 
PAM+/- amygdalar synaptic 
plasticity deficit. Wt and PAM+/- 
littermates were placed on the + 
CuSO4 dietary regimen prior to 
amygdalar slice preparation. 
Thalamic afferents were 
stimulated and pyramidal neuron 
membrane responses were 
recorded in whole-cell mode in the 
lateral nuclei in the presence of 
100 µM picrotoxin. (A,B) Time-
course (1 min bins) of averaged 
LTP experiments using an action 
potential pairing induction 
paradigm at minute 0 (arrow) of 
Wt and PAM+/- neurons from mice 
on the control (A; n = 7 Wt; 7 
PAM+/-) and Cu supplemented (B; 
n = 7 Wt; 8 PAM+/-) diets, 
normalized rise slopes of the 
EPSPs (NL EPSP slope). Insets 
above depict representative 
averaged traces for each 
genotype at baseline (solid) and 
post-induction (dashed). *p< 0.05, 
compared to Wt mice within 
dietary condition; +p<0.05, 
compared to baseline within 
genotype and dietary condition; 
#p<0.05, compared to control diet 
within genotype; NSNot significant 
compared to baseline (unpaired t-
test; Wilcoxon Signed Rank Test). 
(C) A series of hyperpolarizing 
and depolarizing 500 ms current 
steps were applied to Wt 
pyramidal neurons acutely 
isolated from control (left) or Cu 
supplemented (right) mice. 
Representative membrane 
responses demonstrating similar 
action potential activity are 
depicted.  
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in the control water condition. Dietary Cu had no gross effects on neuronal membrane 
excitability as assessed by somatic positive current injection (Fig. 3-3C), demonstrating 
that the effects of dietary Cu on amygdalar synaptic plasticity do not result from changes 
in intrinsic neuronal membrane properties. Thus 10 to 14 days of dietary Cu 
supplementation successfully rescued the synaptic plasticity deficit observed in the 
PAM+/- amygdala.  
The fact that providing PAM+/- mice with supplementary Cu for 10 -14 days can eliminate 
both their behavioral deficit and lack of LTP diminishes concerns that these differences 
arise from altered development. Being deficient in PAM from birth, PAM+/- mice are 
susceptible to potential impairments resulting from PAM deficiency, but the ability of 
dietary to reverse these deficits strongly argues against a developmental cause.  
Alteration in the biosynthesis of amidated neuropeptides is also not likely to be a 
contributing factor because amidating activity is only mildly affected by PAM 
heterozygosity, and neuropeptide amidation is unaffected by dietary Cu supplementation 
(Bousquet-Moore et al., 2010b). PAM+/- impairments in fear behavior and amygdalar 
synaptic plasticity are large and striking, so minute changes in neuropeptides in these 
models are not likely to contribute to these deficits. Therefore, our data support the 
hypothesis that dietary Cu supplementation ameliorates behavioral and physiological 
deficits through remediation of impaired Cu homeostasis in PAM+/- mice. Further 
analysis of the interactions of PAM and Cu in the amygdala should provide insight into 
the mechanisms through which they interact.  
Secreted Cu is essential for LTP  
We next wanted to ask whether amygdalar slices from wildtype and PAM+/- mice differed 
in their dependence on Cu by removing or adding Cu in vitro. We first tested the role of 
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endogenous Cu on thalamic afferent LTP in the amygdala. To do this, we induced LTP 
in wildtype and PAM+/- neurons in the presence of picrotoxin and the cell-impermeable 
specific Cu chelator bathocuproine disulfonate (BCS). To target secreted, endogenous 
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Figure 3-4. Extracellular Cu is essential for LTP at thalamic afferent amygdalar 
synapses. Wt and PAM+/- littermates kept on the control diet were used for slice 
preparation. Thalamic afferents were stimulated and pyramidal neuron membrane 
responses were recorded in whole-cell mode in the lateral nuclei in the presence of 
50 µM bathocuproine disulfonate (BCS). (A,B) Time-course (1 min bins) of averaged 
LTP experiments using an action potential pairing induction paradigm at minute 0 
(arrow) of Wt and PAM+/- neurons from mice in the presence of BCS with picrotoxin 
(100 µM; PTX) (A; n = 12 Wt; 8 PAM+/-) or BCS with PTX and the GABAB receptor 
antagonist CGP34358 (1 µM; CGP) (B; n = 11 Wt; 7 PAM+/-). Synaptic efficacy was 
assessed using the normalized rise slopes of the EPSPs (NL EPSP slope) that were 
normalized for genotypic comparisons. Insets depict representative averaged traces 
for each genotype at baseline (solid) and post-induction (dashed). NSNot significant 
compared to baseline (Wilcoxon Signed Rank Test). 
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Cu, perfusion of BCS began no more than 20 min prior to LTP induction. In the context 
of GABAA receptor blockade with picrotoxin, wildtype amygdala neurons potentiate, but 
PAM+/- neurons do not (Fig. 3-3A) (Gaier et al., 2010). Addition of BCS abolished LTP in 
wildtype neurons and had no effect on PAM+/- neurons (Fig. 3-4A). We had shown 
previously that addition of the GABAB antagonist CGP rescues PAM+/- LTP (Gaier et al., 
2010). Therefore, we tested the effects of BCS on LTP in the context of both GABAA and 
GABAB receptor blockade. Again, BCS completely eliminated LTP in both wildtype and 
PAM+/- neurons (Fig. 3-4B). These data suggest an essential role for endogenous, 
secreted Cu in amygdalar excitatory synaptic plasticity independent of GABAergic 
inhibition. Additionally, removal of extracellular Cu eliminated the genotypic difference in 
LTP in both pharmacological conditions, supporting the hypothesis that altered Cu 
secretion underlies that PAM+/- LTP deficit.  
Copper modulation of synaptic transmission  
The data presented thus far strongly support a disruption in synaptic Cu release. If the 
alterations in PAM+/- synaptic plasticity result from disruption in amygdalar synaptic Cu 
homeostasis, then Cu could have direct effects on synaptic transmission in this brain 
region. To elucidate the effects of Cu on synaptic transmission, we patch clamped 
wildtype lateral nucleus pyramidal neurons and bath-applied 10 µM CuSO4 (Doreulee et 
al., 1997;Leiva et al., 2003). We held neurons at Vholding = -35 mV to simultaneously 
monitor excitatory and inhibitory transmission during Cu application. Voltage-gated Na 
channels were blocked exclusively in the clamped cell by including lidocaine (QX-314; 3 
mM) in the intracellular pipette solution (Fig. 3-5A). The fact that lidocaine also 
suppressed slow feed-forward inhibition, which is mediated by GABAB metabotropic 
receptors (Duvarci and Pare, 2007), is an important caveat (Fig. 3-5B). Stimulation of 
thalamic glutamatergic afferents produced a mono-synaptic excitatory inward current 
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which was closely followed by a di-synaptic inhibitory outward current (Fig. 3-5C). The 
di-synaptic outward current represents feed-forward inhibition of thalamic afferent 
Figure 3-5. Cu enhances feed-
forward inhibition of thalamic 
inputs to the amygdala. (A) Traces 
depict membrane voltage responses 
of Wt lateral nucleus pyramidal 
neurons to hyperpolarizing and 
depolarizing 500 ms current steps (-
300 pA, +300 pA). Neurons were 
patched using normal intracellular 
solution (NL ICS; top) or ICS with 3 
mM lidocaine (QX-314; bottom) to 
block action potential activity. Inset 
below depicts the command voltage. 
(B) Fast (arrow heads; GABAA) and 
slow (arrows; GABAB) components 
of feed-forward inhibition are 
depicted in a single Wt neuron 
patched using NL ICS in current 
clamp (top) and voltage clamp 
(bottom; Vholding = -55 mV). (C-E) 
Neurons were patched with ICS 
containing lidocaine and voltage 
clamped at Vholding = -35 mV while 
current responses to thalamic 
afferent stimulation was monitored. 
(C) Averaged traces from the 
indicated time bins depict 
representative responses to Cu 
application. Inward (downward) 
current represents excitatory 
glutamatergic transmission; outward 
(upward) current represents feed-
forward GABAergic inhibitory 
transmission. (D) Time course data 
(1 min bins) for 7 Wt neurons for the 
10-70% inward rise slope and the 
peak-to-peak slope representing 
excitatory and inhibitory components 
of the response, respectively. (E) 
Time course of normalized series 
resistance (NL RS) and holding 
current (IHolding) responses to Cu. 
+p<0.05, compared to baseline; 
NSNot significant compared to 
baseline (Wilcoxon Sign Rank Test). 
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synapses (Humeau et al., 2005;Gaier et al., 2010). Both currents were sensitive to 
AMPA receptor antagonism with CNQX (10 µM), whereas only outward currents were 
sensitive to GABAA receptor blockade with 100 µM picrotoxin (not shown). Since the 
excitatory and inhibitory events partially overlapped in time, we assessed the efficacy of 
excitatory transmission using the 0-70% rise slope of the inward current and the efficacy 
of feed-forward inhibition using the peak-to-peak slope. 
We recorded these bi-phasic current responses to episodic synaptic stimulations of 
thalamic afferents while bath applying exogenous CuSO4 (10 µM) for 10 min followed by 
a 30 min washout period. Cu application had no effect on excitation but had a profound 
potentiating effect on inhibition (p<0.05) (Fig. 3-5D). This increase in inhibition appeared 
to be reversible, as outward currents returned to baseline with Cu washout. Cu 
application also briefly increased the holding current (p<0.05) (Fig. 3-5E), representing a 
hyperpolarizing effect of Cu on the post-synaptic neuron. This effect on the membrane 
did not correspond to any significant changes in membrane resistance.  
Thus far, the data presented indicate that dietary Cu rescues the behavioral synaptic 
plasticity deficits of PAM+/- mice, and that Cu applied through the perfusate transiently 
enhances GABAergic inhibition of lateral amygdala pyramidal neurons. Together, these 
data support a net inhibitory role for Cu in the amygdala. 
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PAM colocalizes with ATP7A in neurons 
ATP7A, also known as the Menkes disease protein, is the major P-type Cu ATPase 
expressed in brain and delivers Cu to PAM in the secretory pathway (El Meskini et al., 
2003;Steveson et al., 2003). To search for a relationship between PAM expression and 
Cu homeostasis, we visualized PAM and ATP7A in wildtype and PAM+/- brains. We 
observed co-expression of PAM and ATP7A in neurons throughout the forebrain, 
including the amygdala (Fig. 3-6) and hippocampus (not shown). Both proteins overlap 
with the Golgi marker GM130 in these regions (not shown), as reported previously (Niciu 
et al., 2006). Levels of ATP7A are generally higher in the basolateral nucleus of the 
amygdala than in the lateral nucleus (Fig. 3-6A,B). Also, PAM is enriched in the central 
nucleus of the amygdala whereas ATP7A is not. Within the lateral nucleus, PAM and 
ATP7A are expressed at higher levels in a subset of neurons (Fig. 3-6C). We have 
shown previously that PAM is expressed at higher levels in amygdalar GABAergic 
interneurons (Gaier et al., 2010); therefore ATP7A may also be expressed at higher 
levels in interneurons of the basolateral amygdaloid complex. Both PAM and ATP7A 
immunoreactivities were also observed in the neuropil of the lateral nucleus, likely 
representing vesiclular ATP7A and PAM in the dendrites of neurons. ATP7A is present 
in the amygdala of PAM+/- mice, and its expression pattern was not altered by PAM 
heterozygosity (Fig. 3-6B,D). This result provides evidence for co-localization of PAM 
with the major secretory pathway Cu transporter in the amygdala and demonstrates the 
potential for a functional interaction between these two molecules. 
144 
 
 
With PAM and ATP7A in somatic and dendritic compartments of amygdalar neurons, 
PAM could easily influence Cu homeostasis in this brain region. The heterogeneous 
expression of these two proteins suggests they are regulated with cell-type specificity. 
Thus, our data support the hypothesis that PAM heterozygosity mediates its behavioral 
Figure 3-6. PAM co-localizes with ATP7A in the amygdala of wildtype and 
PAM+/- mice. Single focus plane images were taken from 15 µm slices co-
immunostained for ATP7A (red), PAM (green) and nuclei (To-Pro3; blue). Merge is 
yellow. (A,B) Montage of low power images depicting the amygdaloid complex from 
Wt (A) and PAM+/- (B) mice. High power images from the lateral nucleus of Wt (C) 
and PAM+/- (D) mice. One high PAM/ATP7A-expressing neuron (putative interneuron) 
is indicated in each case (arrow). Putative pyramidal neurons were more numerous 
and examples in each case are indicated (arrow heads). Scale bars: low power, 100 
µm; high power 20 µm. 
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and physiological effects through alterations in Cu homeostasis (Bousquet-Moore et al., 
2010b).  
ATP7A localization is altered in PAM+/- mouse amygdala  
ATP7A expression increases and redistributes along with Cu into dendrites in response 
to neuronal activation (Schlief et al., 2005;Dodani et al., 2011). In addition, Cu is 
secreted from neurons in an ATP7A-dependent manner (Schlief et al., 2005). Therefore, 
alterations in ATP7A expression and localization in PAM+/- amygdalar neurons could 
affect Cu secretion. To investigate potential alterations in ATP7A localization, we 
employed a subcellular fractionation method aimed at isolating synaptosomes and the 
complex of proteins at post-synaptic densities (PSDs). Bilateral neocortices were acutely 
isolated from wildtype and PAM+/- mice, tissue samples were fractionated in parallel and 
ATP7A levels in different subcellular fractions were compared between genotypes (Fig. 
3-7A). Detection of NR2B in PSDs and GM130 in the ER/Golgi fractions validated our 
fractionation methods in both genotypes. ATP7A was enriched in the ER/Golgi fraction 
(Fig. 3-7A), consistent with previous reports of ATP7A localization using 
immunohistochemistry (Fig. 3-6) (Niciu et al., 2006). The majority of ATP7A present in 
synaptosomal membranes recovered from the sucrose gradient was Triton-soluble, but a 
fraction was Triton-insoluble, indicating that it was part of the PSD. 
To compare the localization of ATP7A in wildtype and PAM+/- mice, levels were 
normalized to protein for each fraction in each animal (Fig.3-7B). The amounts of 
ATP7A in the input and ER/Golgi fractions appeared greater in PAM+/- cortex compared 
to wildtype; however, these differences did not reach statistical significance. The ratio of 
ATP7A present in the PSD versus the Triton-soluble fractions was 2.5-fold higher in 
PAM+/- cortex compared to wildtype, demonstrating a shift in ATP7A distribution at 
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PAM+/- synapses (Fig. 3-7B). This effect was carried by an increase in ATP7A at the 
PSD rather than by a reduction of ATP7A in the Triton-soluble fraction.  
Gene expression is altered in PAM+/- mouse amygdala 
Another mechanism through which PAM heterozygosity could affect amygdalar function 
is through alterations in gene expression (Francone et al., 2010).  PAM over-expression 
up-regulates Atox-1 mRNA levels in a corticotropic cell line (Francone et al., 2010), and 
PAM heterozygosity reduces Atox-1 transcript levels in mouse pituitary (Bousquet-Moore 
et al., 2010b). To determine whether this effect extends to the amygdala, we used 
quantitative PCR to probe for differences in Atox-1 and ATP7A mRNAs, two Cu binding 
proteins required for Cu delivery to PAM in the secretory pathway (Prigge et al., 2000;De 
et al., 2007;Bousquet-Moore et al., 2010a). Atox-1 is a cytosolic chaperone that delivers 
Cu to ATP7A (Hamza et al., 2001). Tissue was isolated from bilateral amygdalae and 
dorsal hippocampus of individual wildtype and PAM+/- mice and results were compared 
Figure 3-7. ATP7A shifts toward the PSD in PAM+/- cortical synapses. Subcellular 
fractionations of neocortical tissue from individual animals were applied to gels by 
protein (10 µg) and immunoblotted using antisera against ATP7A. (A) Results from 
single Wt (left) and PAM+/- (right) mice are depicted. Blotting for NR2B and GM130 
confirmed isolation of PSD and ER/Golgi fractions, respectively. Coomassie staining 
demonstrates equal protein loading. (B) Quantification of ATP7A levels in the input 
homogenate, ER/Golgi, Triton-soluble (TX) and PSD fractions; data were normalized 
to Wt (n = 3 Wt; 3 PAM+/-). ATP7A levels normalized to total protein for each fraction. 
*p<0.05 compared to Wt within fraction (unpaired t-test). 
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between genotypes. As with all other tissues collected from PAM+/- mice, amygdala and 
hippocampus of PAM+/- mice contained reduced levels of PAM mRNA compared to 
wildtype samples (Fig. 3-8). There was significantly more PAM mRNA in the amygdala 
compared to the hippocampus of each genotype. As was the case for PAM, more Atox-1 
mRNA was present in the amygdala compared to the hippocampus of wildtype but not 
PAM+/- mice. PAM+/- mice expressed significantly less Atox-1 and ATP7A in the 
amygdala than wildtype mice (Fig. 3-8A), but expression of these mRNAs in the 
hippocampus was not different (Fig. 3-8B). Comparable levels of ATP7A were found in 
the amygdala and hippocampus of both genotypes. These data indicate region-specific 
reductions in molecules required for Cu delivery to the secretory pathway and suggest 
potentially decreased delivery of Cu to the secretory pathway in PAM+/- amygdala 
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Figure 3-8. PAM+/- mice display amygdala-specific deficits in Atox-1 and ATP7A 
mRNA expression. Wt and PAM+/- bilateral amygdalae and dorsal hippocampi were 
dissected from individual animals (n = 6 Wt, 5 PAM+/-). Levels of mRNA for each 
primer set were quantified with respect to (wrt) GAPDH and average values for each 
genotype are depicted for the amygdala (A) and hippocampus (B). p values are 
provided for significant comparisons (unpaired t-test). 
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neurons. 
The LTP deficit of PAM+/- mice is GABA-dependent, and PAM+/- mice display enhanced 
GABAergic inhibition in the basolateral amygdaloid complex (Gaier et al., 2010). To 
elucidate a molecular basis for these changes, we probed for differences in mRNA 
encoding GABAergic inhibitory molecular machinery in PAM+/- mice. We compared 
mRNA expression of the predominant GABAA receptor subunit (α1), the obligatory 
GABAB receptor subunit (2), and both the vesicular and cytosolic forms of glutamic acid 
decarboxylase (GAD65 and GAD67, respectively). Levels of GABAergic inhibitory 
molecular machinery were higher in the amygdala compared to the hippocampus in both 
genotypes with the exception of the PAM+/- GABAB receptor subunit. Thus PAM+/- mice 
exhibit a region-specific reduction in GABAB receptor expression that may contribute to 
the alterations in GABAergic inhibition in this region. There were no differences between 
genotypes for the GABAA receptor α1 subunit in either brain region. However, GABAB 
receptor subunit mRNA was significantly and selectively reduced in the PAM+/- amygdala 
compared to wildtype (Fig. 3-8A); no genotypic difference was observed in the 
hippocampus (Fig. 3-8B). No differences were observed for either GAD65 or GAD67 
between genotypes in either region.  
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DISCUSSION 
In the present study, we demonstrated that dietary Cu supplementation rescues the fear 
learning and memory impairment and corresponding synaptic plasticity deficit associated 
with PAM haploinsufficiency. We characterized the inhibitory effect of physiological Cu 
levels on neuronal and synaptic excitability and demonstrated an essential role for 
secreted Cu in amygdalar synaptic plasticity. We also provided novel insight into 
neuronal expression and localization of ATP7A, a key Cu export pump, in limbic 
structures associated with emotionality and memory formation. Taken together, our data 
identify a novel role for the interaction between Cu and PAM in amygdalar functions 
such as emotionality and fear learning and memory. However, the mechanism by which 
PAM heterozygosity alters neuronal Cu handling remains unclear. 
PAM+/- mice have whole brain Cu levels comparable to wildtype mice, and dietary Cu 
supplementation does not change brain total Cu levels in either genotype (Bousquet-
Moore et al., 2010b). However, dietary Cu supplementation has profound effects on the 
behavioral and physiological deficits of PAM+/- mice. Cu levels vary across brain regions 
(Rajan et al., 1976;Bakirdere et al., 2010), and we observed region-specific effects of 
PAM+/- heterozygosity on levels of transcripts encoding Atox1 and ATP7A (Fig. 3-8). The 
compartmentalization of Cu may differ in PAM+/- mice while total levels of brain Cu are 
unchanged (Fig. 3-9); dietary supplementation may normalize the subcellular 
localization of Cu. Regulated delivery of Cu to the secretory pathway is a major means 
of maintaining Cu homeostasis in high Cu environments (La and Mercer, 2007;Lutsenko 
et al., 2007). Our identification of ATP7A in purified PSDs suggests a role for this P-type 
ATPase in the release of Cu into the synapse. In PAM+/- mice, we observed an increase 
in the level of ATP7A at the PSD. Dietary Cu supplementation might alter ATP7A 
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localization or activity, restoring wildtype Cu secretion. Region- and cell-type specific 
expression of PAM and ATP7A is consist with region-specific responses to PAM 
heterozygosity and to dietary Cu supplementation.   
Cu rescue of PAM+/- fear learning and memory 
Dietary Cu supplementation selectively rescued PAM+/- cued fear conditioning, while 
wildtype contextual fear conditioning was impaired (Fig. 3-1). This striking discrepancy 
speaks to the differential role of Cu in these two neural processing pathways. Contextual 
AMPAR
CTR1
Cu2+
Nucleus
Cu2+
sfCD
GABAAR
GABAergic 
terminal
Glutamatergic 
terminal
ER
Golgi
PAM
ATP7A
Atox-1
Cu-containing 
secretory vesicle
151 
 
 
fear conditioning requires hippocampal as well as the amygdalar function, whereas cued 
fear conditioning does not require the hippocampus (Kim and Fanselow, 1992;Phillips 
and Ledoux, 1992). The hippocampus, a very epileptogenic brain region, has a high 
density of NMDA receptors (Rafiki et al., 1998;Meoni et al., 1998). Increased seizure 
sensitivity in PAM+/- mice was the only deficit that was not eliminated by dietary Cu 
(Bousquet-Moore et al., 2009;Bousquet-Moore et al., 2010b;Gaier et al., 2010). 
However, mild dietary Cu restriction increased seizure susceptibility and severity in 
wildtype mice, with no effect on PAM+/- mice (Bousquet-Moore et al., 2010b). Our 
findings suggest that the effects of Cu on hippocampal excitability and function are 
distinct from its effects on the amygdala. 
Cu suppresses NMDA receptor function in hippocampal neurons through a nitrosylation-
dependent mechanism (Schlief et al., 2006) and reduces AMPA receptor mediated 
signaling and LTP in hippocampal slices (Doreulee et al., 1997). An inhibitory effect of 
chronic Cu treatment on hippocampal LTP was demonstrated through diet and Cu 
Figure 3-9. Schematic outlining a pathway that could contribute to altered 
PAM+/- Cu homeostasis in amygdalar neurons. Cu2+ is imported into neurons 
primarily through Cu transporter 1 (CTR1). In the reducing environment of the cytosol, 
Cu+ quickly binds to chaperones such as Atox-1. Atox-1 delivers Cu to the P-type 
ATPase ATP7A for transport into the lumen of the secretory pathway, typically in the 
ER/Golgi (El Meskini et al., 2003). Bi-functional PAM also localizes to the secretory 
pathway (Mains et al., 1995). The cytosolic domain of PAM is multiply phosphorylated 
and cleaved to form a soluble fragment (sfCD), which localizes to the nucleus to 
affect transcription of genes including Atox-1 (Rajagopal et al., 2009;Francone et al., 
2010). PAM and ATP7A are expressed in interneurons and pyramidal neurons of the 
lateral amygdala. At synapses, Cu inhibits α1-containing GABAA receptors which 
localize to interneurons and dendrites of pyramidal neurons in the amygdala 
(McDonald and Mascagni, 2004). Extracellular Cu is required for a presynaptic form 
of LTP at thalamic afferent synapses. Molecules whose valence is reduced in the 
PAM+/- amygdala are indicated with red labels. Atox-1 and ATP7A are down-regulated 
in the PAM+/- amygdala, which could decrease Cu delivery to the secretory pathway, 
limiting the amount that can be released and facilitate synaptic transmission, leading 
to diminished LTP. This effect of PAM heterozygosity demonstrates a clear role for 
PAM outside of amidation in regulating Cu homeostasis in a brain region-specific 
manner.  
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injections (Goldschmith et al., 2005;Leiva et al., 2009), although the extremely high brain 
Cu levels created raise worries of Cu toxicity; performance in the Morris water maze, a 
cognitive behavioral task testing working and long-term spatial (hippocampal-dependent) 
memory, was not affected (Leiva et al., 2009). Cu supplementation had no effect on 
shuttle-box avoidance learning of rats, a behavioral test similar to context-dependent 
fear conditioning (Fujiwara et al., 2006). By contrast, dietary Cu supplementation 
reversed the effects of dietary Zn supplementation on anxiety-like behavior and Morris 
water maze performance in rats; the effects of dietary Cu supplementation were only 
tested following Zn supplementation (Railey et al., 2010). Since Zn and Cu compete for 
uptake in the gut, Cu deficiency may contribute to effects attributed to Zn 
supplementation (Oestreicher and Cousins, 1985). Thus, our data are in agreement with 
previous results, supporting a differential role for Cu in hippocampal and amygdala 
function in rodents.  
Cu is essential for LTP 
We demonstrated that dietary Cu supplementation rescued the deficit in pre-synaptic 
thalamic afferent LTP observed in slices from PAM+/- mice (Fig. 3-3). Previous studies 
focusing on the effects of acute (bath-applied) (Doreulee et al., 1997;Leiva et al., 2003) 
or chronic (dietary supplementation or injection) (Goldschmith et al., 2005;Leiva et al., 
2009) exogenous Cu on hippocampal LTP demonstrated an inhibitory effect of Cu. This 
is thought to result from the inhibitory effects of Cu on NMDA receptors (Doreulee et al., 
1997;Schlief et al., 2006). AMPA receptor-mediated synaptic transmission in the 
Schaffer collateral-CA1 pathway is inhibited by 10 µM CuSO4 while inhibition of NMDA 
receptors is sensitive to 1 µM CuSO4 (Doreulee et al., 1997). Cu also blocks high 
voltage-activated calcium channels in rat cortical (Castelli et al., 2003) and olfactory bulb 
neurons (Horning and Trombley, 2001). Notably, L-type voltage-gated calcium channels, 
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located post-synaptically on dendritic spines and contributing to calcium influx during 
LTP induction (Kullmann et al., 2000;Malenka and Bear, 2004), are sensitive to Cu in the 
low µM range (Korte et al., 2003). Thus Cu could impair hippocampal LTP through 
multiple mechanisms. 
By contrast, we demonstrated that endogenous extracellular (secreted) Cu is necessary 
for pre-synaptic LTP in the amygdala (Fig. 3-4). It may be that secreted Cu is a vital 
component of LTP induction in other brain regions as well, including the hippocampus. 
The action potential pairing LTP induction protocol we employed in this study has been 
shown previously to be L-type voltage-gated calcium channel-dependent and NMDA 
receptor-independent at thalamic afferent synapses (Bauer et al., 2002;Weisskopf et al., 
1999). A different form of LTP may be spared in the context of endogenous Cu 
chelation. One caveat of those experiments concerns the selectivity with which Cu limits 
extracellular Cu availability; while the duration of BCS exposure was kept at a minimum, 
there may have been some unintended effects on intracellular Cu status. Regardless, 
the present study clearly demonstrates an essential role for Cu in a form of LTP that 
tightly correlates with performance in discrete fear learning and memory tasks.  
Cu and GABAergic transmission 
In normal aCSF, we observed a selective potentiating effect of Cu on feed-forward 
GABAergic transmission at thalamic inputs to lateral amygdala pyramidal neurons (Fig. 
3-5). It is not possible to relate these findings to our LTP data because LTP experiments 
were conducted in the presence of picrotoxin. Moreover, addition of lidocaine to the 
intracellular solution and the subsequent blockade of post-synaptic GABAB receptors 
may have occluded additional effects of Cu on the post-synaptic neuron. Nevertheless, 
the effect of Cu we observed on GABAergic transmission was profound and consistent 
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with most reports in the literature. Leiva and colleagues (Leiva et al., 2000) used 
extracellular recordings to investigate the interaction between Cu and GABAergic 
inhibition on excitatory synaptic transmission in the hippocampus. They found 
depressing effects of Cu (10 µM) on synaptic transmission in the Schaffer-CA1 pathway, 
suggesting Cu may suppress glutamatergic transmission by enhancing GABAergic 
inhibition. However, addition of Cu in the presence of picrotoxin remarkably enhanced 
synaptic transmission, implicating non-GABAergic receptors in the actions of copper on 
synaptic transmission (Leiva et al., 2000). 
Direct effects of Cu on GABAA receptors have been demonstrated at physiological Cu 
concentrations (Ma and Narahashi, 1993;Sharonova et al., 1998;Kim and Macdonald, 
2003). Cu concentration in brain tissue has been estimated to be between 80 and 100 
µM, about 5-fold higher than that found in blood (Linder and Hazegh-Azam, 1996;Que et 
al., 2008;Prohaska, 1987). Cu can be released with neuronal activation in a calcium-
dependent manner (Schlief et al., 2006;Dodani et al., 2011) and can reach 
concentrations of 100-250 µM at synapses (Kardos et al., 1989). Cu binds different 
human GABAA receptor subtypes with equal affinity at an EC50 of 2.4 µM (Kim and 
Macdonald, 2003), unlike Zn (Fisher and Macdonald, 1998). Cu reduces coupling of the 
GABA-binding region to channel gating; Cu and Zn both have inhibitory effects on 
GABAA receptor function (Fig. 3-9) (Narahashi et al., 1994;Trombley et al., 1998;Horning 
and Trombley, 2001) [for review see (Mathie et al., 2006)]. Cu-mediated GABAA receptor 
inhibition is reversible (Fig. 3-5) (Ma and Narahashi, 1993), but may require removal of 
Cu from its binding site by using a chelator (Sharonova et al., 1998). Cu enhances the 
binding and activity of other GABAA receptor allosteric modulators such as 
benzodiazepines (Mizuno et al., 1982;Kardos et al., 1984). Interestingly, PAM+/- mice are 
particularly sensitive to the anxiolytic effects of benzodiazepines (Gaier et al., 2010). The 
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residues important for Cu binding include a motif which spans the proximal portion of the 
cysteine loop of the α1 N-terminal domain (Kim and Macdonald, 2003), and two residues 
also important in Zn binding to α6-containing receptors are also required for Cu binding 
(Kim and Macdonald, 2003;Fisher and Macdonald, 1998). 
Importantly, subunit composition of GABAA receptors determines localization, activity 
and physiological function within neurons and networks (Wafford et al., 2004;Rudolph 
and Mohler, 2006). Cu has differential efficacies for various GABAA receptor subtypes, 
with stronger effects on α1- and α2-containing receptors compared to α4- and α6-
containing receptors (Kim and Macdonald, 2003). This subtype specificity is functionally 
relevant; α(1-3)-containing receptors localize to GABAergic synapses and mediate 
phasic or fast inhibition, whereas α(4-6)-containing receptors are extra-synaptic and 
mediate tonic or slow inhibition (Hevers and Luddens, 1998;Jacob et al., 2008;Farrant 
and Nusser, 2005). In the basolateral amygdaloid complex, parvalbumin-positive 
interneurons that mediate feed-forward inhibition (Muller et al., 2006) express high levels 
of the α1 subunit (McDonald and Mascagni, 2004). Inhibition of these α1-containing 
receptors on interneurons could account for Cu-mediated enhancement of feed-forward 
inhibition observed in the present study (Fig. 3-9). Additionally, synaptic GABAA receptor 
subtypes localize to separate synapses in the hippocampus (Nyiri et al., 2001). GABAA 
receptor α1 subunit mRNA expression was not affected by PAM heterozygosity in 
amygdala or hippocampus, but transcripts encoding the GABAB receptor were 
selectively down-regulated in the PAM+/- amygdala (Fig. 3-8). GABAB receptors are 
expressed on GABAergic interneurons, pyramidal neuronal dendrites and glutamatergic 
afferent terminals in the basolateral amygdaloid complex (McDonald et al., 2004). Thus, 
reduced GABAB receptor levels could have multiple effects on afferent signaling in the 
PAM+/- amygdala.  
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ATP7A and Cu are present at synapses 
We demonstrated the presence of ATP7A in synaptosomal and PSD fractions isolated 
from mouse neocortex (Fig. 3-7). ATP7A also co-localized with PAM in the neuropil of 
the basolateral amygdaloid complex (Fig. 3-6). This puts ATP7A and secretable Cu in a 
position to affect synaptic transmission; secreted Cu could participate in the synapse 
specificity of LTP essential to fear memory formation. With this in mind, observing the 
net effects of exogenous Cu applied through the perfusate may not provide information 
physiologically relevant to memory formation. Rather, chelation of endogenous Cu 
secreted following stimulation is likely to reveal the role of Cu in learning and memory.  
The distribution of ATP7A is shifted toward the PSD in the cortex of PAM+/- mice, 
suggesting increased synaptic Cu secretion in the cortex of these mice; total ATP7A 
levels were not significantly altered. ATP7A and Atox-1 mRNA levels were reduced in 
the PAM+/- amygdala compared to wildtype (Fig. 3-8); it is not clear whether this reflects 
region-specificity in the influence of PAM heterozygosity on ATP7A gene transcription 
and/or a disconnect between ATP7A transcript and protein levels. Regardless, our data 
support the hypothesis that releasable synaptic Cu is reduced in the PAM+/- amygdala 
and may contribute to the synaptic plasticity and learning and memory deficits observed 
in these mice.  
Cu homeostasis is tightly regulated, with the roles of different organ systems just 
beginning to be elucidated (Kim et al., 2010a). The brain contains more Cu than most 
other organs (Linder and Hazegh-Azam, 1996;Que et al., 2008;Prohaska, 1987) and our 
data support an essential role for Cu in the modulation of synaptic transmission and in 
synaptic plasticity. The bidirectional relationship between PAM and Cu homeostasis is 
reflected by the diminished Atox-1 and ATP7A transcript levels observed in the PAM+/- 
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amygdala, and likely speaks to an additional essential role for PAM as a Cu sensor (Fig. 
3-9) (Bousquet-Moore et al., 2010a). Other cuproenzymes and Cu-binding proteins 
translocate into the nucleus and affect transcription of genes relevant to Cu homeostasis 
(Lutsenko, 2010). Clearly the network of genes involved in homeostasis is much more 
complex than previously thought. Indeed Cu homeostasis is hypothesized to be 
disrupted, and in some cases causative, of some neurological disorders affecting 
emotionality and learning and memory including Alzheimer’s disease (Lin et al., 2010) 
and Wilson’s disease (Pfeiffer, 2007). This study identifies one small piece of that puzzle 
and expands our current view of the role Cu in normal and pathological nervous system 
function.  
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CHAPTER 4: Serum Cu and PAM activity in frail elderly men 
 
[High serum Cu and Cu/Zn ratios correlate with impairments in bone density, physical 
performance and overall health in a population of frail elderly men. Gaier, Eric D; 
Kleppinger, Alison; Ralle, M; Mains, Richard E; Kenny, Anne M; Eipper, Betty A. J 
Gerontology. Submitted March, 2011.] 
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CONTRIBUTIONS 
My first summer working in the Mains/Eipper lab, I took on a project measuring PHM 
activity in serum from human subjects. We hypothesized that single nucleotide 
polymorphisms in the PAM gene could have functional impacts on serum PHM activity. 
This was the first study to measure amidating activity in human samples. Those 
preliminary data lead to a larger funded study of serum metals and PAM activity in 
serum samples collected from a cohort of 144 frail elderly men as part of a previous 
study [Kenny AM, Kleppinger A, Annis K, Rathier M, Browner B, Judge JO, McGee D 
(2010) Effects of transdermal testosterone on bone and muscle in older men with low 
bioavailable testosterone levels, low bone mass, and physical frailty. J Am Geriatr Soc 
58:1134-1143]. This study was conducted in collaboration with Dr. Anne Kenny at the 
UConn Center on Aging and Dr. Jonathan Covault in the department of Psychiatry. I was 
involved in organizing the data, collecting relevant literature and background, generating 
figures and writing a manuscript. This work was recently completed and the manuscript 
was submitted to the Biological series of the Journal of Gerontology in March, 2011. I 
also presented this work in poster form at the UConn Center on Aging Research Day on 
April 18, 2011. 
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ABSTRACT 
Levels of copper (Cu), an essential trace element, are tightly controlled. Serum Cu levels 
rise with age and high serum Cu levels and Cu/Zinc (Zn) ratios are linked with multiple-
cause mortality in the elderly. To explore a functional link for this phenomenon, we 
assessed serum levels of Cu, Zn and a Cu- and Zn-dependent monooxygenase (PAM), 
along with measures of bone, physical and overall health in a cohort of 144 frail elderly 
men. We found strong connections between high serum Cu levels and high Cu/Zn ratios 
with deficits in femoral bone mineral density, physical performance and hematocrit. High 
Cu/Zn ratios were also associated with reduced muscle mass and strength and 
increased reliance on ADL assistance.  Serum PAM activity correlated with serum Cu 
and exhibited similar associations with functional impairments. Our results support 
studies indicating that serum Cu levels and the Cu/Zn ratio may serve as useful 
biomarkers in the elderly. 
169 
 
 
INTRODUCTION 
Copper (Cu) is essential to the life of organisms from bacteria to humans; its redox 
activity contributes to its utility as a co-factor for electron transfer reactions. Only about a 
dozen cuproenzymes, which require Cu for their catalytic activity, are encoded in the 
mammalian genome; these enzymes are essential to the maintenance of multiple organ 
systems (Crichton and Pierre, 2001;Ridge et al., 2008). Among these are cytochrome c 
oxidase, Cu/Zinc(Zn)-dependent superoxide dismutase (SOD), lysyl oxidase, tyrosinase, 
dopamine β-hydroxylase and peptidylglycine α-amidating monooxygenase (PAM). Many 
other proteins bind Cu and play a role in Cu transport and homeostasis. Cu deficiency 
affects the cardiovascular, musculoskeletal, hematopoietic and nervous systems (Uauy 
et al., 1998;Uriu-Adams and Keen, 2005); symptomology is thought to reflect inadequate 
activities of specific cuproenzymes. For example, dysfunction of Cu/Zn SOD results in 
tissue damage by superoxide and reduced lysyl oxidase cross-linking of collagen 
contributes to musculoskeletal and cardiovascular deficits (Uauy et al., 1998). Menkes 
disease, an X-linked recessive genetic disease of Cu transport, results in severe Cu 
deficiency (Kaler, 2011); reductions in norepinephrine and neuropeptides from impaired 
dopamine β-hydroxylase and PAM activity may contribute to the seizure susceptibility 
observed. Moreover, genetic reduction of PAM in a mouse model is associated with 
increased susceptibility to seizure, anxiety-like phenotype, learning and memory deficits 
and neuronal hyperexcitability in limbic structures (Bousquet-Moore et al., 
2009;Bousquet-Moore et al., 2010b;Gaier et al., 2010). Interestingly, many of these 
deficits can be reversed with dietary Cu supplementation (Bousquet-Moore et al., 
2010b;Bousquet-Moore et al., 2009). It is now clear that a complex regulatory system 
governs copper homeostasis to keep availability of Cu at optimal levels (Kim et al., 
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2010b).   
Copper overload is also detrimental, and is thought to result in oxidative stress through 
Fenton-like reactions and the generation of free-radicals that contribute to 
chronic/degenerative diseases and carcinogenesis (Uriu-Adams and Keen, 2005). 
Higher serum Cu concentrations have been linked with advancement of chronic 
diseases such as diabetes mellitus and Alzheimer’s disease (Uriu-Adams and Keen, 
2005;Mezzetti et al., 1998;Arnal et al., 2010;Viktorinova et al., 2009). Zn, another 
essential element, competes with Cu for uptake in the gut and is thought to serve as a 
natural antioxidant (Uriu-Adams and Keen, 2005;Malavolta et al., 2010). Previous 
studies linked high serum Cu and concomitant low serum Zn to mortality in elderly 
populations (Leone et al., 2006;Malavolta et al., 2010;Reunanen et al., 1996). In several 
cases, the Cu/Zn ratio proved to be a better predictor of disease severity and/or mortality 
than Cu levels (Leone et al., 2006;Malavolta et al., 2010;Reunanen et al., 1996;Mezzetti 
et al., 1998). PAM, which uses both Cu and Zn to catalyze the production of bioactive 
peptides. is released from nerve endings, peptide secreting endocrine tissues and 
endothelial cells and can be assayed in serum (Prigge et al., 2000;Kolhekar et al., 
2002;Prohaska and Broderius, 2006).  
Since serum Cu levels increase steadily with age (Malavolta et al., 2010;Mezzetti et al., 
1998) as does sensitivity to nutritional and physiological challenges, serum Cu, Zn and 
Cu/Zn ratios have been explored as biomarkers (Malavolta et al., 2010). Serum PAM 
activity has not been tested as a biomarker. We assessed the relationship between 
these parameters and physical and mental measures of well-being in a population of frail 
elderly men. We found strong negative relationships between serum Cu and the Cu/Zn 
ratio with bone mineral density, muscle strength and measures of overall health and 
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independence.  Serum PAM activity correlated with Cu levels and shared many of the 
same associations with bone health, physical performance and overall health as the 
Cu/Zn ratio. These results identify serum Cu, Cu/Zn ratio and PAM activity as strong 
associative measures for frailty within elderly populations. 
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METHODS 
Study Population 
Frail men aged 60 years or older residing in the community or assisted living were 
recruited to participate in the study. The individuals were screened for potential 
participation in a previously reported study to assess testosterone effects on bone and 
frailty in men (Kenny et al., 2010). The data used in this analysis are baseline 
assessments, prior to any interventions. Briefly, exclusion criteria were: [1] Diseases or 
medications known to affect bone or muscle metabolism (i.e. Paget’s disease, 
osteomalacia, hyperparathyroidism: current use of corticosteroids, calcitonin, heparin, 
phenytoin, phenobarbital, methotrexane, bisphosphonates, selective estrogen receptor 
modulator or PTH; [2] Use of estrogen, DHEA or androgen in the preceding year; [3] 
metastatic or advanced cancer (other than skin cancer); [4] History of prostate cancer; 
[5] Active cardiac ischemia by history of angina or myocardial infarction in the preceding 
6 months; [6] Elevation of PSA [7] History of sleep apnea; [8] Polycythemia.  All study 
participants provided written informed consent. The institutional review board at the 
University of Connecticut Health Center approved the study. 
Evaluations 
Baseline evaluation of the following outcomes were performed: basic demographic 
characteristics; dietary intake using a 3 day food record; serum Cu and Zn levels; bone 
assessment including bone mineral density (BMD), bone markers, sex and calcium 
regulating hormone levels, body composition and physical function assessment including 
frailty evaluation, body composition, strength measures, multiple physical performance 
measures, self-reported physical activity estimated by Physical Activity Scale for the 
Elderly (PASE) questionnaire (Washburn et al., 1993), activities of daily living and 
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hematocrit; and overall health assessment including Folstein Mini-mental status 
examination, Geriatric Depression scale and lipid analysis. The frailty phenotype 
evaluation was based on Fried et al. (Fried et al., 2001) (frail =3-5 characteristics, 
intermediate frail =1-2 characteristics, non-frail= 0 characteristics). Bone mineral density 
and body composition (Lunar DPX-L, Madison, WI) of the proximal femur, lumbar spine, 
distal radius, and total body (total lean body mass [LBM (kg)], total fat mass (kg) and 
total body bone mineral content (kg)) were obtained.  The coefficient of variation of BMD 
measurement at the proximal femur, spine and total body was <1%, 1.5% and 2%, 
respectively. Appendicular skeletal muscle mass (ASM) was determined by combining 
the lean tissue mass of the regions of the arms and legs, excluding all other regions from 
analysis (Wang et al., 1996). We adjusted ASM for height by dividing each by height2 
(m2).  Leg extension strength [1 repetition maximum (Judge et al., 1996); intra- and inter-
tester variability <10%] was measured on the Keiser Sitting Leg Press.  Physical 
performance was assessed by the Short Physical Performance Battery [ability to rise 
from a chair, static balance and the 8 foot walk ](14), supine to stand test (Alexander et 
al., 1997) and Get Up and Go test (Podsiadlo and Richardson, 1991). Dietary records 
were analyzed using Food Processor (version8.1; Salem, OR).  
 
Biochemical Analysis 
Biochemical analyses of bone turnover markers were previously described (6) and included 
markers of bone formation [bone specific alkaline phosphatase (BAP), N-terminal type I 
procollagen peptide (PINP) and osteocalcin (OC)]; markers of bone resorption [crosslinked 
N-telopeptide (NTX) of type I collagen and free deoxypyridinoline crosslinks (DPD)]; sex 
hormones [total and bioavailable testosterone, SHBG, estradiol, DHEAS]; calcium 
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regulating hormones [ 25OHD and  PTH]; overall health  measures [cholesterol 
measurements, and hematocrit].   
PHM activity was assayed as described using a trace amount of [125I]-Ac-Tyr-Val-Gly, 
0.5 µM Ac-Tyr-Val-Gly and 4.0 µM CuSO4; serum samples were diluted 10-fold into 20 
mM Na TES, pH 7.4, 10 mM mannitol, 1 mg/ml bovine serum albumin, 1% TX-100 
(Surfact-Amps X-100) (Thermo Scientific) and 4 µl (0.4 µl of serum) was assayed in 
triplicate in 100 mM Na MES, pH 5.5 (Bousquet-Moore et al., 2009).  In the absence of 
exogenous Cu, PHM activity cannot be accurately assessed; the addition of exogenous 
Cu (4.0 µM CuSO4) yielded maximal levels of PHM activity for serum samples in the 
upper and lower quintiles.  PAL activity was assayed in triplicate from the same dilutions 
(0.2 µl serum) using a trace amount of [125]I-Ac-Tyr-Val-α-hydroxyglycine, 0.5 µM Ac-Tyr-
Val-α-hydroxyglycine, 1 mM CdCl2, 0.02% Thesit and 100 mM Na MES, pH 5.5 
(Kolhekar et al., 2002). Ceruloplasmin was assayed in duplicate using O-dianisidine 
dihydrochloride (Prohaska and Broderius, 2006); a linear response was observed with 
1.0 to 5.0 µl serum and samples were compared using 2.5 µl serum. 
Measurement of serum Cu and Zn levels 
Inductively coupled plasma mass spectrometry analysis was performed using an Agilent 
7700x equipped with an ASX 250 autosampler. The system was operated at a radio 
frequency power of 1550 W, an argon plasma gas flow rate of 15 L/min, and an Ar 
carrier gas flow rate of 1.04 L/min. Elements were measured in kinetic energy 
discrimination (KED) mode using He gas (4.3 mL/min). For the analysis, serum samples 
were diluted 25-fold into 1% HNO3 (Fisher Scientific). Data were quantified using a 5-
point (0, 1, 10, 100, 1000 ppb (ng/g)) calibration curve with external standards for Fe, 
Cu, and Zn. For each sample, data were acquired in triplicate and averaged. An internal 
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standard (Er) introduced with the sample was used to monitor for plasma instabilities.  
Statistical Analysis  
Baseline and clinical characteristics were reported using percentages, means and 
standard deviations. All variables were checked for normal distribution and the impact of 
outliers. Outliers beyond 3 standard deviations were dropped from the analyses (n=3). 
Correlation coefficients were used to detect preliminary associations of serum Cu with 
other measures of interest. Quintiles for serum metals, enzyme activities and ratios were 
created using the binned function in SPSS software (version 18.0). Four cut points were 
applied to create approximately five equal proportions of the sample distribution 
(quintiles). Independent t-tests were used to compare the means of the lowest quintile to 
the middle or reference quintile. Separate independent t-tests were used to compare the 
means of the highest quintile to the middle or reference quintile. The outcome measures 
being compared among the high and low quintile groups were bone mineral density, 
bone markers, hormones, frailty factors, body composition, physical performance, and 
overall health factors.  Statistical analyses were performed using SPSS version 18.0 
(Chicago, IL). 
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RESULTS 
Subject population. One hundred and forty-four men were included in this analysis with a 
mean age of 77 years and BMI of 27 kg/m2. Baseline information on the group appears 
in Table 4-1. Subjects consumed a mean of 2000 calories/day, 1.21 + 1.07 mg of Cu 
and 12.9 + 10.6 mg of Zn. Dietary intake shared no statistical relationship with serum 
values (not shown). Bone mineral density, bone turnover markers and sex and calcium 
regulating hormone information are summarized in Table 4-1. The mean femoral neck t-
score was -2.12 + 0.75 g/cm2, indicating relatively low bone mass on average. Bone 
turnover markers, sex hormone levels and vitamin D and parathyroid hormone (PTH) 
were above the normal range and typical of those in older men (Ferrini and Barrett-
Connor, 1998). Average results for the assessment of body composition and physical 
function are also outlined; the majority of men (91%) met the criteria for frailty (18%) or 
prefrailty (72%). Approximately 50% of the men had appendicular skeletal muscle mass 
(ASM/Ht2) values that met criteria for sarcopenia or low muscle mass associated with 
aging (Baumgartner et al., 1998). Overall, the men were community dwelling but had 
some limitation in function, with 20% requiring assistance in instrumental activities of 
daily living and 12% requiring assistance in activities of daily living such as dressing, 
toileting and feeding.   
Serum Cu, Zn and the Cu/Zn Ratio. Serum Cu and Zn levels were measured by 
inductively coupled plasma mass spectrometry, and Cu/Zn ratios were calculated for 
each subject. Serum levels of Cu were 1009 ± 241 ppb, Zn levels were 877 ± 281 ppb 
and the Cu/Zn ratio was 1.22 + 0.37 (Table 4-1). Serum Cu, serum Zn, and Cu/Zn ratios 
were normally distributed among subjects in our sample (Fig. 4-1). For analysis, 
subjects were divided into quintiles based on serum Cu, Zn and serum Cu/Zn ratios. In 
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all cases, measures of BMD, physical performance and overall health were compared 
between the lowest or highest quintile and the reference (middle) quintile.   
Serum Ceruloplasmin and the Cu/Ceruloplasmin Ratio. Ceruloplasmin (Cp) is a Cu-
dependent ferroxidase that acts as the major carrier for Cu in the blood. As expected, 
serum Cp levels correlated tightly with serum Cu levels (Fig. 4-2A). Previous studies 
Table 4-1. Characteristics of the whole sample 
 Total 
Mean ± SD 
(N=144) 
Age (yrs) 77.1 ± 7.6 
BMI (kg/m2) 26.9 ± 4.4 
Nutrition  
Calories 2046 ± 1130 
Calcium (mg) 898 ± 660 
Vitamin D (IU) 209 ± 276 
Copper (mg) 1.21 ± 1.07 
Protein (g) 94.8 ± 51.5 
Magnesium (mg) 285.4 ± 161.9 
Zinc (mg) 12.9 ± 10.6 
Iron (mg) 19.8 ± 12.9 
Serum Levels  
Copper (ppb) 1009 ± 241 
Ceruloplasmin (Uu/uL) 188.4 ± 46.3  
Zinc (ppb) 877 ± 281 
Iron (ppb) 970 ± 531 
Copper/Zinc Ratio  1.22 ± 0.37 
Copper/Ceruloplasmin Ratio 5.48 ± 1.10 
PHM Activity (nmol/mL/h) 5.56 ± 1.13 
PAL Activity (nmol/mL/h) 19.00 ± 4.46 
Bone Mineral Density  
Femoral Neck BMD (g/cm2) 0.794 ± 0.098 
Femoral Neck (t-score) -2.12 ± 0.75 
Femoral Total BMD (g/cm2) 0.886 ± 0.113 
Femoral Total (t-score) -1.56 ± 0.87 
Femoral Trochanter BMD (g/cm2) 0.794 ± 0.121 
Femoral Trochanter (t-score) -1.24 ± 1.10 
Radius BMD (g/cm2) 0.551 ± 0.072 
Radius  (t-score) -1.11 ± 1.30 
Total body BMD (g/cm2) 1.160 ± 0.094 
Total body (t-score) -0.75 ± 1.17 
Bone Turnover Markers  
NTX/CR 43.1 ± 41.9 
BAP (U/L) 26.0 ± 15.9 
Osteocalcin (ng/mL) 10.8 ± 6.9 
Sex Hormones and Calcium Regulating Hormones  
DHEA (ug/dL) 55.3 ± 44.9 
Estradiol (pg/mL) 34.2 ± 10.0 
Testosterone (pg/mL) 400 ± 185  
Vitamin D (nmol/L) 86.5 ± 36.2 
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identified free or unbound Cu as having a stronger association with disease than total Cu 
or Cp levels (Arnal et al., 2010). Therefore, we calculated the Cu/Cp ratio for each 
subject as an indicator of unbound Cu in serum and found these values to be normally 
distributed among subjects in our sample (Fig. 4-2B). Subjects were divided into 
quintiles based on their serum Cu/Cp ratio, as had been done for the serum metals.
Table 4-1. Characteristics of the whole sample (continued) 
 Total 
Mean ± SD 
(N=144) 
Body Composition  
and Physical Function 
Nonfrail % (n) 9 (12) 
Prefrail % (n) 72 (94) 
Frail % (n) 18 (24) 
ASM (Kg) 22.5 ± 3.5  
ASM/Ht2 7.6 ± 1.0 
Whole body fat mass (Kg) 28 ± 7 
Whole body lean mass (Kg) 53 ± 7 
Leg Press Strength (Newtons) 666 ± 207 
Leg Press Power (Watts) 254 ± 135 
Handgrip (Kg) 25.3 ± 8.2 
Chair rise time (secs) 15.6 ± 6.3 
Walk best time (m/sec) 0.89 ± 0.23  
Get up and Go (secs) 12.8 ± 8.0 
PASE score 189 ± 134 
SPPB score 9.0 ± 2.6 
Overall Health  
MMSE score 28 ± 2 
CESD score 7.4 ± 6.8 
Total cholesterol (mg/dL) 188 ± 38 
HDL (mg/dL) 45 ± 12 
LDL (mg/dL) 119 ± 33 
Triglycerides (mg/dL) 119 ± 75 
IADL needs assistance % (n) 20 (24) 
ADL needs assistance % (n) 12 (15) 
HCT (%) 41.6 ± 4.3 
Heart disease % (n) 30 (38) 
Hypertension % (n) 23 (30) 
On Cholesterol Medication % (n) 28 (36) 
On Hypertension Medication % (n) 41 (59) 
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Figure 4-1. Serum Metals. Graphs depict frequency histograms for serum Cu (A), 
serum Zn (B), and the Cu/Zn ratio (C). Values for all three parameters were normally 
distributed. Reference lines for histograms denote boundaries for quintile groupings. 
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Serum PAM Activity. Although Cu is essential for the catalytic activity of key enzymes 
such as mitochondrial Cyt c oxidase, cytosolic Cu/Zn SOD and secreted amine 
oxidases, it must be bound to transporters and chaperones in order to limit its ability to 
damage lipids, nucleic acids and proteins. The vesicular PAM enzyme catalyzes the α-
amidation reaction essential to the biosynthesis of many neuropeptides and hormones. 
The first part of this two-step reaction, the -hydroxylation of peptidylglycine, is 
accomplished by the peptidylglycine α-hydroxylating monooxygenase (PHM) domain of 
PAM, which requires Cu. The second step, C-N bond cleavage to yield the final 
amidated product plus glyoxylate, is accomplished by peptidyl-α-hydroxyglycine α-
amidating lyase (PAL), which uses Zn; several other divalent metals can substitute for 
Zn. We evaluated both activities in serum samples from our subjects. Assays were done 
after adding exogenous metals and reflect the amount of PHM and PAL protein, not 
metallation of each enzyme, in serum. Serum PHM and PAL activities were normally 
distributed in our sample (Fig. 4-3A,B). PHM and PAL activities were strongly correlated 
Figure 4-2. Serum Cu and Cp and Cu/Cp Ratios. (A) Serum Cu and Cp correlate 
positively and linearly within the sample. (B) The Cu/Cp ratio represents the level of 
non-Cp-bound Cu in the serum of each subject. Graph depicts frequency histogram 
for Cu/Cp ratios, which are normally distributed among subjects. Reference lines for 
histograms denote boundaries for quintile groupings. 
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(Fig. 4-3C), as would be expected for enzymes cleaved from the same bifunctional 
precursor. Pearson correlation analysis revealed significant associations between PHM 
and PAL activity and serum Cu (Fig. 4-3D,E), but not with serum Zn or the Cu/Zn ratio 
(not shown). As for serum Cu, serum Zn and the Cu/Zn ratio, PHM and PAL activities 
were divided into quintiles and measures of BMD, physical performance and overall 
health were compared between groups. Associations found in the PAL quintile analysis 
(but not for PHM) typically followed those of the Cu/Zn ratio. This may reflect the fact 
that individuals in the high Cu/Zn group also had significantly higher serum PAL activities 
(Fig. 4-3F). Since serum PHM and PAL assays are not widely used, we chose to focus 
on associations with serum metals. 
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Figure 4-3. PAM Activity. Graphs depict frequency histograms for PHM (A) and PAL 
(B) activities. (C) PHM and PAL activities for each subject are positively and linearly 
correlated. PHM (D) and PAL (E) activities are positively and linearly correlated with 
serum Cu. (F) Subjects in the high serum Cu/Zn ratio group have significantly higher 
serum PAL activities than the reference group. Inset depicts scatter plot with 
reference line boundaries for quintile groupings. * denotes P<0.05 compared to the 
reference group. 
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Bone Mineral Density. Mean bone mineral density and factors that contribute to bone 
mineral density were compared across serum Cu levels and Cu/Zn ratios (Table 4-2). 
Bone mineral density measures were lower overall in subjects in the high Cu quintile, 
reaching significance for the femoral neck (Table 4-2A; Fig. 4-4A) and total body. 
Markers for bone turnover, including bone alkaline phosphatase, N-telopeptide 
crosslinks of type I collagen, and osteocalcin, were significantly or near significantly 
elevated in subjects in the low serum Cu group. However, these individuals did not 
display any reduction in bone mineral density. No statistically significant differences 
Table 4-2a.  Copper groupings by bone mineral density and bone turner 
markers 
 Low 
<836.69 ppb 
(n=27) 
Reference 
906.44 - 
1013.91 ppb 
(n=28) 
High 
>1193.06 ppb 
(n=22) 
P 
values 
Low 
P 
values 
High 
Femoral Neck BMD (g/cm2) 0.814 ± 0.087 0.806 ± 0.070 0.747 ± 0.113 .698 .031 
Femoral Total BMD (g/cm2) 0.891 ± 0.085 0.910 ± 0.096 0.845 ± 0.146 .456 .066 
Femoral Trochanter BMD (g/cm2) 0.788 ± 0.094 0.811 ± 0.110 0.757 ± 0.155 .394 .157 
Radius BMD (g/cm2) 0.535 ± 0.084 0.536 ± 0.062 0.540 ± 0.082 .153 .267 
Total Body BMD (g/cm2) 1.150 ± 0.092 1.188 ± 0.069 1.126 ± 0.114 .087 .022 
NTX/CR 43.4 ± 18.1 33.9 ± 18.4 44.6 ± 38.6 .061 .203 
BAP (U/L) 27.7 ± 8.9 22.6 ± 6.4 23.8 ± 9.0 .017 .581 
Osteocalcin (ng/mL) 11.7 ± 6.3 9.0 ± 3.9 10.2 ± 6.2 .060 .439 
DHEA (ug/dL) 62.8 ± 39.5 53.4 ± 57.0 44.5 ± 24.3 .504 .483 
Estradiol (pg/mL) 34.4 ± 9.2 35.3 ± 7.3 31.6 ± 10.3 .690 .146 
Testosterone (pg/mL) 452.2 ± 174.9 386.7 ± 150.7 344.2 ± 204.4 .142 .406 
Vitamin D (nmol/L) 88.7 ± 34.6 89.6 ± 35.3 78.4 ± 37.6 .922 .281 
iPTH (pg/mL) 63.3 ± 21.9 61.5 ± 35.9 82.9 ± 51.8 .822 .094 
Table 4-2b.  Copper:Zinc groupings by bone mineral density and bone turner 
markers 
 Low 
<0.93 
(n=26) 
Reference 
1.12 - 1.27 
(n=27) 
High 
>1.51 
(n=26) 
P 
values 
Low 
P 
values 
High 
Femoral Neck BMD (g/cm2) 0.802 ± 0.063 0.823 ± 0.116 0.750 ± 0.090 .416 .014 
Femoral Total BMD (g/cm2) 0.907 ± 0.078 0.921 ± 0.124 0.833 ± 0.122 .631 .012 
Femoral Trochanter BMD (g/cm2) 0.801 ± 0.089 0.837 ± 0.135 0.743 ± 0.133 .253 .013 
Radius BMD (g/cm2) 0.551 ± 0.071 0.557 ± 0.084 0.539 ± 0.080 .768 .410 
Total Body BMD (g/cm2) 1.166 ± 0.080 1.175 ± 0.091 1.144 ± 0.106 .698 .261 
NTX/CR 38.1 ± 14.1 38.7 ± 19.0 48.3 ± 36.7 .909 .237 
BAP (U/L) 25.1 ± 6.6 25.9 ± 12.4 25.0 ± 9.5 .766 .762 
Osteocalcin (ng/mL) 10.2 ± 4.4 9.2 ± 5.7 11.7 ± 7.1 .452 .159 
DHEA (ug/dL) 60.6 ± 50.9 56.3 ± 55.4 40.3 ± 29.3 .772 .202 
Estradiol (pg/mL) 33.6 ± 8.8 33.5 ± 6.8 32.3 ± 9.6 .974 .590 
Testosterone (pg/mL) 410.9 ± 177.9 408.0 ± 112.7 411.6 ± 190.7 .944 .935 
Vitamin D (nmol/L) 83.9 ± 35.1 78.8 ± 24.6 78.1 ± 37.0 .545 .930 
iPTH (pg/mL) 57.1 ± 21.0 61.1 ± 23.0 89.0 ± 55.4 .519 .020 
Bold represents p values < .05. P values were based on independent t-tests 
comparing mean values between copper level groups. 
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between sex hormones or calcium regulating hormones were found between Cu groups, 
although trends toward lower estradiol and vitamin D and higher PTH were found in the 
high Cu group. Larger significant deficits in BMD, including that of the femoral neck (Fig. 
4-4B), were found in individuals in the high Cu/Zn ratio group (Table 4-2B). No 
differences in bone health measures were found in the low Cu/Zn ratio group. Individuals 
in both the low and high PAL groups had significantly lower femoral neck and total femur 
BMD than the reference group (not shown).  
PTH and vitamin D are important hormonal regulators of bone mineral density and of 
serum calcium. While the average PTH value for our sample was above the normal 
range, as is typical for older individuals, PTH was up significantly in the highest Cu/Zn 
ratio group (Fig. 4-5A). Vitamin D levels were reduced overall in our sample, as 
expected in elderly individuals who receive less sun exposure than the general 
population. Especially low vitamin D levels can result in compensatory increases in PTH 
to maintain serum calcium levels. To determine whether the elevation in PTH in subjects 
with high Cu/Zn ratios could be accounted for by especially low vitamin D levels, we 
Figure 4-4. Bone Mineral Density (BMD). BMD was assessed from the femoral 
neck of each subject. Individuals in the high serum Cu (A) and high Cu/Zn ratio (B) 
groups had significantly lower BMDs than individuals in their respective reference 
groups. 
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compared PTH/vitamin D ratios between the Cu/Zn ratio groups (Fig. 4-5B). There was 
a more prominent increased in the PTH/vitamin D ratio than there was for PTH alone in 
the high serum Cu/Zn ratio group. Similar trends for higher PTH levels and PTH/vitamin 
D ratios both approached significance for the high PAL group (not shown). This result 
suggests that a high serum Cu/Zn ratio is associated with elevated PTH levels, which 
may be driven by a deficiency in vitamin D in those individuals. 
Figure 4-5. Parathyroid Hormone (PTH). (A) Subjects in the high Cu/Zn ratio group 
had significantly higher PTH values than their reference group cohorts. (B) The 
PTH/vitamin D ratio was increased in subjects with high serum Cu/Zn ratios. 
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Physical Performance. Measures of physical performance, including those testing frailty, 
body composition, speed, balance and muscle strength, were also compared across 
serum metal groups. Interestingly, distinct impairments were observed in the high serum 
Cu and Cu/Zn ratio groups (Table 4-3). Subjects in the high serum Cu group displayed 
slower walking speeds and get-up-and-go times (Table 4-3A; Fig. 4-6A). The SPPB 
incorporates measures of speed, muscle strength and balance. Subjects in the high 
serum Cu group had body compositions and muscle strengths similar to the reference 
group. The decrease in SPPB score in the high serum Cu group approached statistical 
Table 4-3a. Copper grouping by frailty and physical performance  
 Low 
<836.69 ppb 
(n=26) 
Reference 
906.44 - 
1013.91 ppb 
(n=27) 
High 
>1193.06 ppb 
(n=20) 
P 
values 
Low 
P 
values 
High 
Nonfrail % (n) 7 (2) 4 (1) 14 (3) .531 .193 
Prefrail % (n) 89 (24) 75 (21) 68 (15) .182 .697 
Frail % (n) 4 (1) 21 (6) 18 (4) .049 .776 
ASM (Kg) 23.1 ± 3.5  22.2 ± 2.9 21.8 ± 3.1 .273 .658 
ASM/Ht2 7.8 ± 0.8 7.5 ± 1.0 7.6 ± 1.0 .280 .695 
Whole body fat mass (Kg) 29.0 ± 5.7 27.4 ± 7.2 29.3 ± 9.0 .366 .411 
Whole body lean mass (Kg) 54.4 ± 7.1 52.8 ± 6.2 51.1 ± 5.9 .392 .332 
Leg Press Strength (Newtons) 742 ± 192 606 ± 139 597 ± 140 .005 .842 
Leg Press Power (Watts) 280 ± 145 256 ± 100 215 ± 108 .492 .186 
Handgrip (Kg) 27.4 ± 8.6 24.8 ± 9.2 24.2 ± 7.9 .287 .824 
Chair rise time (secs) 14.4 ± 4.4 15.0 ± 4.5 17.6 ± 8.2 .681 .172 
Walk best time (m/sec) 0.95 ± 0.17 0.94 ± 0.24 0.76 ± 0.26 .958 .015 
Get up and Go (secs) 10.7 ± 4.8 11.2 ± 3.4 15.6 ± 7.2 .698 .008 
PASE score 212.6 ± 103.5 182.2 ± 119.8 164.4 ± 150.6 .334 .654 
SPPB score 9.8 ± 2.1 9.3 ± 2.0 7.8 ± 3.3 .305 .076 
Table 4-3b. Copper:Zinc grouping by frailty and physical performance  
 Low 
<0.93 
(n=24) 
Reference 
1.12 - 1.27 
(n=27) 
High 
>1.51 
(n=23) 
P 
values 
Low 
P 
values 
High 
Nonfrail % (n) 7 (2) 15 (4) 4 (1) .413 .172 
Prefrail % (n) 85 (22) 70 (19) 65 (17) .215 .697 
Frail % (n) 8 (2) 15 (4) 31 (8) .413 .165 
ASM (Kg) 22.8 ± 3.6  23.6 ± 2.9 21.0 ± 3.1 .406 .003 
ASM/Ht2 7.7 ± 1.0 7.9 ± 1.0 7.3 ± 0.9 .590 .042 
Whole body fat mass (Kg) 29.3 ± 5.3 28.8 ± 6.8 26.2 ± 8.9 .765 .232 
Whole body lean mass (Kg) 53.8 ± 7.7 55.5 ± 5.1 50.0 ± 5.8 .350 .001 
Leg Press Strength (Newtons) 713 ± 228 697 ± 190 564 ± 202 .779 .021 
Leg Press Power (Watts) 309 ± 163 296 ± 137 195 ± 94 .754 .005 
Handgrip (Kg) 24.2 ± 8.1 29.5 ± 8.7 23.0 ± 8.0 .029 .009 
Chair rise time (secs) 12.9 ± 2.6 14.6 ± 5.2 17.5 ± 8.0 .150 .139 
Walk best time (m/sec) 0.95 ± 0.16 0.95 ± 0.25 0.81 ± 0.26 .994 .064 
Get up and Go (secs) 10.6 ± 2.0 11.4 ± 4.4 14.6 ± 7.0 .433 .056 
PASE score 236.2 ± 110.6 184.1 ± 131.5 178.2 ± 170.0 .139 .890 
SPPB score 10.4 ± 1.3 9.7 ± 2.2 7.8 ± 3.0 .178 .014 
Bold represents p values < .05. P values were based on independent t-tests 
comparing mean values between copper level groups. 
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significance. By contrast, subjects in the low serum Cu groups were statistically less 
likely to meet criteria for frailty and had stronger leg press performances than the 
reference group (Table 4-3A). 
In the Cu/Zn ratio analysis, similarly impaired scores in most assessments were 
apparent in the high group (Table 4-3B). However, these deficits were focused on 
measures of body composition (lean body mass) and muscle strength (leg and handgrip 
strength and power), rather than speed (Fig. 4-6B). Moreover, impairments in rise time, 
walk time, and get-up-and-go did not reach statistical significance in the high Cu/Zn ratio 
group. Poorer performance in the SPPB for high Cu/Zn subjects was statistically 
significant (Fig. 4-7). Subjects in the high PAL group also had significantly diminished 
muscle strengths and lower SPPB scores near statistical significance (not shown). The 
only difference in physical performance measures for the low Cu/Zn ratio group was an 
isolated decrease in handgrip strength (Table 4-3B).  
Figure 4-6. Speed and Muscle Strength. (A) Subjects were tested for speed with 
the get-up-and-go task. Individuals in the high serum Cu group took significantly more 
time to complete the get-up-and-go task than the reference group. (B) Subjects were 
also tested for muscle strength by measuring power generated by right leg press. 
Individuals in the high Cu/Zn ratio generated significantly less power than the 
reference group.  
188 
 
 
Overall Health. Measures of overall health included cognitive and emotional battery test 
scores, blood lipid profiles, hematocrit values, and need for assistance with IADLs and/or 
ADLs. Some similar trends between the high serum Cu and Cu/Zn ratio groups emerged 
with these measures (Table 4-4). No significant differences were observed between 
serum Cu or Cu/Zn ratio groups for cognitive performance (MMSE) or depression scale 
(CESD) scores. To verify the results of a previous study (Arnal et al., 2010), we made 
comparisons between Cu/Cp ratio groups (representing non-Cp-bound Cu) in the 
assessment of cognitive impairment in our cohort. Subjects in the high Cu/Cp ratio group 
performed more poorly on the MMSE than those in the reference group (Fig. 4-7B), 
confirming previous reports.  
Interesting interactions between serum metals and PAL activity were found for lipid 
profile measures. No differences in lipid profiles were observed between serum Cu 
(Table 4-4A) or PHM activity groups. Subjects in the high Cu/Zn ratio group had 
significantly lower total cholesterol levels and triglyceride levels (Table 4-4B; Fig. 4-8A). 
Figure 4-7. Short Physical Performance Battery (SPPB) and Mini Mental Status 
Exam (MMSE). (A) Individuals in the high Cu/Zn ratio group achieved significantly 
lower SPPB scores than individuals in the reference group. (B) Individuals in the high 
Cu/Cp ratio group had significantly lower MMSE scores than individuals in the 
reference group.  
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Since triglycerides contribute to total cholesterol levels and no differences were 
observed for LDL or HDL, the effect of Cu/Zn ratio grouping on lipid profile appeared to 
be specific to triglycerides. This relationship was carried by significantly lower triglyceride 
levels in the low Zn group (Fig. 4-8B). There was also a significant reduction in total 
cholesterol for subjects in the high PAL group (Fig. 4-8C); this effect was carried by a 
significant reduction in LDL levels rather than triglycerides (Fig. 4-8D).  
Table 4-4a. Copper groupings for overall health 
 Low 
<836.69 ppb 
(n=26) 
Reference 
906.44 - 
1013.91 ppb 
(n=27) 
High 
>1193.06 ppb 
(n=20) 
P 
values 
Low 
P 
values 
High 
MMSE score 28.4 ± 1.7 27.9 ± 3.1 28.0 ± 1.28 .480 .869 
CESD score 6.1 ± 5.1 7.3 ± 6.0 5.5 ± 4.4 .435 .267 
Total cholesterol (mg/dL) 192 ± 34 183 ± 47 175± 43 .443 .552 
HDL (mg/dL) 42 ± 11 44 ± 11 45 ± 10 .604 .666 
LDL (mg/dL) 124 ± 30 114 ± 42 111 ± 36 .335 .811 
Triglycerides (mg/dL) 152 ± 116  117 ± 55 101 ± 46 .154 .294 
IADL needs assistance % (n) 8 (2) 18 (5) 26 (5) .245 .528 
ADL needs assistance % (n) 8 (2) 4 (1) 15 (3) .507 .170 
HCT (%) 43.5 ± 3.2 41.5 ± 5.0 38.5 ± 4.2 .079 .030 
Table 4-4b. Copper:Zinc groupings for overall health 
 Low 
<0.93 
(n=24) 
Reference 
1.12 - 1.27 
(n=27) 
High 
>1.51 
(n=23) 
P 
values 
Low 
P 
values 
High 
MMSE score 28.4 ± 1.2 28.1 ± 1.5 28.0 ± 3.4 .510 .879 
CESD score 5.9 ± 5.5 8.8 ± 8.9 6.9 ± 3.9 .176 .348 
Total cholesterol (mg/dL) 184 ± 40 193 ± 29 173 ± 40 .333 .041 
HDL (mg/dL) 44 ± 12 45 ± 14 46 ± 12 .794 .739 
LDL (mg/dL) 120 ± 41 120 ± 27 111 ± 31 .981 .318 
Triglycerides (mg/dL) 131 ± 115 138 ± 64 84 ± 49 .785 .001 
IADL needs assistance % (n) 4 (1) 11 (3) 32 (7) .357 .074 
ADL needs assistance % (n) 4 (2) 0 22 (5) .284 .011 
HCT (%) 43.0 ± 2.9 43.0 ± 3.8 39.0 ± 5.1 .990 .002 
Bold represents p values < .05. P values were based on independent t-tests 
comparing mean values between copper level groups. 
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Hematocrit values were significantly lower in both the high serum Cu and Cu/Zn ratio 
groups compared to their respective reference groups (Table 4-4; Fig. 4-9A,B). The 
same significant reduction was evident for the high serum PHM and PAL activity groups 
(not shown). Homeostatic pathways and Fe mobilization require the activity of Cu-
dependent ferroxidases. Thus alterations in Cu levels could affect ferroxidase activity 
and Fe transport. To determine whether Fe transport was affected in these high metal 
and PAM activity subjects, we compared serum Fe levels between those groups with 
Figure 4-8. Lipid Metabolism. (A) Individuals in the high Cu/Zn group had 
significantly lower total cholesterol levels than the reference group. This difference 
was carried by a reduction in triglycerides in those individuals (B). (C) Individuals in 
the high PAL activity group also had significantly lower total cholesterol levels than 
their reference group cohorts; the difference was driven by a reduction in LDL levels 
(D).  
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their respective reference groups. There was a significant reduction in serum Fe for 
subjects in the high Cu/Zn ratio group (Fig. 4-9C). However, in the high serum Cu, PHM 
activity and PAL activity groups, no significant decreases in serum Fe were observed. 
Subjects in these high metal or enzyme activity groups did not have daily dietary Fe 
intakes that differed from their respective reference groups (not shown), suggesting that 
the deficit in hematocrit and/or serum Fe does not result from reduced Fe intake. No 
significant differences in hematocrit were found for the low Cu or low Cu/Zn ratio groups 
(Table 4-4). 
Function and independence were assessed in our cohort by determining whether each 
subject required assistance with IADLs or both ADLs and IADLs (Table 4-4). A greater 
proportion of individuals in the high Cu/Zn ratio group required ADL assistance (Table 4-
4B); a similar trend was observed for the high serum Cu group, but this increase was not 
statistically significant (Table 4-4A). Serum PHM and PAL groups were not associated 
with changes in IADL or ADL assistance (not shown). These data suggest a reduction in 
independent function in individuals with high serum Cu/Zn ratios that likely stems from 
impairments in physical function and/or overall health.  
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Figure 4-9. Hematocrit. Individuals in the high serum Cu (A) and the high Cu/Zn ratio 
(B) groups all had significantly lower hematocrit values than subjects in their 
respective reference groups. (C) The high Cu/Zn ratio subjects also had significantly 
lower serum Fe levels than their reference group cohorts. 
193 
 
 
DISCUSSION 
In the present study we found significant relationships between serum metals and PAM 
enzymatic activity with clinically relevant measures of health and independence in a 
cohort of frail elderly men. Several recent studies have demonstrated a clear link 
between increased serum Cu levels and several progressive, degenerative diseases 
(Arnal et al., 2010;Viktorinova et al., 2009) and increased risk for all-cause mortality in 
the elderly (Leone et al., 2006;Malavolta et al., 2010). In many of these cases, the Cu/Zn 
ratio proved to be a better predictor for disease and mortality than levels of either trace 
element alone. This phenomenon speaks to the tight relationships between homeostatic 
pathways for various trace metals as well as their respective essential yet potentially 
dangerous roles in biology. Here, we have provided evidence for deficits in bone health 
and physical performance associated with high serum Cu/Zn ratios, which may 
contribute to disease progression and mortality in elderly populations.  
Our measures of serum Cu and Zn by inductively coupled plasma mass spectrometry 
were consistent with previously reported values using similar methods (Easter et al., 
2010;Leibovitz et al., 2009;Malavolta et al., 2010). Serum metal values were not related 
to dietary intake, consistent with the presence of an intact regulatory system in our 
cohort (Kim et al., 2010b). Even within normal ranges, high serum Cu and Cu/Zn ratio 
values predicted impairments in bone density and turnover, muscle mass and strength, 
hematocrit, and activities of daily living. While these relationships cannot implicate any 
causative effects of high serum Cu or the Cu/Zn ratio, they highlight the importance of 
serum Cu and the Cu/Zn ratio as well as their potential clinical utility as markers for 
overall health and independence.   
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Serum Metals and Enzyme Activities  
Consistent with previous reports, serum Cu/Zn ratios appeared to provide more useful 
information than serum Cu levels alone. Our results support the potential role of the 
Cu/Zn ratio as a functional and predictive biomarker (Malavolta et al., 2010) and provide 
evidence that a secreted enzyme may contribute to the pathologies commonly 
associated with aging. 
Since PHM and PAL are derived from the same gene product, with PHM requiring Cu 
and PAL using Zn, assessment of their serum levels and their associations provided 
important functional insight regarding these serum trace metals. Levels of both PHM and 
PAL were correlated with serum Cu, not with serum Zn or the Cu/Zn ratio, suggesting 
that Cu is a key determinant of serum PAM levels. While studies of PAM processing and 
secretion in a pituitary tumor cell line identified a regulatory role for copper, it is not yet 
possible to extend these in vitro studies of one cell type to the in vivo situation (De et al., 
2007). Current studies in the lab are aimed at elucidating this interaction using a PAM 
deficient mouse model (Gaier et al, in preparation).    
Specific Measures 
The importance of Cu in bone health has been studied in the context of Cu deficiency 
and osteoporosis (Palacios, 2006;Chaudhri et al., 2009;Lowe et al., 2002). The bone 
mineral densities of our cohort fit criteria for osteopenia (t-scores between -1.0 and -2.5) 
for measurements in the femur (neck and trochanter) and radius, but not for total body 
density. Chaudhri et al. (Chaudhri et al., 2009) found a linear relationship between 
serum Cu values and bone density in post-menopausal women. We found that our 
subjects with low serum Cu levels had increased values of bone turnover markers 
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(specifically BAP), suggesting ongoing bone loss; however, their bone mineral densities 
were similar to those of the reference group. Our results disagree, however, with respect 
to men with high serum Cu levels; high serum Cu and a high Cu/Zn ratio were 
associated with lower bone mineral densities. Parathyroid hormone elevation and 
concomitant vitamin D reduction may contribute to progressive bone loss in these 
groups. Importantly, measures of vitamin D alone were not significantly associated with 
high serum Cu levels or high Cu/Zn ratios. Thus, serum Cu and the Cu/Zn ratio could 
serve as a useful biomarker for determining individuals at risk for bone loss in elderly 
populations. These findings have significant clinical relevance since the head and neck 
of the femur (sites for several associations in this study) are common sites for bone loss 
and clinically important fracture in the elderly.  
The serum Cu/Zn ratio has been studied in the context of several chronic progressive 
diseases. A high ratio was found to predict mortality in cardiovascular and cancer 
patients in several prospective studies with 3.5 to 18 year follow-ups (Leone et al., 
2006;Malavolta et al., 2010;Reunanen et al., 1996). In the present study we found a 
similar trend in physical tasks, but with a clear distinction between deficits associated 
with high serum Cu levels and Cu/Zn ratios. Elderly men in the high serum Cu group 
demonstrated deficits in tasks with a stronger cardiovascular component (slower walk 
and get-up-and-go times), whereas men in the high serum Cu/Zn ratio group displayed 
more impaired performances in discrete tasks of muscle strength (weaker leg press and 
hand grip). Men with high serum Cu/Zn ratios also had significantly lower muscle mass 
(ASM and whole body lean mass) than their cohorts. This curious divergence likely 
speaks to distinct interactions between Cu and Zn in cardiovascular versus 
musculoskeletal systems, since quintile comparisons for serum Zn alone revealed no 
clear trends in physical performance tasks. 
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Not all of our data were consistent with previous reports. In a cross-sectional study, 
Mezzeti et al. (Mezzetti et al., 1998) found an association between high serum Cu and 
LDL and triglycerides that purportedly contributed to the association with cardiovascular 
disease. We found that a high Cu/Zn ratio predicted lower triglyceride and total 
cholesterol levels. These conflicting results may reflect a survivor effect in the frail 
elderly and/or differences in participant selection criteria between studies. 
A significantly decreased hematocrit was evident in groups with elevated serum Cu, 
Cu/Zn ratio, PHM and PAL; thus reduced hematocrit was the most dominant finding of 
this study. A well-documented symptom of chronic Cu deficiency is anemia that is 
refractory to Fe supplementation (Uauy et al., 1998;Halfdanarson et al., 2008) and does 
occur in elderly populations (Carmel, 2008). In contrast, we observed a reduction in 
hematocrit in the high serum Cu and Cu/Zn ratio groups and not in any of the low metal 
groups. This reduction in hematocrit was accompanied by a reduction in serum Fe levels 
in subjects in the high Cu/Zn ratio group. This unexpected result likely reflects the 
complex interconnected pathways of Fe and Cu homeostasis that extend far beyond Cu-
dependent ferroxidases such as ceruloplasmin (Uriu-Adams and Keen, 2005;Uauy et al., 
1998;Collins et al., 2010). Subclinical anemia could also contribute to a heightened risk 
of cardiovascular mortality through long-term increased demand on the heart. 
Additionally, the poor physical performance of elderly men with high serum Cu and 
Cu/Zn ratios could arise through inadequate delivery of oxygen to muscle.  
Independent of the cause, poor physical performance of men with high Cu/Zn ratios has 
high clinical and functional relevance. Strength, speed and stability contribute to an 
individual’s level of independence through his ability to care for himself. Indeed, we 
found a significantly increased proportion of the men in the high Cu/Zn group required 
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ADL assistance. This novel finding suggests an increased demand for daily care in 
individuals with high serum Cu/Zn ratios in addition to risks for disease and mortality. In 
fact, this parameter alone could contribute to the association between high serum Cu 
and Cu/Zn ratio with mortality risk through psychological mechanisms. Assuming that 
serum Cu and the Cu/Zn ratio are important causative factors, intervention to normalize 
serum Cu and the Cu/Zn ratio may reduce frailty and increase independence and life 
expectancy.  
Potential Roles for Cu and Zn 
The oxidative properties of Cu and the antioxidant properties of Zn are hypothesized to 
be influential factors in chronic progressive conditions such as cardiovascular disease 
(Leone et al., 2006;Reunanen et al., 1996), neurodegenerative disease (Mezzetti et al., 
1998;Arnal et al., 2010), and secondary complications of diabetes mellitus (Viktorinova 
et al., 2009). Many studies consistently report an age-dependent increase in serum Cu, 
but a concomitant reduction in serum Zn predicts disease in an age-independent manner 
(Malavolta et al., 2010;Mezzetti et al., 1998). Imbalance of Cu and Zn is thought to result 
in oxidation of lipids, which in turn compromises the integrity of vascular and neuronal 
membranes. In combination with other factors, oxidative stress mediated through trace 
metal imbalances could contribute to the increase in susceptibility to and progression of 
degenerative diseases with age. 
A regulatory system for Cu transport to the heart was recently identified (Kim et al., 
2010b). Kim and colleagues generated a cardiac-specific knockout of the major plasma 
membrane Cu transporter CTR1. In addition to impairments in cardiac function, these 
transgenic mice had reduced levels of Cu in the liver and increased expression of the Cu 
transporter ATP7A in the liver and gut. The changes in ATP7A expression were shown 
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to be mediated through a serological factor. These data also highlight the importance of 
adequate Cu levels in cardiac function. While the details of this system are still unclear, 
we can draw the hypothesis that the elderly men in the high serum Cu and Cu/Zn ratio 
groups may suffer from perturbations in the very same system that results in 
cardiovascular impairments. Alternatively, cardiovascular impairment may be primary, 
and high Cu levels represent a reactive engagement of a functioning Cu regulatory 
system. This regulatory system is surely not exclusive to cardiac function; other organ 
systems that are heavily reliant on Cu and participate in serum Cu regulation could 
contribute to the alterations associated with age. Clearly this topic requires further 
investigation to elucidate the interaction between serum Cu and multiple organ systems, 
particularly as it relates to elderly populations.  
In conclusion, we have characterized a set of significant relationships between serum Cu 
and Zn, and clinically relevant measures of physical function and independence in frail 
elderly men. Our findings highlight the importance and potential clinical utility of trace 
elements as serological markers in identifying at-risk elderly and raise a major question 
for future study: Can manipulation of Cu and the Cu/Zn ratio alone improve physical 
performance and independence? Prospective studies will be needed to test whether 
serum Cu and the Cu/Zn ratio change over time with and without treatment within 
individuals and to determine the predictive power of serum Cu and Cu/Zn ratios in long-
term health. 
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CHAPTER 5: Kalirin7 is required for synaptic structure and function 
 
[Kalirin7 is required for synaptic structure and function. Ma XM, Kiraly DD, Gaier ED, 
Wang Y, Kim EJ, Levine ES, Eipper BA, Mains RE. J Neurosci. 2008 Nov 
19;28(47):12368-82.] 
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CONTRIBUTIONS 
In addition to PAM, our lab studies the physiological roles of Kalirin, a guanine 
nucleotide exchange factor (GEF). One isoform of Kalirin, Kalirin7, is the predominant 
form of Kalirin in the brain and localizes to the post-synaptic density of dendritic spines. 
The role of GEFs in signal transduction combined with the localization of Kalirin7 highly 
suggested a role for Kalirin7 in synaptic function. Our lab employed a variety of 
techniques to test this hypothesis. The results of these experiments were published in 
the Journal of Neuroscience in November, 2008. I conducted electrophysiological 
recordings in hippocampi of wildtype and Kalirin7 knockout mice, collected and analyzed 
results, and wrote a section of the paper based on my findings. This section comprised 
one full figure and one supplemental figure.  
After that paper was published, I performed similar recordings from nucleus accumbens 
medium spiny neurons from wildtype and Kalirin7 knockout mice. Those data have been 
added to the results section.  
  
204 
 
 
ABSTRACT 
Rho GTPases activated by GDP/GTP exchange factors (GEFs) play key roles in the 
developing and adult nervous system.  Kalirin-7 (Kal7), the predominant adult splice 
form of the multifunctional Kalirin RhoGEF, includes a PDZ binding domain and localizes 
to the postsynaptic side of excitatory synapses. In vitro studies demonstrated that 
overexpression of Kal7 increased dendritic spine density whereas reduced expression of 
endogenous Kal7 decreased spine density. To evaluate the role of Kal7 in vivo, mice 
lacking the terminal exon unique to Kal7 were created. Mice lacking both copies of the 
Kal7 exon (Kal7KO) grew and reproduced normally. Golgi impregnation and electron 
microscopy revealed decreased hippocampal spine density in Kal7KO mice. Behaviorally, 
Kal7KO mice showed decreased anxiety-like behavior in the elevated zero maze and 
impaired acquisition of a passive avoidance task, but normal behavior in open field, 
object recognition and radial arm maze tasks. Kal7KO mice were deficient in hippocampal 
long-term potentiation.  Western blot analysis confirmed the absence of Kal7 and 
revealed compensatory increases in larger Kalirin isoforms.  PSDs purified from the 
cortices of Kal7KO mice showed a deficit in Cdk5, a kinase known to phosphorylate Kal7 
and play an essential role in synaptic function. The early stages of excitatory synaptic 
development proceeded normally in cortical neurons prepared from Kal7KO mice, with 
decreased excitatory synapses apparent only after 21 days in vitro.  Expression of 
exogenous Kal7 in Kal7KO neurons rescued this deficit.  Kal7 plays an essential role in 
synaptic structure and function, affecting a subset of cognitive processes.  
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METHODS 
Slice Preparation. Mice of 4-5 weeks of age were sacrificed by decapitation and their 
brains quickly removed in ice-cold artificial cerebral spinal fluid solution (ACSF; in mM): 
125 NaCl, 26 NaHCO3, 10 glucose, 2.3 KCl, 2 CaCl2, 2 MgSO4, 1.26 KH2PO4 (aerated 
with 95% O2 and 5%CO2; pH=7.3; 310 mOsm/kg) (Zhou et al., 2008b). Coronal slices, 
300 µm thick, were allowed to incubate at room temperature for at least 1 hour before 
recordings.  
Whole Cell Recordings. Slices were transferred to a recording chamber heated to 32°C 
and perfused with aerated ACSF with the addition of 50 µM Picrotoxin (PTX; Sigma-
Aldrich) to isolate excitatory neurotransmission.  Recording pipettes with 3-5 MΩ tips 
were filled with internal solution containing (in mM): 135 KGluconate, 10 HEPES, 10 
PCreatine, 3 Na2ATP, 2 MgCl2, 0.3 Na2GTP (pH=7.3; 285 mOsm/kg) (Zhou et al., 
2008b). Cells were patched under visual guidance using infrared differential interference 
contrast optics. Data were collected using a Multiclamp 700B amplifier (Axon 
Instruments/Molecular Devices Sunnyvale, CA) and recorded/analyzed using pClamp 
9.2 software (Axon Instruments).   
Intrinsic Membrane Properties. Integrity of each patch was assessed through a series of 
negative and positive steps in current clamp mode (20 x 100 pA steps, -600 pA to +1300 
pA; 100 msec steps). The three initial negative steps were used to calculate membrane 
resistance; single exponential curve fits yielded tau () and capacitance. Action potential 
threshold was defined as the point of voltage inflection for the first spike fired in the 
lowest current step. Inter-spike interval (ISI) was assessed in steps eliciting 3 or more 
spikes and defined as time between peaks of the last two spikes within a step.   
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Spontaneous Glutamatergic Activity. We recorded spontaneous Excitatory Post Synaptic 
Currents (EPSCs) while voltage clamped at -70 mV for 1 minute for each cell. Events 
observed in the full minute were analyzed using MiniAnalysis (Synaptosoft Inc, Chapel 
Hill, NC). Two outlier cells from each group were excluded from statistical analysis; their 
event frequency values were far greater than 2 standard deviations above their group 
mean.  
Long Term Potentiation. Bipolar tungsten electrodes (World Precision Instruments, 
Sarasota, FL) were placed in the stratum radiatum to stimulate Schaffer collateral axons. 
EPSCs were recorded in voltage clamp mode at -70 mV, with stimulation strength 
adjusted to obtain 20-50 pA EPSCs at baseline. Test pulses were applied at 0.1 Hz to 
establish averaged baseline (10-25 pulses) and post-LTP induction EPSC values (25-50 
pulses, recorded within 15 min after LTP induction). EPSC amplitudes were measured 
as the absolute difference between baseline and peak inward current within 50 ms after 
the stimulus artifact. A small subset of cells was recorded in the absence of PTX, and 
included in the analysis because their electrophysiological measures were consistent. 
LTP induction was initiated using Theta Burst Pairing in voltage clamp mode and always 
within 15 minutes after achieving whole cell configuration. LTP induction consisted of 15 
4-pulse bursts at 100 Hz separated by 200 ms intervals, and each burst was paired with 
a 50 msec depolarizing voltage step to 0 mV. Cells that required greater than 200 µA of 
stimulation or showed LTP smaller than 120% were excluded from analyses (Kauer and 
Malenka, 2007). Statistical comparisons were made using Student’s T-test. 
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RESULTS 
Kalirin7KO electrophysiology in hippocampus 
To assess the functional consequences of Kal7 knock-out, we performed 
electrophysiological recordings from acute slice preparations. First, we evaluated 
passive membrane properties. Capacitance is a measure of cell surface area and 
dendritic spines contribute 40–70% of the total surface area of hippocampal CA1 
pyramidal cells (Harris and Stevens, 1989;Mainen et al., 1996;Inoue et al., 2001). Given 
the reduction in spine density observed in the CA1 pyramidal neurons of Kal7KO mice, 
we expected to see slightly reduced capacitance values for Kal7KO versus Wt neurons. 
Hyperpolarizing and depolarizing current steps were applied to patched CA1 
hippocampal neurons to provide measures of membrane resistance and τ so that 
capacitance could be calculated (Fig. 5-1A). On average, Kal7KO neurons had higher 
input resistance (Wt, 122 ± 7 MΩ; Kal7KO, 147 ± 5 MΩ; p = 0.008; 32 Wt neurons and 29 
Kal7KO neurons) and lower membrane capacitance (Wt, 66 ± 3 pF; Kal7KO, 57 ± 2 pF; p = 
0.028); time constants did not differ (Wt, 7.6 ± 0.3 ms; Kal7KO, 8.1 ± 0.3 ms; p = 0.19). 
The resting potential and action potential threshold for knock-out and Wt pyramidal 
neurons were identical (Fig. 5-2A). In knock-out neurons, the number of action 
potentials fired during weak depolarizing current steps was slightly increased (Fig. 5-
2B), whereas latency to fire the first action potential after step initiation was decreased 
(Fig. 5-2C); both results are consistent with the decreased membrane capacitance 
(decreased surface area) observed in Kal7KO neurons. There was no significant 
difference in interspike interval between the two groups. Because the CA1 pyramidal 
neurons of Kal7KO mice have fewer dendritic spines, we assessed spontaneous EPSCs 
(Fig. 5-1B); as predicted, spontaneous EPSC frequency was significantly decreased in 
Kal7KO neurons. No difference was observed in amplitude (Fig. 5-2). We went on to 
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compare plastic properties of Wt and Kal7KO synapses. EPSCs, evoked via Schaffer 
Figure 5-1. Electrophysiological deficits. (A) Representative traces from Wt and 
Kal7KO CA1 pyramidal neurons of membrane responses to positive and negative 200 
pA somatic current injections. (B) Composite spontaneous EPSC frequency (N = 24 
Wt, 18 KO neurons; p = 0.023; left) and LTP (N = 7 Wt, 13 KO neurons; p = 0.0079; 
right) data. Error bars indicate SEM. (C) Averaged traces of EPSCs recorded from 
single CA1 pyramidal neurons from Wt and Kal7KO mice before and within 15 min 
after theta burst pairing. 
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collateral stimulation, were of similar amplitude and required similar stimulation strengths 
in Wt and Kal7KO neurons (Fig. 5-2E,F). Taken with the lack of difference in spontaneous 
EPSC amplitude, these data suggest normal strength of basal synaptic transmission in 
Kal7KO neurons. To measure LTP, EPSCs were examined before and after applying a 
TBP paradigm. A single TBP trial resulted in significant LTP that was maintained for at 
least 1 h in both Wt and Kal7KO slices (Fig. 5-1C). LTP was quantified by comparing 
EPSC amplitudes within 15 min after the TBP trial to averaged baseline EPSC 
amplitudes. Compared with Wt neurons, Kal7KO neurons showed markedly blunted LTP 
(Fig. 5-1B,C). This deficiency in LTP may correlate with the decreased ability to acquire 
behavioral training, because LTP is typically considered to be one cellular correlate of 
learning. 
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Figure 5-2. Other electrophysioliogical deficits. (A) Resting membrane potential 
and action potential threshold were similar in Wt and KO cells. (B-C) For the 100 pA, 
200 pA and 300 pA injections, average values for the number of action potentials in 
the 100 msec step (B) and latency to fire the first spike (C) are plotted. KO cells only 
fired significantly more action potentials in the 100 pA step (p=0.0499). KO cells fired 
the first spike significantly sooner in the 200 pA and 300 pA steps (p=0.0021 and 
p=0.0045, respectively). (D) There was no significant difference in spontaneous 
EPSC amplitude. (E) There was no difference in the amplitude of evoked EPSCs 
recorded for baseline values in LTP experiments. (F) There was no difference in the 
stimulation strengths used to elicit those responses.
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Kalirin7KO electrophysiology in nucleus accumbens 
To determine whether the synaptic aberrations present in the Kal7KO hippocampus also 
extend to the nucleus accumbens, a specialized forebrain structure involved in the 
dopaminergic reward pathway. Involvement of this pathway has been implicated in 
addiction for several drugs of abuse including cocaine. Kal7KO mice show abnormal 
responses to cocaine and other members of the lab were investigating this phenotype 
along with molecular changes in the nucleus accumbens in KAl7KO mice. To gain insight 
into physiological changes that may contribute to baseline differences in nucleus 
accumbens function of KAl7KO mice, I recorded membrane and synaptic responses in 
nucleus accumbens medium spine neurons. Methods for this project were identical to 
those in the previous section. 
Membrane responses to hyperpolarizing and depolarizing current steps elicited changes 
in membrane potential that yielded quantifiable information regarding passive and active 
membrane properties of the patched neuron. There were no differences between 
wildtype and Kal7KO in membrane potential (Fig. 5-3A) or parameters of single action 
potential kinetics (not shown). Membrane resistances were substantially higher for 
medium spiny neurons compared to hippocampal pyramidal neurons. There was a 
significant reduction in the membrane resistance of Kal7KO neurons compared to 
wildtype (Fig. 5-3B). In contrast to the hippocampus, Kal7KO nucleus accumbens 
neurons had capacitance values similar to their wildtype counterparts (Fig. 5-3C). 
Depolarizing current steps elicited action potentials in both medium spiny neurons of 
both genotypes. The interval between the first two action potentials in the train was 
significantly longer in Kal7KO neurons compared to wildtype (Fig. 5-4). Notably, this 
effect was present in both hippocampal CA1 neurons and medium spiny neurons of the 
nucleus accumbens. Therefore, differences in passive membrane properties cannot 
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account for this effect. Spontaneous glutamatergic synaptic activity was also recorded in 
Figure 5-3. Kal7KO nucleus accumbens medium spiny neurons have decreased input 
resistances. Hyperpolarizing current steps elicited changes in membrane potential 
and parameters relating to passive membrane properties were quantified. Plots 
depicting resting membrane potential (RMP) (A), membrane resistance (B), and 
capacitance are plotted (D). The change in voltage caused by 3 hyperpolarizing steps 
(-50 to -150 pA) are depicted for each genotype. N = 15 Wt; 15 KO. * indicates 
p<0.05 between genotypes.  
‐80
‐70
‐60
‐50
‐40
‐30
‐20
‐10
0
‐150 ‐100 ‐50
Ch
an
ge
 in
 Vo
lt
ag
e (
m
V
)
Current Step Amplitude (pA)
* *
‐80
‐70
‐60
‐50
‐40
‐30
‐20
‐10
0
Wt KO
RM
P (
m
V
)
0
100
200
300
400
500
600
Wt KO
Re
si
st
an
ce
 (M
Ω)
0
10
20
30
40
50
60
Wt KO
Ca
pa
ci
ta
nc
e (
pF
)
*
A
C
B
D
Wt
KO
213 
 
 
nucleus accumbens medium spiny neurons (Fig. 5-5). Unlike the hippocampus, there 
was no difference in sEPSC frequency in the nucleus accumbens of wildtype and Kal7KO 
neurons (Fig. 5-5A). There was also no difference in the amplitude of sEPSCs (Fig. 5-
5B). However, the average decay time (to 37% of the maximum) of sEPSCs recorded 
from Kal7KO neurons was prolonged compared to Wt (Fig. 5-5C). This difference also 
enhanced the charge of Kal7KO events as assessed by sEPSC area (Fig. 5-5D). This 
trend in prolonged decay and enhanced charge was also present in sEPSCs recorded 
from hippocampal neurons, but those changes did not reach statistical significance. 
  
Figure 5-4. Prolonged inter-spike-interval in Kal7KO neurons is not region-
specific. Depolarizing current steps elicited action potentials in neurons of both 
genotypes. The time between the peaks of the first 2 action potentials within train 
elicited by 200 and 300 pA 500 ms current steps was measured and compared 
between genotypes in CA1 of the hippocampus (A) and the nucleus accumbens (B). N 
= 15 Wt; 14 KO. * indicates p<0.05 between genotypes.  
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Figure 5-5. Prolonged decay and enhanced charge of spontaneous 
glutamatergic events recorded from Kal7KO medium spiny neurons. sEPSCs 
were recorded at Vholding = -70 mV in medium spiny neurons in the wildtype and 
Kal7KO nucleus accumbens. Plots depicting the average frequency (A), amplitude (B), 
decay time (C) and charge (D) of these events are shown. * indicates p<0.05 
between genotypes. 
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DISCUSSION 
Kal7 plays an essential role in neuronal function in vivo 
A series of in vitro studies demonstrated that Kal7 is necessary for the formation and 
maintenance of dendritic spines (Ma et al., 2003;Ma et al., 2008b). We show here that 
mice lacking Kal7 have deficits severe enough to affect synaptic transmission and 
specific behaviors. Shank1 and Kal7 are essential for dendritic spine formation in vivo 
and in culture, but Kal7KO produces a greater drop in hippocampal spine density than 
Shank1 (15 vs 6%) (Hung et al., 2008), making Kal7 an important model for human 
disease. Mental retardation syndromes are often associated with dysregulation of 
dendritic spines (Benarroch, 2007;Laumonnier et al., 2007). For example, Patau 
syndrome (trisomy 13), Down syndrome (trisomy 21), and fragile X all have alterations in 
the number and shape of dendritic spines (Kaufmann and Moser, 2000;Govek et al., 
2004;Grossman et al., 2006). Understanding why a subset of behaviors is affected by 
loss of Kal7 whereas other learning tasks are not affected should provide new insights 
into signaling.  
Comparing in vitro and in vivo phenotypes  
As observed for other PSD protein knock-out mice (Migaud et al., 1998;Elias et al., 
2006;Varoqueaux et al., 2006), the phenotype of the Kal7KO mouse is less severe than 
would have been predicted from in vitro studies. Several factors may contribute to this 
difference. Most importantly, alternative splicing allows the larger isoforms of Kalirin to 
accumulate in Kal7KO neurons. Lacking the Kal7 exon, the splicing machinery associated 
with Kalirin transcripts would be expected to splice exon 33 to exon 34, creating the 
increased levels of Kal8, Kal9, and Kal12 in total homogenates. The other targeting 
strategy considered, insertion of a stop codon within the Kal7 exon preceding the PDZ 
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binding motif, would have generated a truncated product, complicating analysis in a 
different manner. Because the Sec14p and spectrin-like repeats target Kalirin to 
membranes, the nine copies of Kal7 present at the “typical” synapse in wild-type mice 
may be replaced by six copies of these larger Kalirin isoforms, which could help 
preserve excitatory synapses and alter synaptic function in a region- and context-specific 
manner.  
Recent studies assigning an essential role for Kal7 in activity-dependent activation of the 
Rac and N-cadherin/afadin pathways used an shRNA directed against the spectrin 
repeat region (nucleotides 1229–1250; spectrins 2–3) (Xie et al., 2007;Xie et al., 2008), 
reducing expression of all major forms of Kalirin, not just Kal7. Although this approach 
led to the conclusion that Kal7 regulates the GluR1 content of pyramidal neuron dendritic 
spines and AMPA receptor-mediated synaptic transmission (Xie et al., 2007), the GluR1 
content of PSDs purified from Kal7KO neurons is indistinguishable from wild-type. 
Selective elimination of Kal7 using antisense or shRNA targeted to its unique 3′-
untranslated region (Ma et al., 2008b) produced a more profound decrease in spine 
density (approximately two-fold) than observed in cultures prepared from Kal7KO mice. A 
Kal7-specific shRNA would not be expected to increase levels of the larger kalirin 
isoforms; in addition, breakdown products generated from Kal7 transcripts targeted by 
the shRNA could contribute to the effects observed (Kim and Rossi, 2008).  
Spine and plasticity analysis 
Ultrastructural analyses demonstrated a substantial decrease in the number of synapses 
(PSD with presynaptic terminal) in CA1 hippocampal neurons from Kal7KO mice. Our cell 
culture data showed a similar decline in synapses assessed as Vglut1/PSD-95 clusters. 
Golgi staining revealed a less dramatic decrease in linear spine density. Although 
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Vglut1-positive terminals in wild-type neurons usually align with PSD-95 clusters, this 
strict association is lost in Kal7KO neurons. Neither unpaired spine-like structures nor 
unpaired presynaptic endings would be counted by EM analysis. The PSDs in Kal7KO 
mice were narrower and thinner than in wild-type mice. These changes in PSD 
dimensions were consistent and comparable with changes seen in Shank1KO mice 
(Hung et al., 2008).  
Unlike pyramidal neurons in the hippocampus, medium spiny neurons in the nucleus 
accumbens have normal dendritic spine densities. The electrophysiological data 
presented here, including normal capacitance and sEPSC frequency, are consistent with 
this in distinguishing nucleus accumbens recordings from those in the hippocampus. 
Thus these electrophysiological studies in Kal7KO mice substantiate the biochemical 
analyses in these respective brain regions.  
Tracking the development of synapses in cortical cultures prepared from Kal7KO mice 
was revealing. Both in vivo and in culture, synapses begin to form before Kal7 is 
expressed. Synaptic development proceeded normally for 21 d in the absence of Kal7; 
Vglut1-positive presynaptic endings contacted dendritic shafts aligned with PSD-95 
clusters. Although spine density increased between DIV21 and DIV28 in wild-type 
neurons, no increase was observed in Kal7KO neurons; it is not clear what distinguishes 
the spines formed between P21 and P28. Kal7 may play an essential role in the 
maturation and/or maintenance of dendritic spines, as proposed for the neuroligins 
(Varoqueaux et al., 2006). Consistent with the conclusion that Kal7 has a role late in 
synaptic development, no differences in LTP were apparent when slices from P21 and 
younger mice were examined. When synaptic plasticity was tested in Kal7KO mice older 
than P28, deficits were apparent.  
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Although PSD length and width were reduced in Kal7KO mice, the effect was small, 
consistent with our inability to see dramatic changes in PSD content of a number of 
proteins. Indeed, similar results have been seen with other PSD-protein knock-outs. 
Ablation of PSD-95 caused no change in spine volume, but made spines longer and 
thinner and decreased the number of AMPA receptors (Beique et al., 2006;Elias et al., 
2006). Knock-out of Shank1, which caused a decrease in spine number and PSD size, 
decreased levels of GKAP (guanylate kinase-associated protein) and Homer and 
weakened basal synaptic transmission, leaving synaptic plasticity unaltered (Hung et al., 
2008).  
Potential mechanisms 
Determining how the absence of Kal7 causes these changes in spine number and 
synaptic function will require detailed analysis of the deficits. Kal7KO PSDs contained 
less Cdk5 and less NR2B than wild-type PSDs. Cdk5 plays a complex and important 
role in postsynaptic signaling and architecture (Benavides and Bibb, 2004;Cheung et al., 
2006;Cheung and Ip, 2007) and the decrease in Cdk5 may contribute to many of the 
changes observed. For example, the GEF activity of Kal7 is increased after Cdk5-
catalyzed phosphorylation of Thr1590 (Xin et al., 2008). Although Kal7 with either a T1590A 
or T1590D mutation caused spine formation when expressed in rat cortical neurons, spine 
morphologies differed (Xin et al., 2008). Based on the fact that dominant-negative Cdk5 
blocked the ability of Kal7 to affect PC12 cell morphology, this interaction appears to 
play a critical role in Kalirin function.  
Like Kal7, the Cdk5/p35 complex affects Rac/Pak signaling (Nikolic et al., 1998), which 
alters cytoskeletal dynamics in dendritic spines (Tashiro et al., 2000). Through its effects 
on ephrins, the decreased Cdk5 in Kal7KO PSDs may contribute to the dearth of dendritic 
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spines. Cdk5 plays a role in EphA-dependent spine retraction (Fu et al., 2007), whereas 
Kal7 plays a role in EphB-dependent spine maturation (Penzes et al., 2003). Cdk5 
phosphorylates PSD-95, regulating its clustering (Morabito et al., 2004), which might 
contribute to the changes in PSD size and shape seen in Kal7KO mice. Importantly, Cdk5 
plays a role in the phosphorylation of NR2B, resulting in its stabilization in the membrane 
(Zhang et al., 2008). The decreased levels of Cdk5 in Kal7KO PSDs may cause the 
decreased levels of NR2B. Additional studies are underway to determine how Kal7 and 
Cdk5 interact to contribute to the changes observed in Kal7KO mice.  
Kal7 is essential for specific memory processes 
Given the spine changes seen in mental retardation and the role of dendritic spines in 
memory formation (Benarroch, 2007), it is not surprising that Kal7KO animals exhibit 
learning deficits. Although numerous knock-out mice have demonstrated deficits in 
hippocampal learning processes, few have revealed disparities in appetitive spatial and 
aversive contextual hippocampal-dependent learning paradigms (Bach et al., 1995;Hung 
et al., 2008). It has been posited that different mechanisms underlie single-trial versus 
more gradual repetitively learned tasks (Bach et al., 1995;Hung et al., 2008). The Kal7KO 
mice were normal in nonaversive tests of learning and memory (object recognition, radial 
arm maze), but abnormal in tests of anxiety and fear learning (elevated zero maze, 
passive avoidance). Perhaps specific proteins or signaling pathways are essential for the 
formation/function of synapses necessary for particular types of learning (e.g., fear 
learning) but not others (e.g., spatial learning). The hypothesis that specific synapses or 
molecular pathways underlie different forms of hippocampal memory was put forth 
previously (Bach et al., 1995), but has received little additional investigation. Future 
behavioral and neurochemical mapping studies of Kal7KO and Kal7CKO mice will help 
clarify the role of different spine proteins in different types of learning.  
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Kal7 plays a key role in synaptic plasticity and in human psychiatric conditions 
Kal7 is the only RhoGEF specifically trafficked to the PSD (Sheng and Hoogenraad, 
2007) and the only RhoGEF identified in the complex of NR2B-associated proteins 
(Collins et al., 2006). Decreased levels of Kal7 were observed in postmortem cortices 
from schizophrenics and Alzheimer disease patients (Tataki et al., 2005;Hill et al., 
2006;Youn et al., 2007). In addition to the present findings, preliminary studies with 
Kal7KO mice revealed aberrant responses to drugs of abuse and additional deficits in 
synaptic plasticity and cognitive function. Kal7KO mice have now emerged as a valuable 
model for understanding synaptic malfunctions and human psychiatric disorders. 
 
 
221 
 
 
REFERENCE LIST 
Bach ME, Hawkins RD, Osman M, Kandel ER, Mayford M (1995) Impairment of spatial 
but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal 
LTP in the range of the theta frequency. Cell 81:905-915. 
Beique JC, Lin DT, Kang MG, Aizawa H, Takamiya K, Huganir RL (2006) Synapse-
specific regulation of AMPA receptor function by PSD-95. pnas 103:19535-19540. 
Benarroch EE (2007) Rho GTPases: role in dendrite and axonal growth, mental 
retardation, and axonal regeneration. Neurology 68:1315-1318. 
Benavides DR, Bibb JA (2004) Role of cdk5 in drug abuse and plasticity. nyas 1025:335-
344. 
Cheung ZH, Fu AKY, Ip NY (2006) Synaptic roles of cdk5: implications in higher 
cognitive functions and neurodegenerative diseases. Neuron 50:13-18. 
Cheung ZH, Ip NY (2007) The roles of cyclin-dependent kinase 5 in dendrite and 
synapse development. Biotech J 2:949-957. 
Collins MO, Husi H, Yu L, Brandon JM, Choudhary JS, Grant SGN (2006) Molecular 
characterization and comparison of the components and multiprotein complexes in the 
postsynaptic proteome. J Neurochem 97 Suppl 1:16-23. 
Elias GM, Funke L, Stein V, Grant SGN, Bredt DS, Nicoll RA (2006) Synapse-specific 
and developmentally regulated targeting of AMPA receptors by a family of MAGUK 
scaffolding proteins. Neuron 52:307-320. 
Fu WY, Chen Y, Sahin M, Zhao XS, Shi S, Greenberg ME, Ip NY (2007) Cdk5 regulates 
EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. 
Nature Neurosci 10:67-75. 
Govek EE, Newey SE, Akerman CJ, Cross JR, Van der Veken L, Van Aelst L (2004) 
The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine 
morphogenesis. Nature Neurosci 7:364-372. 
Grossman AW, Aldridge GM, Weiler IJ, Greenough WT (2006) Local protein synthesis 
and spine morphogenesis: Fragile X syndrome and beyond. J Neurosci 26:7151-7155. 
Harris KM, Stevens JK (1989) Dendritic spines of CA 1 pyramidal cells in the rat 
hippocampus: serial electron microscopy with reference to their biophysical 
characteristics. J Neurosci 9:2982-2997. 
Hill JJ, Hashimoto T, Lewis DA (2006) Molecular mechanisms contributing to dendritic 
spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 
11:557-566. 
222 
 
 
Hung AY, Futai K, Sala C, Valtschanoff JG, Weinberg RJ, Sheng M (2008) Smaller 
dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice 
lacking Shank1. J Neurosci 28:1697-1708. 
Inoue M, Hashimoto Y, Kudo Y, Miyakawa H (2001) Dendritic attenuation of synaptic 
potentials in the CA1 region of rat hippocampal slices detected with an optical method. 
Eur J Neurosci 13:1711-1721. 
Kauer JA, Malenka RC (2007) Synaptic plasticity and addiction. Nature Rev Neurosci 
8:844-858. 
Kaufmann WE, Moser HW (2000) Dendritic anomalies in disorders associated with 
mental retardation. Cereb Cortex 10:981-991. 
Kim DH, Rossi JJ (2008) RNAi mechanisms and applications. Biotechniques 44:613-
616. 
Laumonnier F, Cuthbert PC, Grant SGN (2007) The role of neuronal complexes in 
human X-linked brain diseases. Am J Hum Genet 80:205-220. 
Ma XM, Huang JP, Wang Y, Eipper BA, Mains RE (2003) Kalirin, a multifunctional Rho 
GEF, is necessary for maintenance of hippocampal pyramidal neuron dendrites and 
dendritic spines. J Neurosci 23:10593-10603. 
Ma XM, Wang Y, Ferraro F, Mains RE, Eipper BA (2008) Kalirin-7 Is an Essential 
Component of both Shaft and Spine Excitatory Synapses in Hippocampal Interneurons. 
J Neurosci 28:711-724. 
Mainen ZF, Carnevale NT, Zador AM, Claiborne BJ, Brown TH (1996) Electrotonic 
architecture of hippocampal CA1 pyramidal neurons based on three-dimensional 
reconstructions. J Neurophysiol 76:1904-1923. 
Migaud M, Charlesworth P, Dempster M, Morrison JH, O'Dell TJ, Grant SGN (1998) 
Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic 
density-95 protein. Nature 396:433-439. 
Morabito MA, Sheng M, Tsai L-H (2004) Cyclin-dependent kinase 5 phosphorylates the 
N-terminal domain of the postsynaptic density protein PSD-95 in neurons. J Neurosci 
24:865-876. 
Nikolic M, Chou MM, Lu W, Mayer BJ, Tsai LH (1998) The p35/Cdk5 kinase is a neuron-
specific Rac effector that inhibits Pak1 activity. Nature 395:194-198. 
Penzes P, Beeser A, Chernoff J, Schiller MR, Eipper BA, Mains RE, Huganir RL (2003) 
Rapid induction of dendritic spine morphogenesis by trans-synaptic ephrinB-EphB 
receptor activation of the Rho-GEF kalirin. Neuron 37:263-274. 
Sheng M, Hoogenraad CC (2007) The postsynaptic architecture of excitatory synapses: 
a more quantitative view. Annu Rev Biochem 76:823-847. 
223 
 
 
Tashiro A, Minden A, Yuste R (2000) Regulation of dendritic spine morphology by the 
rho family of small GTPases: antagonistic roles of Rac and Rho. Cerebral Cortex 
10:927-938. 
Tataki M, Paek M, Kamiya A, Balkissoon R, Tomoda T, Penzes P, Sawa A (2005) 
Disrupted-in-schizophrenia-1 (DISC1) binds to Kalirin-7 and modulates its function as a 
GDP/GEP exchange factor. Soc Neurosci Abstracts674.9. 
Varoqueaux F, Aramuni G, Rawson RL, Mohrmann R, Sudhof TC, Brose N (2006) 
Neuroligins determine synapse maturation and function. Neuron 51:741-754. 
Xie Z, Photowala H, Cahill ME, Srivastava DP, Woolfrey KM, Shum CY, Huganir RL, 
Penzes P (2008) Coordination of synaptic adhesion with dendritic spine remodeling by 
AF-6 and Kalirin-7. J Neurosci 28:6079-6091. 
Xie Z, Srivastava DP, Photowala H, Kai L, Surmeier J, Penzes P (2007) Kalirin-7 
controls activity-dependent structural and functional plasticity of dendritic spines. Neuron 
56:640-656. 
Xin X, Wang Y, Ma XM, Rompolas P, Keutmann HT, Mains RE, Eipper BA (2008) 
Regulation of kalirin by cdk5. jcs 121:2601-2611. 
Youn HS, Jeoung MK, Koo YB, Ji H, Markesbery WR, Ji I, Ji TH (2007) Kalirin is under-
expressed in Alzheimer's Disease hippocampus. J Alzheimers Disease 11:385-397. 
Zhang S, Edelmann L, Liu J, Crandall JE, Morabito MA (2008) Cdk5 regulates the 
phosphorylation of 1472 NR2B and the surface expression of NMDA receptors. J 
Neurosci 28:415-424. 
Zhou WL, Yan P, Wuskell JP, Loew LM, Antic SD (2008) Dynamics of action potential 
backpropagation in basal dendrites of prefrontal cortical pyramidal neurons. Eur J 
Neurosci 27:923-936. 
 
 
  
224 
 
 
 
 
 
 
 
 
 
 
CHAPTER 6: Future directions 
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Demonstrating causality of Cu mishandling in PAM+/- emotional dysregulation 
The data presented in Chapter 3 strongly suggest that alterations in Cu homeostasis 
underlie the PAM+/- deficits in emotionality, learning and memory. Through the pursuit of 
these mechanisms, we have uncovered several novel and interesting aspects of Cu 
usage in the brain. Moreover, we have shown that region-specificity and subcellular 
distribution of molecules that bind and transport Cu across membranes are likely to be 
important to normal neuronal/synaptic function with alterations resulting in behavioral 
consequences. While PAM+/- mice exhibit abnormal central and peripheral Cu handling 
(Chapter 3)(Bousquet-Moore et al., 2010b), a direct link between these abnormalities 
and the physiological and behavioral deficits observed in these mice has yet to be 
shown. Possible alternative explanations include abnormal neuropeptide signaling, 
developmental abnormalities, and disruptions of catecholaminergic signaling. One 
important future direction is to test the hypothesis that there is a causal relationship 
between disrupted Cu handling and the neurophysiological and behavioral dysfunction. 
To do this, PAM and other molecules essential to Cu handling must be selectively 
targeted.   
One effective contemporary approach is conditional knockout of PAM and ATP7A using 
the Cre/lox system. By flanking an early and essential exon of a gene with loxP sites, 
expression of that gene can be selectively targeted for deletion with great experimental 
control. Crossing heterozygote or homozygote floxed animals with transgenic mice 
expressing Cre under cell- or tissue-specific promoters will selectively target the gene of 
interest. Alternatively, injection of a virus encoding Cre recombinase into specific brain 
regions can selectively target floxed genes. Behavioral and physiological comparisons 
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between targeting conditions within floxed mice will demonstrate specific causal 
relationships.  
One interesting avenue for this approach involves conditionally knocking out ATP7A 
expression in bilateral basolateral amygdalae via viral-mediated Cre expression driven 
by the CamKII or GAD65 promoter. This should selectively impair the ability of pyramidal 
neurons or interneurons of the basolateral complex to secrete Cu through an ATP7A-
dependent process. Based on the data presented in Chapter 3, we expect that impairing 
Cu secretion will abolish LTP at thalamic amygdalar synapses and impair cue-
dependent fear conditioning. It will be interesting to see whether this effect arises from 
targeting the ATP7A knockout to pyramidal neurons or interneurons.  
Another advantage of using the viral-mediated knockout system is that it provides the 
ability to make within subject comparisons. Animals could be run through two different 
discrete fear learning tasks (e.g. one involving a light and the other a tone). Mice could 
receive an infusion of virus encoding Cre recombinase into the amygdala before the 
second test and performance compared to mice that had completed the task before virus 
injection. This type of analysis provides substantial power in determining causality, 
assuming the proper controls are performed. A pharmacological approach to these 
studies could involve acute injection of the Cu-specific chelator BCS into the amygdala 
prior to fear conditioning.  Based on our slice recordings, we predict that ATP7A 
knockout or BCS injection in the amygdala will impair the expression of fear associations 
learned after treatment and spare those learned before. 
Furthering our understanding of Cu signaling in the amygdala is highly pertinent to 
several neurological and psychiatric disorders in humans including epilepsy, anxiety, 
post-traumatic stress disorder (PTSD), Alzheimer’s disease, and prion-related diseases. 
227 
 
 
In the case of PTSD, the role of Cu in amygdala memory formation could be taken to a 
clinical level. It has been proposed by others that pharmacological agents could be used 
during therapy sessions to target synapses representing the traumatic memory. During 
recall, these synapses are temporarily rendered labile. Cu chelators, such as trientine or 
disulfiram which are already FDA approved for use in Wilson’s disease and alcohol 
dependence, respectively, could be candidates for one of these therapeutic agents for 
PTSD if the connection between amygdalar Cu and fear learning and memory can be 
further validated (see above).  
Does amygdalar Cu go beyond fear? 
We have shown that amygdalar Cu is important for fear-related behaviors and anxiety-
like behavior (Chapter 3), but this is only one face of amygdalar function. The amygdala 
also plays essential roles in mediating appetitive behaviors, reward and social 
interactions. Autism spectrum disorders comprise a heterogeneous class of CNS 
illnesses with neurological and psychiatric manifestations that are often associated with 
deficits in learning/memory, emotionality and social interactions. While many studies 
have asked whether alterations in amygdalar function are associated with autism, few 
have explored a connection with Cu homeostasis. A connection between autism and 
oxidative stress has been proposed (Chauhan and Chauhan, 2006), and the ratio of 
serum Cu to Zn is elevated in autistic patients (Faber et al., 2009). One study suggested 
that Cu levels are elevated in the hair of autistic patients, but a more recent meta-
analysis disproved this assertion (De Palma et al., 2011). Probing for changes in the 
periphery or at the level of the whole brain will not necessarily yield relevant information. 
For example, PAM+/- mice do not show altered levels of total brain Cu but clearly display 
region-specific alterations in Cu homeostasis with profound behavioral correlates 
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(Chapters 2 and 3). In addition, given the broad spectrum and multifactorial 
pathogenesis of autism spectrum disorders, it is difficult to rule out a possible connection 
with amygdalar Cu that may be relevant to a subset of autistic cases. 
Social interaction behavioral testing is simple to perform, and properly done analyses 
provide objective measures. Evaluation of social interaction in PAM+/- mice and/or in a 
model of amygdala-specific knockout of ATP7A would yield valuable information 
regarding the role of amygdalar Cu in mediating social interactions. Again, the 
pharmacological approach of using BCS injection directly into the amygdala just prior to 
testing could substantiate findings made in transgenic models. The hypothesis is that 
mice with deficient Cu signaling in the amygdala will show reductions in social interaction 
behaviors.  
Altering Cu homeostasis with neuronal excitation 
Studies in cultured neurons demonstrated that calcium influx in response to neuronal 
activity induced up-regulation of ATP7A and shifted ATP7A into dendrites (Schlief et al., 
2005;Dodani et al., 2011). This phenomenon has only been demonstrated in cultured 
neurons, never in vivo. Seizure activity induced by electroconvulsive shock should 
produce extensive, broad and coordinated neuronal activation. Mice sacrificed 1, 3, 6 
and 12 hours after shock could be analyzed in order to determine whether a similar 
response occurs in vivo and its time-course. Based on in vitro data, we would expect 
ATP7A mRNA levels and the ATP7A protein levels to increase with shock. It may also 
be possible to observe insertion of ATP7A into the PSD of synapses at earlier time-
points, perhaps allowing synaptic release of Cu.  
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This same experimental design could be extrapolated to a behaviorally-relevant model. 
Specifically, shifts in ATP7A expression and localization may be detectable in the 
amygdala following fear conditioning. It may also be interesting to determine whether 
PAM heterozygosity affects the response of ATP7A expression and localization to shock 
or fear training. We would expect fear conditioning to affect ATP7A expression and 
localization in the same way as ECS. Whether PAM+/- ATP7A is affected in the same 
way will also provide valuable insight into how PAM+/- amygdala synapses are altered. 
Data from PAM+/- cortex suggests that ATP7A is abnormally distributed at baseline. A 
lack of ATP7A response in the amygdala to fear conditioning could indicate 
abnormalities in mechanisms upstream that trigger changes in ATP7A. The number of 
neurons incorporated into a fear memory trace has been estimated to be at or below 
20% (Reijmers et al., 2007;Zhou et al., 2009). Admittedly, detection of these changes in 
a small subset of amygdala neurons may not be possible using these methods. Stronger 
fear conditioning training protocols may be needed to elicit detectable changes at the 
level of the whole amygdala.  
Elucidating the essential role of Cu at amygdala afferent synapses 
Inclusion of BCS in the perfusate completely eliminated LTP induced by AP pairing in 
the amygdala independent of GABAergic transmission (Chapter 3). The AP pairing 
induction protocol used in these studies was previously shown to be VGCC-dependent 
and NMDA receptor-independent (Bauer et al., 2002). It would be interesting to 
determine whether BCS also abolishes NMDA receptor-dependent LTP. This could be 
tested using a theta burst stimulation paradigm. PAM+/- mice are deficient in theta burst-
induced LTP at thalamic afferent synapses of the amygdala (Chapter 2). Consistent with 
our hypothesis that the PAM+/- phenotype results from impaired Cu signaling, we would 
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expect that NMDA receptor-dependent LTP is impaired bath application of BCS. On the 
other hand, NMDA receptor function is inhibited by Cu (Schlief et al., 2006), so removal 
of endogenous extracellular Cu may enhance NMDA receptor-dependent LTP.  
Shin and colleagues (Shin et al., 2010) recently characterized two induction protocols 
that selectively induce pre- and post-synaptic forms of LTP. With different mechanisms 
of LTP expression, these two induction protocols should be extremely helpful in 
narrowing down the LTP signaling pathway for which Cu is required.   
Several signaling pathways have been characterized at thalamic afferent synapses 
important for LTP induction and maintenance. These include cAMP-PKA signaling 
(Huang and Kandel, 1998) and NO-cGMP-PKG signaling (Ota et al., 2008) pathways. 
Cell-permeable stable analogs of cAMP and cGMP, 8-Br-c(A/G)MP, can lower the 
threshold for LTP at amygdala afferent synapses when present in the perfusate. It would 
be interesting to test whether these analogs have the same effect in the presence of 
BCS. If the efficacy of one is impaired with BCS, it would suggest that Cu signaling is 
involved in that signaling pathway and not the other. If the efficacy of both analogs is 
impaired with BCS, it would suggest that secreted Cu is involved in the initiating signals 
and/or induction of LTP upstream of cyclase activation.  
MMP9 and BDNF may also be involved in LTP induction through a mechanism involving 
Cu (Chapter 1). Previous studies connecting Cu to MMP9 and BDNF were performed in 
the hippocampus, but BDNF signaling is also known to play a role in amygdala-
dependent learning and memory (Rattiner et al., 2005). MMP9 and BDNF are sufficient 
to induce LTP in the hippocampus. If extracellular Cu is required for MMP9- and/or 
BDNF-induced LTP, neither compound will be active in the presence of BCS. Assuming 
the mechanism of MMP9/BDNF-dependent LTP in the amygdala is similar to the 
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hippocampus, we would expect MMP9-LTP to be sensitive to BCS and BDNF-LTP not to 
be sensitive. This result would confirm an essential role for Cu in facilitating MMP9 
activity, thus enhancing BDNF cleavage, release and receptor binding (see Chapter 1).  
Assessment of hippocampal function in PAM+/- mice 
Neurophysiological and behavioral testing of PAM+/- mice has focused on the amygdala 
up to this point. No behavioral tests have been conducted to directly assess the status of 
hippocampal function in this mouse model. PAM+/- mice are deficient in contextual fear 
conditioning, a behavioral learning task that requires the hippocampus. The majority of 
neurophysiological studies concerning Cu have been performed in hippocampal 
neurons. Thus information regarding the status of PAM+/- hippocampal function could be 
interpreted in the context of a broad foundation of knowledge regarding potential 
neurophysiological mechanisms.  
Tests of hippocampal function typically involve components testing spatial learning and 
memory. Tests such as the Barnes and Morris water mazes use negative reinforcement 
to motivate the animal to a “safe” area. In the Barnes maze, mice are motivated to 
escape an open area through holes surrounding the open area. The animals must use 
spatial memory to recognize which holes lead to a drop box to escape more efficiently. 
In the Morris water maze, mice are placed in murky water and forced to swim until they 
reach a hidden platform. The mice must rely on spatial cues to find the platform faster on 
subsequent days. Importantly, the anxiety-like phenotype of PAM+/- mice (Chapter 2) 
may confound the animal’s performance in these tasks through a stronger motivation to 
escape the open area or find the platform in the Barnes and Morris mazes, respectively. 
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Thus hippocampal tests that do not use negative reinforcement are better suited to 
testing hippocampal function in PAM+/- mice. 
The radial arm maze should allow evaluation of hippocampal function in PAM+/- mice. In 
this task, mice must find food at the end of discrete arms of the maze labeled with 
different symbols. Mice must use these symbols to locate the food more efficiently. Food 
provides positive reinforcement to motivate animals to learn. However, it is important to 
show that hunger is an equally motivating factor for PAM+/- and wildtype mice. In an 
unrelated experiment not mentioned in this body of work, I tested feeding and satiety in 
PAM+/- mice. Since many neuropeptides, including vasoactive intestinal peptide and 
cholecystokinin, are involved in signaling hunger and satiety in mammals, I hypothesized 
that hunger and satiety signaling would be altered in PAM+/- mice. I removed wildtype 
and PAM+/- littermate females from their normal ad libitum feeding schedule and gave 
them free access to food for only 1 h per day. I monitored the weight of each animal and 
the food consumed over the 5 days on the diet. All mice lost weight and consumed more 
food each day as the experiment progressed. PAM+/- weight loss and food consumption 
over the 5 days were indistinguishable from that of wildtype mice, suggesting normal 
hunger and satiety signaling in PAM+/- mice. These results serve as an important control 
for testing hippocampal function of PAM+/- mice in the radial arm maze.  
If radial arm maze performance is impaired in PAM+/- mice, it would suggest that the 
synaptic plasticity deficits in the amygdala that correlate with fear learning and memory 
deficits can be extrapolated to hippocampal synapses. If not, it suggests that normal 
PAM levels are not required for normal hippocampal function. In either case, synaptic 
plasticity should be assessed at Schaffer-CA1 synapses using NMDA receptor-
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dependent and -independent LTP induction protocols. The role of endogenous secreted 
Cu in hippocampal LTP should also be tested using bath-applied BCS (Chapter 3). 
Uncovering the mechanism underlying the anxiolytic effects of TRH 
During the summer of 2009, I hosted 3 students from Farmington High School in our lab. 
We were to complete a small project for them to present at the end of two weeks. I 
chose a simple project aimed at investigating the effect of an amidated peptide, 
thyrotropin releasing hormone (TRH; pyro-Glu-His-Pro-NH2) on GABAergic transmission 
in the amygdala. Behaviorally, TRH has a potent anxiolytic effect in mammals 
(Yarbrough et al., 2007;Gutierrez-Mariscal et al., 2008) and TRH receptor 1 deficient 
mice exhibit increased anxiety-like behavior (Zeng et al., 2007). However, the 
neurophysiological effects of TRH in the amygdala, a region of the brain involved in 
anxiety-like emotional behaviors, have never been investigated and published. Only one 
study investigated the effects of TRH on limbic GABAergic signaling; TRH enhanced 
GABAergic signaling in the hippocampus (Deng et al., 2006).  
In the summer project, we recorded spontaneous and evoked IPSCs in BLA pyramidal 
neurons as 1 or 10 µM TRH was applied through the perfusate. We found a robust 
enhancement of evoked IPSC responses when TRH was applied. These experiments 
were performed in a small number of neurons and were never replicated. A proper study 
of the effects of TRH on synaptic transmission and membrane excitability would be 
simple to complete and would provide valuable insight into the potential neural 
mechanisms underlying TRH-mediated anxiolysis. 
Whole-cell patch clamp recordings should focus on pyramidal neurons of the BLA. 
Membrane properties can be tested through episodic current step application to initiate 
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action potential firing. A sensitive way to monitor synaptic function is by recording at 
Vholding = -35 mV while stimulating afferent fibers. This allows simultaneous monitoring of 
excitatory and inhibitory signals. Lidocaine should be added to the pipette solution to 
avoid synaptically evoked voltage-gated Na currents. The stimulating electrode should 
be placed in the LA to record intra-amygdaloid signaling. In separate experiments 
monitoring membrane or synaptic transmission, TRH should be bath applied as it was 
previously. These two experiments should be very sensitive to any effects of TRH. 
Additional experiments would be needed to pursue the effects of TRH on particular 
currents in the case of membrane excitability or particular synapses in the case of 
synaptic function.  
 
  
 
